Next Article in Journal
Quercetin Attenuates Acetaldehyde-Induced Cytotoxicity via the Heme Oxygenase-1-Dependent Antioxidant Mechanism in Hepatocytes
Previous Article in Journal
Effects of Fasting on THP1 Macrophage Metabolism and Inflammatory Profile
Previous Article in Special Issue
The Potential of Korean Bioactive Substances and Functional Foods for Immune Enhancement
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Brassicaceae Mustards: Phytochemical Constituents, Pharmacological Effects, and Mechanisms of Action against Human Disease

by
Mahmudur Rahman
1,2,
Amina Khatun
1,2,
Lei Liu
2 and
Bronwyn J. Barkla
2,*
1
Southern Cross Analytical Services, Southern Cross University, Lismore, NSW 2480, Australia
2
Faculty of Science and Engineering, Southern Cross University, Lismore, NSW 2480, Australia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(16), 9039; https://doi.org/10.3390/ijms25169039 (registering DOI)
Submission received: 7 July 2024 / Revised: 13 August 2024 / Accepted: 16 August 2024 / Published: 20 August 2024
(This article belongs to the Special Issue Latest Review Papers in Bioactives and Nutraceuticals 2023)

Abstract

:
The Brassicaceae genus consists of many economically important mustards of value for food and medicinal purposes, namely Asian mustard (Brassica juncea), ball mustard (Neslia paniculata), black mustard (B. nigra), garlic mustard (Alliaria petiolata), hedge mustard (Sisymbrium officinale), Asian hedge mustard (S. orientale), oilseed rape (B. napus), rapeseed (B. rapa), treacle mustard (Erysimum repandum), smooth mustard (S. erysimoides), white ball mustard (Calepina irregularis), white mustard (Sinapis alba), and Canola. Some of these are commercially cultivated as oilseeds to meet the global demand for a healthy plant-derived oil, high in polyunsaturated fats, i.e., B. napus and B. juncea. Other species are foraged from the wild where they grow on roadsides and as a weed of arable land, i.e., E. repandum and S. erysimoides, and harvested for medicinal uses. These plants contain a diverse range of bioactive natural products including sulfur-containing glucosinolates and other potentially valuable compounds, namely omega-3-fatty acids, terpenoids, phenylpropanoids, flavonoids, tannins, S-methyl cysteine sulfoxide, and trace-elements. Various parts of these plants and many of the molecules that are produced throughout the plant have been used in traditional medicines and more recently in the mainstream pharmaceutical and food industries. This study relates the uses of mustards in traditional medicines with their bioactive molecules and possible mechanisms of action and provides an overview of the current knowledge of Brassicaceae oilseeds and mustards, their phytochemicals, and their biological activities.

1. Introduction

Mustards are commonly cultivated worldwide and valued for their oil content in their seeds as well as for the chemical compounds they produce [1]. They are members of the Brassicaceae (syn. Cruciferae) family, commonly known as ‘mustard family’ (Table 1), and have been consumed for centuries as vegetables, and their seeds are used as a spice in condiments and as edible and industrial oils [2]. Rapeseed mustard is one of the highest oil-yielding and high protein-containing crop species, supplying around 20% of world oil production and 12 to 15% of world protein meal production [3,4]. In this study, the species of Brassicaceae that are valued for their oil content in the seed are included, other relevant species were included if they showed similar chemical constituents [1].
Mustards of the Brassicaceae family originated from the Mediterranean to the Middle East with a secondary center of origin in Asia [47]. Among the family members, Brassica nigra was believed to be introduced into Egypt from Asia by Aesculapius, the god of medicine, and Ceres the deity of seeds as both a potential source of food and as medicine [15]. In ancient Greece, the leaves of the young plants were eaten as spinach and the seeds were used as spices and in medicines [48]. Documentation shows that the Greek physicians including Aesculapius and scientists including Pythagoras and Hippocrates exploited the seeds for their healing powers [15,24]. Oceania, comprising the countries of Australia, New Zealand, New Guinea, Micronesia, Melanesia, and Polynesia have one of the oldest living cultural histories in the world, which goes back 50,000–65,000 years. Proof of the consumption of mustards is documented in early literature of this region [1,49,50,51,52,53,54]. Evidence of the antimicrobial effectiveness of mustard were addressed for the first time in the 1880s [55].
“Canola” is the second most important edible oilseed crop globally, second only to soybean [56]. The term Canola includes varieties of Brassica napus and Brassica rapa which are shown to have seed oil with less than 2% erucic acid and low aliphatic glucosinolate (less than 30 µmol/g) developed through selective breeding [1,57]. It is the major oilseed crop in Australia, Brazil, Canada, China, India, Europe, and the United States [58,59]. It contains low pungency, low erucic acid (less than 2% in the USA and 5% in the EU by weight) [60], and low aliphatic glucosinolate (less than 30 µmol/g) in the defatted meal [61,62]. Mustard oil is another high-value oilseed product from this family [11], popular in many Asian countries, which adds a typical hot and spicy flavor to food [16]. Traditional mustard oil or rapeseed oil (colza oil, ravison oil, sarson oil, toria oil, or turnip rape oil) is produced from the seeds of B. napus, B. juncea, Brassica rapa var. campestris, and Brassica tourneforti [63].
With the advent of new “omics” technologies focusing on the detection of genes (genomics), mRNA transcripts (transcriptomics), proteins (proteomics), and metabolites (metabolomics), new insights on the constituents of rapeseed and mustard, along with bioactivity data, have been reported [64,65,66,67,68,69]. The genome of B. juncea var. ‘tumida’ was first assembled in 2016 [70]. We reported shotgun proteomic analysis for B. rapa seeds for the first time which identified and catalogued 323 seed proteins [57,71]. Combining this proteomic data with other genomic datasets developed at Southern Cross University, a new reference genome was reported for Brassica rapa subsp. trilocularis R-o-18 and is deposited in the NCBI GenBank data base (accession GCA_017639395.1) and is being processed to appear in the EMBL-EBI Ensembl Plant Genome portal [72]. In this review, current knowledge of Brassicaceae mustards, their phytochemicals, and the biological activities of these compounds is discussed.

2. Phytochemical Constituents of Mustards

Mustard seeds are composed mostly of oil (28–42%), followed by protein (25–40%), carbohydrate (15–35%), fiber (10–15%), minerals (5–10%), and plant secondary metabolites (up to 10%), including glucosinolates, phenolic compounds, and tannins [59,73,74]. Plants accumulate secondary metabolites as a tolerance response to biotic and abiotic stress [75,76]. Mustard secondary metabolites are exploited for therapeutic purposes for their wide range of bioactivities [77,78,79,80,81].

2.1. Oil and Fatty Acids

Mustard seed oil is composed mainly of lipids in the form of triacylglycerides (Table 2), including the three major fatty acid types: saturated fatty acids (SFA; around 7–12%), monounsaturated fatty acids (MUFA; 15 to 65% of total fatty acid, depending on variety), and polyunsaturated fatty acids (PUFA; around 8–40% of total fatty acid, depending on variety) [18,22,82,83,84,85,86,87]. MUFAs consist mainly of erucic acid (C22:1, 40–50%) and oleic acid (C18:1, 5–12%). PUFAs are primarily linoleic acid (C18:2, 10–15%) and linolenic acid (C18:3, 8–15%), along with other minor fatty acids, namely eicosenoic or gondoic acid (C20:1, 5–10%), nervonic acid (C24:1, 2–8%), palmitic acid (C16:0; 2–5%), docosahexaenoic acid (C22:6, 0.1–1%), and eicosapentaenoic acid (C20:5, 0.1–1%). Linoleic acid is the major short-chained n-6 fatty acid (omega-6 fatty acids); linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid are the main long-chain n-3 polyunsaturated fatty acids (omega-3 fatty acids); and oleic acid, erucic acid, nervonic acid are the commonly occurring n−9 fatty acids (omega-9 fatty acid) [18,22,82,83,84,88]. Different species of mustard and Canola oils, including B. napus, B. rapa, and B. juncea, typically have less SFA, moderate to high MUFA profile, and high n-3 PUFA profile and a low n-6:n-3 PUFA ratio (2:1) [22,89,90]. This lipid profile is considered one of the best amongst vegetable oils in terms of favorable health benefits, which include lowering of blood total cholesterol and low-density cholesterol, decreasing cardiovascular risk, increased insulin sensitivity and glucose tolerance, reduced inflammation, and reduced cancer cell growth [89,91].
Erucic acid is the characteristic monounsaturated long-chain fatty acid (C22:1) of the Cruciferae family and the major acyl component of most cruciferous oilseeds [86,104]. B. rapa var. campestris seeds have the highest erucic acid levels (up to 59% of total fatty acids) [95]. The trans-isomer of this acid is recognized as brassidic acid [105]. Erucic acid was found to be toxic to both rats (>0.7 g/kg body weight per day) [86,90], and humans, following prolonged intake (>7 mg/kg body weight per day), causing the gradual accumulation of lipid droplets known as myocardial lipidosis [105,106,107]. Because of this toxicity, Canola was developed from the designed breeding of several cultivars of B. rapa var. campestris, B. juncea, B. napus, B. rapa, and S. alba, bred through traditional plant-breeding techniques [108,109] and interspecific crossing between low erucic acid containing varieties, inbreeding and selection of low erucic plants within the same variety [92]. Canola (B. napus) was approved by the US Food and Drug Administration (FDA) as GRAS (generally recognized as safe) in 1985 for human consumption [91], however, mustard oil with high erucic acid has industrial applications such as for the formulation of lubricants and manufacturing detergents, plasticizers, polyesters, surfactants, rubber additives, elastic gums and biofuels [86,110].
The potential therapeutic usage of other fatty acids found in mustards and Canola has not been widely tested. For instance, nervonic acid, a low abundant fatty acid in mustard, is found in the white matter of animal brains and is also an important precursor for the biosynthesis of nerve cell myelin (Table 2); and docosahexaenoic acid, an omega-3 fatty acid found in mustard, is a structural element of the cerebral cortex, retina, and skin, but neither are well studied [88,111].
Other important fats and oils in Brassica seeds are diverse membrane lipids, various signaling molecules, namely galacto-oxylipins [112,113]; sterols (100–500 mg sterols/100 g seeds) like beta-sitosterol, stigmasterol, campesterol, and avenasteriol [18,114,115]; brassicasterol (24-methyl cholest-5, 22-dien-3β-ol), a lipid compound exclusive to Brassicaceae [114,116,117,118,119]; and brassinosteroids, classified as a plant hormone, which have very similar chemical structure to animal steroidal hormones and insect ecdysteroids [120,121]. In addition, there are prostaglandins, thromboxanes, and leukotrienes, as well as fat-soluble vitamins including A, D, E (tocopherols), and K (Table 3) [22].

2.2. Glucosinolates

Generally, all mustards have a typical pungent flavor due to the presence of amino acid-derived, sulfur-containing glucosinolates (beta-thioglucoside-N-hydroxysulfates) [132,133]. These are chemically glycosides, formed by decarboxylation on amino acids such as tyrosine, phenylalanine, and tryptophan [134]. All glucosinolates are synthesized from amino acids and sugars and share a common parent structure, consisting of a thioglycoside with a sulfonated aldoxime group that is attached to sugar via a sulfur molecule (Table 4). A side chain derived from amino acids is attached to the aldoxime moiety, which differs in various glucosinolates (Table 4). Nearly 200 individual glucosinolates are known, varying only in their characteristic side chain (Table 4 and Table 5) [134,135], and are classified into three groups—aliphatic, aromatic, and indolic glucosinolates [136]. The most abundant glucosinolates are gluconapin, sinigrin, sinalbin, glucoraphanin, progoitrin, napoleiferin, glucobrassicanapin, and glucobrassicin [8,27,137,138]. Glucosinolates and their relative amounts vary between different Brassica species, cultivars, genotypes, and within plant tissues, being affected by environment and plant age [139,140,141]. Their combined content positively correlates with oil, erucic acid, and soil sulphur content [12,86,93].
Glucosinolates are important chemical defense components that are stored in the vacuoles of Brassica leaf, root, and seed tissue, which when activated safeguard the plant against biotic stress [142,143,144]. External stimuli including tissue disruption, and insect attack compromise cell compartmentation, causing a breakdown in the natural cell partitioning of the glucosinolate from the hydrolytic thioglucosidase enzyme-myrosinase (also known as β-thioglucoside glucohydrolase) [144]. The release of myrosinase acts to hydrolyze the glucosinolate compounds into an organic aglycon (isothiocyanate, thiocyanate, or indole), glucose, and sulfate ions, in the form of potassium bisulfate (Table 4) [145,146]. The organic aglycon may then go through an intermolecular rearrangement reaction following enzyme hydrolysis. This can produce isothiocyanate (R-N=C=S) or spontaneously rearrange to give various products including nitrile (R-C≡N) and sulfur, thiocyanate (R-S-C≡N) or an oxazolidine-thione [134,147,148].
Table 4. The general structure of glucosinolates, their intermediate and final degradation products, and their classification depend upon the structure of their parent amino acid precursors. R is the variable amino acid-derived side chain. Adapted from [46,135,149,150,151,152,153,154].
Table 4. The general structure of glucosinolates, their intermediate and final degradation products, and their classification depend upon the structure of their parent amino acid precursors. R is the variable amino acid-derived side chain. Adapted from [46,135,149,150,151,152,153,154].
Ijms 25 09039 i001
Glucosinolate In the Parent Structure of GSL Above, R = Breakdown Product(s) Structure of Breakdown Product(s)
Aliphatic GSL (Alkenyls derived from methionine)
GlucocapparinCH3-Methyl ITC.CH3—N=C=S (Methyl ITC),
Sinigrin
(Allyl-GSL or 2-propenyl-GSL or potassium myronate, modern name sinigroside, C10H16KNO9S2)
CH2=CH-CH2Allyl ITC (2-Propenyl-ITC), allyl cyanide, 1-cyano-2,3-epithiopropane, allyl thiocyanate and allyl nitrile. After further breakdown, allyl-ITC may produce highly toxic nitriles.CH2=CH-CH2—N=C=S (Allyl ITC),
KHSO4 (Potassium bisulphate),
CH2=CH-CH2-CN (allyl cyanide),
CH2=CH-CH2—S—C≡N (allyl thiocyanate), CH2=CH-CH2—C≡N (allyl nitrile),
Ijms 25 09039 i002
1-cyano-2,3-epithio propane
Gluconapin
(But-3-enyl GSL, C11H19NO9S2)
CH2=CH(CH2)2-
(but-3-enyl or 3-butenyl)
Butyl ITC or 3-butenyl-ITC.CH2=CH(CH2)2—N=C=S (Butyl ITC or 3-butenyl-ITC)
Glucobrassicanapin
(pent-4-enyl GSL, C12H21NO9S2)
CH2=CH(CH2)3-
(pent-4-enyl)
Pent-4-enyl ITC or 4-pentenyl ITC.CH2=CH(CH2)3—N=C=S (Pent-4-enyl ITC or 4-pentenyl ITC)
Glucoiberverin,
(3-methyl thio propyl GSL, C11H21NO9S3)
CH3-S-(CH2)3-
[or CH3-S-CH2-CH2-CH2-]
Iberverin [(3-(methyl thio) propyl ITC, (C5H9NS2)] and iberverin nitrile [4-(methylthio) butane nitrile].CH3-S-CH2-CH2-CH2—N=C=S (Iberverin)
Glucoerucin,
(4-methyl thio butyl GSL, C12H23NO9S3)
CH3-S-(CH2)4- [or CH3-S-CH2-CH2-CH2-CH2-]Erucin [4-(methyl thio) butyl ITC or [isothio cyanato-4-(methyl thio)-butane]CH3-S-CH2-CH2-CH2-CH2—N=C=S (Erucin)
Glucoberteroin
(5-Methyl-thio-pentyl-GSL, C13H25NO9S3)
CH3-S-(CH2)5-5-Methyl-thio-pentyl-ITC.CH3-S-(CH2)5—N=C=S (5-Methyl-thio-pentyl-ITC)
Glucoiberin (3-(methylsulfinyl) propyl GSL, C11H21NO10S3)CH3-SO-(CH2)3Iberin (3-Methyl sulfinyl propyl ITC) or (1-isothiocyanato-3-(methylsulfinyl)-propane) which is the Structural analog of 4-(methyl sulfinyl) butyl isothiocyanate (sulforaphane).CH3-SO-(CH2)3—N=C=S (Iberin)
Glucocheirolin
(3-methyl-sulfonyl-propyl-GSL, C11H21NO11S3)
CH3-SO2-(CH2)3-Cheirolin [3-(methyl sulfonyl) propyl ITC] or 1-ITC-3- (methyl sulphonyl) propane.CH3-SO2-(CH2)3—N=C=S (Cheirolin)
Glucoraphanin
(4-methyl sulfinyl butyl GSL, C12H23NO10S3)
CH3-SO-(CH2)4-Sulforaphane [1-isothiocyanato-(4R)-(methyl sulfinyl) butane] or 4-methyl-sulfinyl-butyl-ITC. CH3-SO-(CH2)4—N=C=S (Sulforaphane)
Glucoalyssin
(5-methyl-sulfinyl-pentyl-GSL, C13H25NO10S3)
CH3-SO-(CH2)5-5-methyl-sulfinyl-pentyl ITC.CH3-SO-(CH2)5—N=C=S (5-methyl-sulfinyl-pentyl ITC)
Progoitrin
(2-hydroxy 3-butenyl-GSL, C11H19NO10S2)
CH2=CH-CH(OH)-CH2-Goitrin [(2R)-2-hydroxy-3-butenyl-ITC or 5-ethenyl-1,3-oxazolidine-2-thione (C5H7NOS)], a cyclic thio-carbamate, unstable ITC and 3-hydroxy-4,5-epithio pentane nitrile.CH2=CH-CH(OH)-CH2—N=C=S
Ijms 25 09039 i003
Epiprogoitrin
(2(S)-hydroxy-3-butenyl GSL, C11H19NO10S2)
CH2=CH-CHOH-CH2-Epiprogoitrin does not break down to stable ITC, a further hydrolysis produces epigoitrin [(R)-5-vinyloxazolidine-2-thione] and finally goitrin.CH2=CH-CH(OH)-CH2—N=C=S
Ijms 25 09039 i004
Glucoalyssin
(5-methyl-sulfinyl-pentyl-GSL, C13H25NO10S3)
CH3-SO-(CH2)5-5-methyl-sulfinyl-pentyl ITC.CH3-SO-(CH2)5—N=C=S (5-methyl-sulfinyl-pentyl ITC)
Glucolepidiin
(Ethyl GSL, C9H17NO9S2)
CH3-CH2-Ethyl isothiocyanate.CH3-CH2—N=C=S (Ethyl isothiocyanate).
1-cyano-2-hydroxy-3-butene (or 2-hydoxybut-3-enyl cyanide, CH2=CH-CHOH-C≡N)- a Nitrile
(R-C≡N)
-3-butenonitrile (2-methyl-3-butenenitrile), 4-methylthiobutanonitrile (4-methylsulfanylbutanenitrile oxide).CH2=CH-CH2-C≡N (3-butenonitrile)
CH3-S-CH2-CH2-C≡N=O (methylthiobutanonitrile)
Indolyl GSLs (Indolyl derivatives from tryptophan)
Glucobrassicin
(3-indolyl methyl GSL, C16H20N2O9S2)
Ijms 25 09039 i005
(3-indolyl methyl-)
Myrosinase breaks down glucobrassicin to 3-indoly-methyl-ITC (unstable) and simultaneously releases thiocynate anion (SCN-) to yield indole-3-carbinol (3-hydroxymethyl-
indole). Indole-3-carbinole can combine with ascorbic acid to form Ascorbigen.
Ijms 25 09039 i006
indole-3-carbinol
Napoleiferin (gluconapoleiferin) (2-hydroxy-4-pent enyl GSL, C6H9NOS); it is a natural homolog of goitrin.R=CH2CH(OH)CH2CH=CH2-
(2-hydroxy-4-pent enyl-)
Oxazolidine-2-thione. Ijms 25 09039 i007
Oxazolidine-2-thione
Neoglucobrassicin
(1-Methoxy-3-indolyl methyl GSL, C17H22N2O10S2)
Hydrolysis yields unsTable 1-methoxy-3-indolyl methyl ITC and thiocyanate ion (SCN).
Aromatic GSL (Arylalkyls derivatives from phenylalanine)
Sinalbin
(C30H42N2O15S2) (p-hydroxy benzyl GSL, sinapine glucosinalbate) or 4/p-hydroxybenzyl GSL or glucosinalbin), the choline ester of sinapic acid
p-OH-C6H4-CH2-Allyl isothiocyanate, and on hydrolysis by myrosinase, produces unstable para hydroxy benzyl ITC. Para hydroxy benzyl ITC can further decomposes to para hydroxyl benzyl alcohol and thiocyanate ion (SCN) and/or corresponding hydroxyl derivatives like di-(para hydroxyl benzyl disulphide). It also produces p-hydroxy benzyl amine known as the ‘white principles’.CH2=CH-CH2—N=C=S (Allyl ITC),
p-OH-C6H4-CH2—N=C=S (para hydroxy benzyl ITC),
p-OH-C6H4-CH2—OH
(para hydroxyl benzyl alcohol),
HO—C6H4-CH2—NH2 [p-hydroxy benzyl amine (4-Hydroxybenzylamine)]
Gluconasturtiin
(2-phenyl ethyl-GSL, C15H21NO9S2)
R=C6H5-CH2-CH2-Phenethyl ITC (2-penyl-ethyl ITC).C6H5-CH2-CH2-N=C=S (Phenethyl ITC)
Glucotropaeolin, Benzylglucosinolate (C14H19NO9S2)R=C6H5-CH2-Benzyl ITC, benzyl cyanide and benzyl thiocyanate.C6H5-CH2-N=C=S (Benzyl ITC)
GSL = Glucosinolate, ITC = Isothiocyanate. Aliphatic glucosinolates are also further classified into three classes (i) three carbon chain length aliphatic glucosinolates (i.e., sinigrin, glucoiberin, and Glucoiberverin), (ii) four carbon chain length aliphatic glucosinolates (i.e., glucoerucin, dehydroerucin, glucoraphanin, glucoraphenin, gluconapin, and progoitrin), and (iii) five carbon chain length aliphatic glucosinolates (i.e., glucoberteroin, glucoalyssin, glucobrassicanapin and gluconapoleiferin) [135].
Table 5. Biological activities of major glucosinolates and their metabolites found in mustards.
Table 5. Biological activities of major glucosinolates and their metabolites found in mustards.
Glucosinolates (GSL)MustardsBiological Activity of GSLs and Their Metabolites (Referred from Table 4)References
Glucosinolates (secondary metabolites)
Sinigrin, allyl glucosinolate (C10H16KNO9S2)Brassica nigra
(1% sinigrin), Sinapis alba, B. rapa var. campestris, B. carinata, B. juncea, Calepina irregularis, Alliaria petiolata, B. rapa, B. napus
Anti-cancer, anti-inflammatory, antibacterial, anti-fungal, antioxidant, and wound healing activity. Allyl-isothiocyanate is responsible for internal and external irritation and local vasodilation. It has been shown to prevent urinary bladder cancer and anti-proliferative activity against human prostate cancer cells. 1-cyano-2,3-epithiopropane has in vitro anti-cancer activity against human hepatocellular carcinoma.[22,31,118,137,146,147,151,155,156,157,158,159,160,161,162,163,164]
Gluconapin, 3-Butenylglucosinolate, Butyl isothiocyanate (C11H19NO9S2)B. rapa var. campestris, B. juncea, B. napus, Sinapis albaTumour inhibiting activity.[22,147,160,165,166,167,168,169]
Glucocheirolin (C11H20NO11S3)Calepina irregularis, Erysimum corinthiumAnti-proliferative activity on cancerous cells. Cheirolin improves cellular antioxidant defense and stress response mechanisms.[31,34,146,155,170]
Glucoraphanin, 4-methylsulphinyl-butyl glucosinolate (C12H23NO10S3)B. rapa var. campestris, B. nigraUsed in the treatment of neurodegenerative disorders as an antioxidant, gastric ulcers caused by Helicobacter pylori; against cancer like fibroblasts and malignant melanoma and employed to improve autism. Sulforaphane is a strong cancer chemopreventive agent both in vitro and in vivo and a potent monofunctional phase II enzyme inducer.[22,24,30,38,155,171,172,173,174,175]
Progoitrin, (R)-2-hydroxybut-3-enylglucosinolate (C11H19NO10S2)Brassica napus, B. rapa var. campestris, B. junceaThyroperoxidase enzyme inhibition and interference with the uptake and use of iodine by the thyroid gland. Anti-cancer effects.[22,147,151,160,165,166,176]
Epiprogoitrin (C11H19NO10S2)Brassica napus, B. olareciaNematicidal activity and insecticidal property as an effective fumigant.[152,177,178]
Glucobrassicanapin, 4-pentenyl glucosinolate (C12H21NO99S2)B. rapa var. campestris, B. napus, B. rapaAnti-cancer activity[22,147,165]
Napoleiferin (C6H9NOS)Brassica rapa, B. oleracea, B. napus, B. rapa var. campestris, B. nigra, B. juncea, B. carinata.Goiterogenic substance.[167,179,180,181,182]
Nitriles R-C≡N
Erucin, 1-isothiocyanato-4-(methylthio)-butayl isothiocyanate (C6H11NS2)Eruca sativa Mill. (rocket).Erucin is a sulfone analog of sulforaphane. It is an enzymatic hydrolysis product of glucoerucin, responsible for the characteristic aroma of broccoli. Chemically, it is the reduced form of sulforaphane. It has antioxidant, neuroprotective, anti-fungal, and anti-inflammatory activities. It has strong cancer chemopreventive activity. It induces apoptosis in cancer cells, exerts antiproliferative effects, and causes cell cycle arrest in cancer cells.[183,184,185,186]
Erucin nitrile (1-cyano-4-(methylthio)butane) may Brassica oleracea var. italica (broccoli)-seeds, sprouts and root Erucin nitrile could be formed in the anaerobic environment of the cecum or by hydrolysis of glucoerucin by reduction of sulforaphane nitrile. Erucin nitrile has potential activity as a phytoalexin, i.e., antimicrobial and antioxidant activities. [183,186]
Sulforaphane nitrile, 5-(methylsulfinyl) pentanenitrile (C6H11NOS)Brassica oleracea var. italica (broccoli) sprouts, Brassica oleracea var. botrytis (cauliflower)Myrosinase cofactor epithiospecifier protein breaks down glucoraphanin to sulforaphane nitrile. Both sulforaphane and sulforaphane nitrile have chemoprotective, antioxidant, and anti-cancer effects, but sulforaphane nitrile is substantially less potent than sulforaphane.[187,188]
Epithionitrile
Ijms 25 09039 i008
Epithionitriles, major hydrolysis products Brassica rapa, B. oleracea, B. napus, B. rapa var. campestris, B. nigra, B. juncea, B. carinata.3-butenonitrile has anti-cancer and antimicrobial activities. 4-methylthiobutanonitrile has a characteristic aroma. 1-cyano-2,3-epithiopropane, and 1-cyano-3,4-epithiobutane, 1-cyano-4,5-epithiopentane have cancer-preventative activities. [189,190,191,192]
Glucoalyssin (C13H25NO10S3)B. rapa var. campestris, B. napus, Degenia velebiticaThe flavor component of cooked Brassicas. It is an antioxidant.[163,193]
Gluconapoleiferin (C12H21NO10S2)B. napus, B. rapa, B. rapa var. campestris, B. juncea, B. nigraTasteless, but hydrolytic, susceptibility to peptic digestion. A precursor to glucobrassicanapin biosynthesis. Thyroid gland function inhibitory effect.[163,194]
Glucolepidiin (C9H17NO9S2)Calepina irregularisAntibacterial activity.[31,146]
Thiocyanates
R-S-C≡N
Glucobrassicin, the unsubstituted indole glucosinolate. (C16H20N2O9S2)B. juncea, B. napusAntioxidant, anti-inflammatory, and anti-cancer activities. It stimulates the bodily natural detoxifying enzymes.[151,160,163,166,167,195,196,197]
Neoglucobrassicin (C17H22N2O10S2)B. napus, S. officinale.Antioxidant and anti-cancer activity.[151,163,195]
Glucoiberin (C11H21NO10S3)B. napus, B. incana, B. oleracea, Calepina irregularis, Erysimum corinthium, Iberis amara, Moringa oleiferaAnti-cancer effects [22,31,34,146,147,151,165]
Glucoiberverin (C11H21NO9S3)Calepina irregularisRepellent and acts against insect herbivory[31,146].
Glucoerucin (C12H23NO9S3)Calepina irregularisInhibition of cancerous cell proliferation.[31,146,155].
Sinalbin, P-Hydroxybenzyl Glucosinolate (C14H19NO10S2)Sinapine is present in all the mustards in different amounts. Chiefly found in white mustard Sinapis alba (2.5% of seed weight) and also reported in B. rapa var. campestris, B. napus B. juncea and B. nigraAntioxidant, anti-microbial, and anti-fungal activity. Sinapine and sinamic acid have antimicrobial, antioxidant, and anti-cancer properties.
[22,28,58,147,157,165,198,199,200]
Isothiocyanates
R-N=C=S
Glucotropaeolin or benzyl glucosinolate, precursor of benzyl isothiocyanate
(C14H19NO9S2)
[C6H5-CH2-GSL]
Alliaria petiolate, B. juncea; B. nigra, Calepina irregularis, Lepidium sativum (garden criss), Sinapis alba. Benzyl isothiocyanate or Glucotropaeolin has potential cancer-preventive activities, anti-tumorigenic (lung and esophagus in humans) activity, and works as an antimetastatic agent. It is also used as a food preservative because of its antimicrobial activity. [31,146,155,160,166,169,201,202,203]
Gluconasturtiin or Phenethylglucosinolate, the precursor of phenethyl isothiocyanate (C15H21NO9S2)B. napus, Nasturtium officinale (watercress) Inhibits the development of tobacco-specific carcinogen-induced lung tumors. [22,147,151,165,201,204]
Sulforaphane, 1-isothiocyanato-4-(methyl-
sulfinyl) butane (C6H11NOS2). Sulforaphane is derived from glucoraphanin.
B. oleracea var. italica (broccoli) sprouts, kale, B. oleracea var. botrytis (cauliflower) or B. oleracea var. gongylodes (kohlrabi)Anticarcinogenic activity by induction of cell cycle arrest and apoptosis in various human cancer cells; antioxidant, antiproliferative, anti-inflammatory, antimicrobial, anti-fungal, and antiviral activities.[79,186,205,206,207]
Indole-3-carbinol, derived from glucobrassicin. (C9H9NO)B. oleracea var. italica (broccoli), B. oleracea var. acephala (kale), Brassica oleracea var. capitata (cabbage) Anti-cancer, antioxidant, and antiatherogenic activities.

2.3. Phenolics and Flavonoids

Hydroxyl group-containing aromatic compounds known as phenolic or polyphenolic compounds represent the most abundant plant secondary metabolites in rapeseed, almost 50% of secondary metabolites, namely phenolic choline esters, predominantly sinapate choline esters [208]. They occur mainly in the form of phenolic acids, flavonoids, and soluble and insoluble condensed tannins [209]. These compounds can be present as free or bound in the form of esters and glycosides. The most abundant free phenolic acid found in oilseed mustards is p-hydroxybenzoic acid [115], whereas sinapic acid, also known as sinapinic acid, a naturally occurring hydroxycinnamic acid, is the most abundant bound phenolic acid (90–95% of the total phenolic acids identified in rapeseed) [210], and is present mainly in the esterified form [59,210]. The choline ester of this short-chain fatty acid is sinapine, an alkaloidal amine (Figure 1), and is an integral component for the biosynthesis of lignin and flavonoids in plants [74]. Oilseeds (excluding Canola) contain 12–15 g sinapine per kilogram of seeds [28]. The other minor phenolics are apigenin (4′,5,7-trihydroxyflavone), syringic acid, 1,2-disinapoylglucose [165,211,212], p-hydroxybenzoic, p-coumaric, trans-ferulic acid, gentisic, gallic, protocatechuic, syringic and vanillic acids (Figure 1) [213,214]. These antioxidant polyphenolics act as a preservative, preventing the reserved oil in the seed from degrading over time [215]. As a consequence of this, they also act as preservatives to counter the rancidity of the extracted oil, preventing it from discoloring and becoming cloudy [216]. Studies indicate that seed roasting reduces the amount of phenolic compounds in mustard seeds and increases the oxidative stability [217,218,219].
Flavonoids are composed of a fifteen-carbon-containing skeleton where two aromatic rings are interlinked by a three-carbon chain (C6-C3-C6) [209,220]. They are found in the seeds of many mustard species and include proanthocyanidins and anthocyanidins; flavan-3-ols, namely catechin and epicatechin; flavonols including kaempferol and quercetin; and flavonoid glycosides [6,10,38,39,43,44,160,166,212,214]. Phenolic acids and tannins give the astringency and dark color to commercially processed seed extracts [59,74,210]; specifically, Kaempferol 3-O-(2‴-O-Sinapoyl-β-sophoroside) has been identified as the major compound responsible for the unpleasant bitter taste of mustard protein isolates [221]. Oriental mustard oil (B. juncea) is notably darker in color due to the presence of higher phenolics than yellow mustard (S. alba) [222].
Figure 1. Basic structures of phenolic acids found in Brassicaceae oilseeds. Adapted from [59,209,223,224,225].
Figure 1. Basic structures of phenolic acids found in Brassicaceae oilseeds. Adapted from [59,209,223,224,225].
Ijms 25 09039 g001

2.4. Proteins

Mustard seeds contain high amounts of proteins and the de-oiled seed contains up to 40% proteins [74,160,161,226]. Among them, the major seed storage proteins are cruciferin, napin, and the oil-body protein oleosin [74]. Cruciferins are 12S legumin-type globulin proteins with a molecular weight of about 300–420 kDa [227,228]. These proteins comprise up to 35–50% of the total seed protein. Napins belong to the 2S albumin seed storage protein family, make up 20–40% of total seed protein, and have a molecular weight in the range of 12–16 kDa [74,229]. Oleosins, which are the main protein found in the lipid bodies of the seeds, make up 6–8% of the total seed protein and have a molecular weight of approximately 18–25 kDa [74,229,230]. The other relatively abundant proteins found in mustard seeds are myrosinase, the glucosinolate-degrading plant defense enzyme found in all mustards which has a molecular weight of 120–150 kDa [158,159,231] and thionins, now also known as defensins, low-molecular-weight (about 5 kDa) cationic peptides abundant in sulfur-containing cysteine residues with plant defense action [232,233]. Additionally, heat-sensitive trypsin inhibitor proteins of 18–19 kDa ranging from 2–2.5% of crude protein [62,234,235] and lipid transfer proteins of 7–9 kDa which accounts for 2–3% of the total protein, are also found in the seed [236,237,238].

2.5. Minor Chemical Compounds

The amount of carbohydrates is comparatively lower in the seeds of rape and Canola than that of other oilseeds and seed grains [239]. In general, the seeds contain around 10% soluble sugars, 4–5% cellulose, 4–5% pectin, 3% hemicellulose, and less than 1% starch of dry seed weight [59]. The levels of oligosaccharides were found to be approximately 20 g/kg dry matter and raffinose was approximately 3–4 g/kg dry matter in seed meal [240].
High levels of the major minerals including iron (0.01–0.02%), calcium (0.3–0.45%), phosphorus (0.6–0.84%), potassium (0.5–0.65%), zinc, magnesium (0.1–0.15%), and manganese (0.003–0.008%) are found in the seed. Metals such as copper (0.001–0.007%), lead, cadmium, and selenium (0.00002%) have also been measured in the seeds [123,241,242,243,244,245,246,247]. Mustard seeds contain crude fibre including pentosans and lignin, which accounts for 7–15% of the total seed weight [28,198].

3. Use of Mustard to Treat Ailments

Mustards are described in many official herbal compendia including The British Pharmacopoeia, The Pharmacopoeia of China, and other publications of herbal, Ayurvedic, and homeopathic relevance as a natural ointment to heal various forms of pain [14,43,137,248,249]. They have been used for years for the treatment of disease and pathological conditions (Table 6).
The traditional uses of mustards and their components in vitro and in vivo have been well documented in the literature [272,273,274]. The rationale and possible mechanism of action behind the uses are discussed in the following sections.

3.1. Antimicrobial and Antiviral Activities

Glucosinolates demonstrate a wide range of antibacterial and anti-fungal properties with direct or synergistic effects in combination with other compounds. Different glucosinolate metabolites, namely nitriles, thiocyanates, and isothiocyanates, can strongly inhibit most Gram-positive and Gram-negative bacteria [275], as well as fungus and yeast [149,252]. In addition, other hydrolysis products of glucosinolates such as allyl nitrile, allyl isothiocyanate and ionic thiocyanates (SCN-), phenolic compounds, and tannins have also demonstrated potential anti-microbial activity [276,277]. The best studied of the mustard seed anti-microbial metabolites is allyl isothiocyanate along with its related isothiocyanates [278]. These hydrophobic compounds have a multi-targeted mechanism of action, affecting bacterial metabolic pathways, membrane integrity, and cell wall structure [216]. They have the ability to disrupt the bacterial cell membrane, causing the leakage of both metabolites and ions and a reduction in both intracellular ATP and pH [216,252,279,280] resulting in cell death. This mechanism of action is quite similar to the class of polymyxin and related peptide antibiotics, both of which have strong affinities for membrane lipids and lipopolysaccharide [281,282].
Natural isothiocyanates and their analogs have also been shown to be effective against a wide range of fungi including Aspergillus niger, Penicillium cyclopium, Rhizopus ryzae, and common Saprophytic fungi [283]. Allyl isothiocyanate was found to be toxic [284] to Penicillium expansum, a fungus which causes postharvest disease to economically important fruits like apples and vegetables in storage [285]. Benzyl isothio-cyanate was found effective against ectomycorrhizal fungi [203,286].
Sinapic acids and 4-hydroxy-3-nitrophenylacetic acid were found to have antibacterial activity against several different pathogenic bacteria. Structure–activity relationship studies revealed that different methoxyl, hydroxyl, nitro, and propenoic groups present in the compounds are necessary for effectiveness [287].
Several seed proteins have been shown to have both anti-microbial and anti-fungal activities. The seed storage protein napin was reported to have significant antimicrobial activity against pathogenic bacteria, namely Bacillus subtilis, B. cereus, B. megaterium, and Pseudomonas aeruginosia, and against the highly toxigenic fungus Fusarium langsethiae [281,288,289,290,291,292,293,294,295]. The anti-microbial activity of the seed storage protein napin was attributed to the presence of abundant positively charged amino acids, giving the protein a net charge of +1 or greater. A high proline content and a high proportion of alpha-helices in their secondary structure were also found to be important. It is thought that these properties enable the protein to compete for binding with calmodulin and inhibit calcium signaling. The anti-tryptic activity of napins could also hinder microorganism growth [73,292,296]. There is also evidence that the basic residues of napin create electrostatic contacts with the acidic phospholipid membrane bilayer of the pathogen and thus permeabilize the microbial plasmalemma [297,298], as well as inhibit their growth [299].
Another seed storage protein, vicilin, which was reported in B. rapa for the first time among the Brassicaceae mustards [281], has also been shown to possess antimicrobial activity [300]. Thionins have been reported to have potential antimicrobial activity against Clavibacter michiganensis, Micrococcus luteus, Rhizobium meliloti and Xanthomonas campestris, and toxic fungus Fusarium solani [236,299,301]. Noteworthy, in silico studies have found that both the napin and cruciferin seed storage proteins have high binding affinity to selective metabolic enzymes [62,281] and microbial membranes [302] in pathogenic bacteria. These findings suggest that these proteins are able to form protein–enzyme complexes that may cause alteration of regular bacterial metabolism, plasma membrane permeability, and chemical or reactive oxygen species balance as the conformation of the enzyme or membrane changes, leading to cell death [289,303,304,305].
Interestingly, applying these compounds together has shown additive antibacterial and anti-fungal effects. In the case of napins, these proteins were found to exert synergistic effects when applied in combination with thionines by interacting with membrane phospholipid permeabilization in the case of bacteria and increasing K+ efflux from fungal hyphae and changing membrane ion permeability [306]. Relevantly, glucosinolate hydrolysis products from the leaf, stem, and inflorescence of broccoli (Brassica oleracea var. italica L.), particularly iberin- and indole-derived glucosinolate hydrolysis products, which are also present in the Brassicaceae mustard seeds, were shown to have anti-fungal activity against Botrytis cinerea, a necrotrophic fungus that infects many plant species [307].
Mustard seed extracts are also recommended to fight against candidiasis, a fungal infection caused by an overgrowth of any species of the genus Candida yeast [308,309]. Mustard seed extracts are also given for the treatment of other topical fungal infections [310]. The antimicrobial and antimycotic activities of mustard seed support their uses in human diseases involving bacteria and fungi as well as the use in herbal and food preparations as preservatives [281,301,308,311,312].
Rapeseed protein hydrolysates were also tested in E. coli expressing the HIV protease. Measuring the inhibitory activity, it was found that the proteins act as the inhibitor of human immunodeficiency virus (HIV) protease which opens the possibility to develop antiviral drugs as well as combat HIV [313]. Brassinosteroids, a group of steroidal substances, found in most of the mustard seeds, were found to have substantial anti-viral activity against human pathogenic viruses including herpes simplex virus type 1, RNA viruses, and even the measles virus [314].

3.2. Antidiabetic Action

Diabetes mellitus is a major endocrine disease in which the pancreas produces insufficient insulin or the produced insulin cannot bind with the appropriate receptor. The lack of insulin signaling leads to high blood sugar levels which can cause secondary complications and in some cases be fatal. Anti-diabetic drugs, medications used to treat diabetes mellitus by decreasing glucose levels in the blood, and hypoglycemic agents, the agents used to help reduce the amount of sugar present in the blood, are used to treat this growing global health problem [16,315].
Seeds of B. juncea and B. nigra have been reported to have anti-diabetic properties, including the ability to lower blood glucose and improve high glucose tolerance in diabetic animals [253,316,317]. Mustard seeds have also been found to suppress gluconeogenic and glucolytic enzymes, including α-glucosidase [254,317,318]. This enzyme catabolizes the breakdown of complex carbohydrates to glucose and thus its inhibition would ultimately decrease blood glucose levels [319]. The flavonoids found in rapeseed including flavones, isoflavones, flavanones, flavonols, and anthocyanidins have the ability to reverse the signs of type II diabetes. For example, abscisic acid, a plant growth regulator, in the flavonoid biosynthesis pathway, can act in a similar manner to the widely used thiazolidinediones class of anti-diabetic drugs by targeting the thiazolidinedione receptor and enhancing insulin secretion [320].
B. juncea seed powder extract has also been shown to have significant hypoglycemic action [254,317], increasing the concentration of hepatic glycogen by increasing glycogenesis via glycogen synthetase activity. It also increases glycogen by decreasing glycogenolysis and gluconeogenesis via the depressing activity of glycogen phosphorylase and gluconeogenic enzymes [253].
The increased blood glucose levels in diabetes mellitus generate various free radicals and reactive oxygen species including superoxide anions, which generate hydroxyl radicals via the Haber–Weiss reaction. This results in the peroxidation of membrane lipids and ultimately leads to oxidative damage to cell membranes [256]. Antioxidant molecules present in mustard can help to neutralize the harmful free radicals by different mechanisms including electron donation, metal ion chelation, or by gene expression regulation [215,317,318], safeguarding membrane lipids from lipid peroxidation [321,322].
It is also well known that food rich in MUFA, such as has been shown for mustard seed (Section 2.1), can increase the peripheral insulin sensitivity of the insulin receptor and thus lower blood glucose levels [323,324]. Fibers present in foods, particularly soluble fibers, can also affect the glucose and insulin levels in the blood [325]. Mustard mucilage (soluble fiber) at different dietary levels was found to have antidiabetic effects on elevated blood sugar levels (post-prandial glucose level) and insulinemia in laboratory rats [253,254,326,327]. Measuring hypoglycemic activity is the most common and accepted method to evaluate the antidiabetic activity of natural products. The complete profiling of the hypoglycemic activity of mustard components as well as human trials are scarce for antidiabetic activity and warrants further investigation. Antihyperglycemic agents reduce the excess accumulated sugar in the blood [328]. B. juncea oil and seeds showed potential antihyperglycemic effects, i.e., a significant reduction in blood glucose levels in experimental diabetic rats by increasing insulin activity [328,329]. Leaves of B. juncea and B. compestris exert similar antidiabetic effects and anti-hyperglycemic effects in diabetic mice [273,330].
Rapeseed protein hydrolysates derived peptide RAP-8 was tested on an in vivo mouse model to assess its effect on glucose tolerance and insulin resistance. The peptide was found to significantly improve insulin resistance, glucose intolerance, and lipid metabolism as well as markedly reduce hepatic inflammation, fibrosis, liver injury, and metabolic deterioration in mouse models of non-alcoholic steatohepatitis and hepatic fibrosis [331].

3.3. Hypolipidemic Effects

Hypolipidemic compounds are substances which lower the lipid and lipoprotein levels in the blood while hypocholesterolemic compounds decrease cholesterol absorption and increase bile acid excretion, thus reducing serum cholesterol by stimulating the further conversion of cholestenol to bile acids [332,333,334].
The low SFA and high MUFA profile of mustard oil (Table 2) has the potential to lower cholesterol. Studies conducted on healthy human subjects revealed that high MUFA diets reduce both blood cholesterol and triacylglycerol levels (total cholesterol by 10% and LDL cholesterol by 14%) [323]. The ingestion of rapeseed oil was found to reduce cholesterol absorption from food and increase the excretion of cholesterol, bile acids, and metabolites of steroid hormones from the digestive tract, thus reducing the serum cholesterol level in the blood [332]. Rapeseed oil was also found to reduce low-density lipoprotein (LDL) cholesterol, blood lipids, and plasma apo-lipoproteins in a study which compared the effects of consumption with olive oil in healthy male participants [335]. B. nigra seeds, added to the diet of diabetic rats, reduced serum cholesterol and triacylglycerol levels and raised the level of good cholesterol (high-density lipoprotein, HDL) [316]. Seeds of B. juncea were tested on 1–2 dimethyl hydrazine-induced colon carcinogenesis and found to decrease the plasma cholesterol and phospholipid levels while increasing the fecal bile acids and neutral sterols [336,337]. Erucic acid present in all mustards was tested and found to exhibit hypocholesterolemic and hypolipidemic effects on the plasma and tissues of hypercholesterolemic rats [333].
Another mechanism that serves to lower cholesterol is the degradation of consumed fiber by the intestinal flora which produces propionic acid, that is then absorbed into the blood stream, and serves to inhibit hepatic cholesterol synthesis [338,339]. In addition, most of the phytosterols found in mustards, namely brassicasterol, campesterol, sitosterol, avenasteriol, and stigmasterol have been shown to have plasma cholesterol-lowering activity [90,114]. A peptide from rapeseed protein hydrolysates demonstrated the ability to improve lipid metabolism in experimental mouse models [331]. Improved lipid metabolism significantly leads to the burning of stored fats, weight loss, cardiac, pulmonary, and metabolic performance; delays aging; and ultimately optimizes bodily physiological functions [340,341].

3.4. Cytotoxic and Anti-Cancer Activity

Mustard and its components are alleged to have cytotoxic and anti-cancer properties mainly due to their demonstrated anti-oxidative properties [342]. Different isothiocyanate, erucic acid, phenols, and phytins possess the ability to scavenge free radicals which may have anti-cancer effects [14,343]. Erucic acid was found to possess anti-tumor effects on animal models as well as human cancer cell lines [344]. Sinigrin, progoitrin, and glucocheirolin showed a marked in vitro cytotoxicity against human erythroleukaemic K562 cells [152]. Mustard oilseeds also demonstrate higher antioxidant potential in terms of DPPH (2,2-diphenyl-1-picrylhydrazyl) scavenging potential, ferric-reducing ability, total phenolic content, and chelating power [345,346]. It was found that the consecutive hydrolysis of rapeseed proteins using the digestive enzymes pepsin and pancreatin exhibited the most active DPPH radical scavenging hydrolysate [347].
Antioxidant molecules act as free radical scavengers; they neutralize free radicals produced from the body cells by delivering some of their own electrons to the free radicals produced from the normal essential bodily cell metabolic processes or from external sources. Mustard oilseeds are a great source of antioxidants which scavenge free radicals including phenolic compounds, ligands, flavonoids, and phenolic acids (Table 5, Figure 1) [218]. Antioxidant molecules target cellular free radicals, neutralizing the excess reactive oxygen species, and may ultimately help to reduce the potential risks of developing cancer [348,349,350].
More direct evidence for the anti-cancer effects of mustard compounds has been shown in studies using cancer cell lines and animal models. Sinigrin and its metabolites isolated from the leaves of B. carinata were reported to have potential tumor growth inhibition activity in studies on both in vivo animal models and in vitro cell-line models [12]. Extracts from B. juncea seeds were shown to decrease the cancerous cells in the colon and intestine in 1–2 dimethyl hydrazine-induced colon carcinogenesis in rat models [336,337]. Recent research has demonstrated that the mucilage/meal fraction obtained from Sinapis alba following oil extraction contains a complex mixture of polysaccharides which were shown to exert a protective role in the development of sporadic and obesity-associated colon cancer in preclinical azoxymethane-induced obese rat models compared to untreated obese rats [351].
Mustard seed extract was also reported to act by suppressing the expression of lymphocyte activating factor, tumor necrosis factor alpha (TNF), and interleukin (IL)-6 mRNA, and inhibiting Langerhans cell migration in the epidermis of Albion mice cancer models [352]. More specifically, a regulatory protein NPR1, found in B. juncea seeds, has been shown to inhibit the activity of nuclear factor-kappa B (NF-κB), a member of the family of dimeric transcription factors which regulate immune responses, the proliferation rates of cancerous cells and apoptosis in human cell lines [353].
Several glucosinolates and their metabolites have also been shown to have anti-cancer activity against a wide range of cancerous cells and exert their effect by several mechanisms (Table 5). High-glucosinolate-containing B. rapa subsp. trilocularis (yellow sarson) and B. rapa subsp. chinensis (pak choi) along with their low-glucosinolate-containing counterparts were tested against human colorectal cancer (CRC) cells. The high-glucosinolate-containing lines showed anti-cancer activities in terms of anti-proliferative pro-apoptotic activities, the inhibition of the nuclear factor NF-κB pro-inflammatory signaling, and ERK pathways that suppress the proliferation of cancer cells [354,355]. Many components of mustard seed were also investigated and found to have antiproliferative activity, acting to prevent or retard the spread of cells, especially malignant cells, into surrounding tissues [356,357,358] through proapoptotic effect. These components were also shown to promote or cause the apoptosis of cancer cells [358,359] and induce cell cycle arrest of the rapidly proliferating cancer cells [357,358]. Allyl isothiocyanate has the ability to prevent urinary tract cancer and was also shown to have antiproliferative activity against human prostate cancer cells [164]. Allyl isothiocyanate is also reported to exert antiproliferative activity resulting in cell cycle arrest to bladder cancer cells and apoptosis [357] as well as in vitro human colon cancer cells [360]. Phenethyl isothiocyanate (gluconasturtiin), alone [204] or combined with sulforaphane, and their N-acetylcysteine conjugates can inhibit the growth of various tumors and cancerous human and animal cell lines [204,361,362]. Benzyl isothiocyanate (glucotropaeolin) has the ability to prevent the growth of various types of cancer cells by inducing apoptosis leading to cell death at low concentrations and causing cellular necrosis at high concentrations [363,364,365,366,367,368]. Similar effects were also observed for brassinosteroid treatment on human cancer cell lines [369,370], which additionally affected cancer cell cycle progression [371]. Iberin, a glucosinolate decomposition product, has also been shown to have apoptotic potential against tumor cells, reducing the proliferation of human glioblastoma and neuroblastoma cells [175,372]. Sulforaphane, found in mustard oil [373] in combination with resveratrol, which is also a component of mustard seed [374,375], or its analog also acts as anti-tumor agent [174,376]. Enzymatic hydrolysis of glucobrassicin by myrosinase yields indole-3-carbinole (or 3-indolylmethylisothiocyanate) which further combines with ascorbic acid to form ascorbigen with stronger in vitro antioxidant activity and significantly higher in vivo activity than ascorbic acid alone, and Trolox, the two known strong antioxidant molecules commonly used as standard antioxidants [377,378]. Ascorbigen was found to prevent tert-buthyl hydroperoxide-induced cytotoxicity in human keratinocytes cultured cells to a greater extent than ascorbic acid [378].
The mustard seed proteins and protein-derived peptides were reported to exhibit in vitro and in vivo anti-cancer activities. The seed defense protein thionin [236] also has anti-cancer properties [379]. The application of thionin to cancer cells prevents the uptake of sugar, nutrients, and proteins and causes nucleotides to leak out from the cell, ultimately destroying the cancer cells [380]. Rapeseed peptides were also found to have significant in vivo free radical-scavenging ability and cytotoxic activity against human cancerous HepG2 cell lines [381], as well as liver injury, inflammation, fibrosis, and metabolic deterioration by suppressing the fibrosis-associated gene expression in mouse models [331]. Furthermore, rapeseed protein-derived anti-oxidative peptides demonstrated potent cytoprotection anti-proliferative activity against chemical-induced human cell lines and cancer cell lines through the inhibition of cell apoptosis [382,383,384,385,386].
Although it has been proposed that some isothiocyanates inhibit protein synthesis and affect carbohydrate metabolism, the activity of these compounds seems to be mainly due to the chemical reactivity of the isothiocyanate group, which binds easily to protein. Moreover, some hydrolysis products could be considered as antimitotic substances, given their strong anti-proliferative activity [155].
A lowered risk of lung, stomach, breast, prostate, pancreas, colon, and rectal cancers has been linked to the consumption of vegetables of the Cruciferae family and it is thought this may be due to the presence of active anti-cancer metabolites including glucosinolates and their breakdown products [31]. In Asia, people consume high amounts of cruciferous vegetables, up to 24% of the total vegetable intake [387], including mustard leaves and seeds [117,171,344], and they are shown to have a lower occurrence of cancer, increased life expectancy, and generally greater wellbeing than people from countries that eat less of these vegetables [10,117,171]. The regular consumption of B. nigra seeds improves the body’s biological defense mechanism against cancer development, and epidemiologic studies have shown that consumption reduces the rate of colon, bladder, and lung cancer [362].

3.5. Broncho- and Vaso-Dilating Properties

Mustard oil can be applied to the chest and back as a poultice to reduce chest congestion [388], serving to loosen phlegm, and aiding in its expulsion. Children with colds, coughs, and chest congestion are rubbed with mustard oil to alleviate their discomfort [389]. A syrup made from boiled willow bark, mullein, and rue combined with mustard oil has been described as an excellent syrup for treating cough and also eases aches and fever [390]. S. officinale dry plant extract has long been traditionally used to alleviate laryngitis, bronchial catarrh, and throat congestion [40].
Dry plant extracts of S. officinale applied to guinea pig tracheal smooth muscle were found to deactivate the histaminic, muscarinic, and cysteinyl leukotriene LTC4 receptors responsible for the contraction and triggering of inflammatory and allergic responses, and relax the smooth muscle [39]. Sinigrin (allylisothiocyanate) and sinapine in mustard may counteract the bronchial contraction [43]. These ingredients help to reduce congestion in the respiratory tract by dilating local blood capillaries, and increasing the circulation of blood to the area [391]. A mustard footbath has also been shown to move congestion out of the chest by increasing circulation to the lower part of the body, soothing deep muscle aches, and treating headaches. Mustard inhalation improves circulation to the head via the nasal passages and is used to treat chest and sinus colds [392]. However, when isothiocyanate is inhaled with oil or aspirated from mustard, it can cause airway irritation in the nasal tract in some individuals [232,393].

3.6. Action on Cardiovascular System

According to the World Health Organization, cardiovascular disease (CVD) is the number one cause of death globally resulting in the deaths of 17.5 million people worldwide annually [394]. Hypertension, caused by the constriction of blood vessels and high blood pressure, is one of the leading causes of CVD. Food and drugs which inhibit the angiotension 1 converting enzyme (ACE) are used to treat hypertension [395]. Leaves and seeds of the mustard B. juncea have been shown to have significant ACE inhibitory activity [148], and antihypertensive peptides from B. napus and B. rapa var. campestris have also been shown to inhibit ACE in vitro and in vivo [396,397,398,399,400]. The mechanism of inhibition was revealed from in vivo experiments whereby rapeseed protein, specifically rapakinin, Arg–Ile–Tyr, derived from the mustard 2S albumin type protein napin, caused the spontaneous dilation of the mesenteric artery in hypertensive rats via the prostaglandin-mediated prostanoid receptors. This was followed by cholecystokinin A receptor-dependent vasorelaxation [401,402]. When the blood vessels are relaxed, it causes a reduction in blood pressure, termed antihypertensive activity [402]. In addition, the oral administration of bioactive peptides, including a novel peptide Gly-His-Ser derived from rapeseed protein digest, was found to inhibit ACE and renin activities in hypertensive rats [347,398,403,404,405,406,407]. Peptides from Broccoli (Brassica oleracea L. var. italica Planch) stem and leaf protein hydrolysates were found to inhibit ACE activity [408].
Peptide concentrates derived from B. napus seed proteins were found to be able to prevent the development of hypertension and prevent CVD [395]. Canola protein isolate from B. napus showed the most prolonged antihypertensive effect in vivo, and low molecular weight peptides were found to decrease blood pressure at a faster rate [396].
Several cardiac diseases like atherosclerotic vascular disease are directly linked to oxidative stress and high blood fat levels. Superoxide anions generate pro-aggregatory isoprostanes, which contribute to an increased risk of heart attack. Mustard flavonoids can scavenge superoxide anions and lower oxidative stress. In addition, they reduce the formation of isoprostanes, facilitate anti-aggregatory PGI2 formation, and thereby exhibit anti-thrombotic action [409]. Numerous studies have suggested that flavonoids have cardioprotective and vasodilating effects, as well as acting as protective agents against coronary disease and metabolic disorders [410,411]. As edible oils, mustard oils, specifically Canola oil, contain significant quantities of unsaturated fatty acids, which can reduce cardiovascular disease. The addition of alpha-linolenic acid and other omega-3 polyunsaturated fatty acids which are abundant in rapeseed oil to the diet was proven to lower the risk of stroke and other CVDs [412,413,414]. Likewise, the oil has a notably small amount of palmitic acid compared to most other vegetable oils. Mustard and Canola oils have considerably lower profiles of palmitic acid than other plant-based edible oils (Table 2). Palmitic acid is considered as a “potential cardiovascular risk factor”, and the low profile also makes mustard and Canola oils healthier than other vegetable oils [91]. Another component of mustard oil, erucic acid was found to lower chemically induced necrosis in mice hearts [344].
S. officinale leaves are used to treat chest pain, cardiac weakness, and other cardiac problems and as a cardiotonic in folklore medicine [415,416,417]. The leaves were found to contain cardioactive steroidal glycosides-corchorosid A and helveticosid [39,43]. Their action is similar to the well-known cardiac glycoside digitalis which exerts its action on the heart by increasing myocardial contractability [162,415,416], relieving weak heart muscle-related complications. This may provide a scientific basis for the use of this plant in folklore medicine as a cardioactive drug.

3.7. Counter Irritation Action

Historically, mustard seed paste, powdered seeds, and oils have been used topically to create a counter-irritant effect by stimulating the removal of stored blood from capillaries. A counter-irritant causes cutaneous vasodilatation by stimulating the sensory nerve endings and inducing a neurogenic inflammatory response by the excitement of the capillaries of the skin or border membrane. This elicits the dilation of the blood vessels and increases the flow of blood [418], serving to block the intense pain at the site of application. The use of heat to the area of pain before applying the counter irritants effectively maximizes their pain-relieving action [419]. Glucosinolates produce a warming sensation and reddening related to the dilation of capillaries on the skin and thereby provide relief from pain [420]. Because of these properties, B. nigra seeds are used in the crude drug industry in a poultice inside a protective dressing [421] to apply over an inflamed, painful area of skin to improve circulation and relieve pain [422,423]. Mustard plasters are a blend of oily or waxy mixtures together with mustard seed powder alone or with other herbs and are usually placed on the chest or abdomen wherever tenderness exists. In traditional medicine, the blends were dispersed onto a cloth and wrapped tightly for storage and unrolled and applied when required [424].
To treat peritonitis, an inflammation of the serous membrane lining the abdominal cavity, a large mustard plaster was traditionally applied to the abdomen [425,426]. Likewise, to treat cholera morbus, an acute gastroenteritis with symptoms of spasmodic diarrhea, pain, and vomiting, mustard plasters were placed on the abdomen [427]. The application of mustard poultices and paste produces the quickest relief for inflammatory and related arthritic conditions by drawing out pustular constituents and toxins through the skin and dispersing the congesting blood from inside the body. The rubefacient action causes mild irritation to the skin, stimulating circulation to that area and relieving muscular and skeletal pain [428]. For endocarditis, an inflammation of the internal lining of the heart, mustard poultices to the chest were prescribed to hasten the absorption of the deposit of interstitial fluids [427].

3.8. Antiinflammatory and Analgesic Action

Mustards have a long history of being used in pain management [429] as poultice, cataplasms, or warm oil massage because of their counter irritant properties. Mustard seeds are used by traditional practitioners as cataplasm which is a medical dressing containing soft heated seeds that is spread on a sterile gauze or cloth and applied to the skin to treat inflamed areas to improve circulation [430]. A warm mustard poultice or oil massage can also be applied to reduce pain and inflammation providing relief from arthritis, and back, joint, muscle, and leg pain by stimulating blood flow. The heat activates the volatile allyl isothiocyanate metabolite which acts by binding directly to the transient receptor potential (TRP) ion channel receptor proteins located on the surface of animal cells responsible for detecting the sensation of high temperature, pain, inflammation and additional stimuli and sends signals to the brain [431,432]. The mechanism of action of isocyanates is similar to the mechanism of capsaicin, the active component of chili peppers. Both target the same populations of neurons, acting on TRPV1 and TRPA1 ion channels in nociceptive neurons where they trigger a signaling cascade which leads to peripheral dilation and permeabilization of blood vessels [433] and reversibly abolishes the induction of pain and inflammation in nerve cells [431].
Other compounds in the mustard extracts have also been shown to have anti-inflammatory effects [14]. Aerial parts of B. rapa subspecies chinensis (L.) Hanelt were applied to mice following induced pain using either an acetic acid-induced writhing test or tail immersion assay and the plant material was found to have significant analgesic effects [434]. Moreover, dry mustard seed powder contains a significant amount of salicylate (mono-hydroxy-benzoates, around 26 mg per 100 g powder) [435], a metabolite of aspirin widely used for pain, fever, and inflammation [435,436]. The high content of selenium and magnesium in mustard oil could also account for anti-inflammatory activity. The oil stimulates sweat glands assisting to decrease temperature when the body is inflamed [242]. The aerial parts of Erysimum corinthium were reported to possess triterpenes-amyrin which exerts antinociceptive and anti-inflammatory properties by the activation of cannabinoid receptors and inhibition of the production of pain mediators like cytokines and expression of NF-κB, CREB, and cyclooxygenase 2 in mice [437,438] as well as lupeol which has strong anti-inflammatory, antiarthritic properties [437,439]. Flavonoids can inhibit cyclooxygenase and lipoxygenase enzymes and thus reduce the formation of pro-inflammatory pain mediators (prostaglandins, leukotrienes, reactive oxygen species, and nitric oxide) and strongly inhibit prostacyclin production [409]. Sinapis alba seed extract was found to reduce inflammatory infiltrations of T-cells, dendritic cells, macrophages, nuclear factor (NF)-kB, interferon, and interleukin in experimental mice cells; reduce some inflammatory mediators at the level of mRNA and protein [440]. As mentioned previously B. nigra seeds were also found to raise the high-density lipoprotein cholesterol (HDLC) level [316] which has anti-inflammatory properties [441]. A regulatory protein NPR1 in B. juncea can inhibit NF-κB, a family of dimeric transcription factor protein complexes which regulate inflammation and are linked to cancer, inflammatory, and autoimmune diseases [353]. Another mustard metabolite, sulforaphane was also found to inhibit the NFκB complexes [440]. Sulforaphane is also reported to induce anti-inflammatory effect and increase the local antinociceptive actions of morphine [442]. Indole-3-carbinol, a mustard component, can act as a ligand for the aryl hydrocarbon receptor which has the ability to influence both immune-regulatory T cell and T-helper 17 cell differentiation, inhibit delayed-type hypersensitivity by inducing a shift from pro-inflammatory T-helper 17 cells to regulatory anti-inflammatory T cells and thus play an important role against inflammation [197]. Cruciferins, one of the major seed storage proteins [73], from rapeseed (B. napus) and radish (Raphanus sativus) showed significant in silico overall occurrence frequency for DPP-III inhibitory peptides which suggested that they may have high potential to possess an antinociceptive activity [443].

3.9. Antiarthritic Action

The use of mustard to treat arthritis is approved by Commission E in Herbal Medicines, a German-based European scientific advisory body which approves substances and products used in traditional, folk, and herbal medicine [43]. Osteoarthritis is associated with joint pain and characterized in part by defective articular cartilage [440,444]. The lack of curative drugs to treat osteoarthritis means that the management of the disease, by the use of bioactive phytochemicals, offers a novel and attractive approach to preventing the onset and/or progression of the disease [440]. Sulforaphane in mustard seeds was found to impact articular cartilage in experimental osteoarthritis models, reducing the cytokine-induced expression of proteinase enzymes that degrade cartilage from chondrocyte cells; in addition, it inhibited the cytokine-induced degradation of cartilage explants; and ultimately, it diminished cartilage destruction caused by osteoarthritis [373,440].

3.10. Diuretic Action

Mustards have been traditionally used as diuretics [21]. In general, diuretics help turn excess body water into urine, interfering with normal kidney function by reducing the amount of sodium and water absorbed back into the bloodstream [445]. Glucosinolates of mustard seeds cause irritation to the mucus tissues of the renal system producing a diuretic response. Mustard seeds contain crude mucilage which accounts for 5% to 20% of the seed depending on the species [446]. Usually, this mucilage contains 80% to 94% carbohydrates [13]. These carbohydrates also play a role in diuresis. For instance, B. juncea mucilage was found to raise serum glucose levels, preventing the rise of creatinine levels in urine and ultimately increasing the volume of urine in animal studies [317]. Mustard, rapeseed, and Canola seeds also contain mannitol (0.7 mg/g dry weight) [447] which acts as an osmotic diuretic. When mustard is ingested in large amounts, the mannitol is absorbed slowly from the gastrointestinal tract into the blood stream, increasing the volume of fluid [436]. The presence of mannitol causes the retention of water to balance the osmotic pressure of the urine. The saponins and vanillin present in the seed also have diuretic properties [448].

3.11. Anthelmintic Activity

Different mustard seeds and oilcakes were found to diminish the population of plant parasitic nematodes in the soil when cultivated and are used in agriculture as rotation crops to eliminate these pests [449]. Mustards have also been found to have anthelmintic activity in humans and animals, helping to expel internal parasitic worms. Seeds and purified secondary metabolites—sinigrin, sinalbin, gluconapin, epi-progoitrin, glucoiberin, and glucoerucin, were tested on a simulated human gastrointestinal tract infected with an earthworm (Pheretima posthuma) model as well as other nematodal models and found to have dose-dependent anthelmintic potential [177,450,451]. The seeds were found to paralyze (vermifuge action) and eventually kill the earthworms (vermicidal activity). However, compared to a standard anthelmintic drug, mebendazole, the mustard seeds required a prolonged time to kill the worms at the dose of 20 and 40 mg/mL [452]. Additionally, volatile compounds released from mustards prepared as infusions have been shown to be effective for the expulsion of tapeworm but ineffective against hookworm, roundworm and whipworm [450].
Mustard secondary metabolites may exert their anthelmintic activity by several mechanisms. They can produce end-products such as phenolics, ammonia, fatty acids, and hydrogen sulfide which are directly toxic to the nematodes [453,454]. In previous studies, it was also revealed that tannins [367] and the polyphenolic compound ellagic acid [368] are present in mustard seeds in adequate amounts to produce anthelmintic activity in a large dose. Additionally, mustard seed and oilcake preparations increase the activity of bacteria and fungi which are antagonistic to parasitic nematodes [455,456].
Mustard seed is one of the ingredients of the commercial product Kochi free (Amber technologies) used to control avian coccidiosis, a disease of birds and mammals that chiefly affects the intestines, caused by coccidia, a single-celled parasite [457].

3.12. Emetic Action

Emetics are used to expel toxins from food or other poisonings by inducing vomiting by either acting on the vomiting nerve center of the brain or locally by irritating the nerves of the gastric mucus membrane. In the case of mustard, several isothiocyanate products (methyl isothiocyanate, allyl isothiocyanate, and phenyl isothiocyanate) act as irritants on the nerves of the stomach and mucus membrane [249] which consequently results in immediate nausea, vomiting, and colic [450]. When mustard seeds are eaten raw, trypsin inhibitor proteins can also irritate the human digestive system [292,458] which may also lead to vomiting.

3.13. Laxative Action

Sufficient ingestion of mustards stimulates gastric mucosa, increases pancreatic secretions, and causes irritation to the gastrointestinal tract which decreases the amount of time food remains in the intestine and consequently reduces water absorption. This results in a higher-than-normal release of water in the feces causing laxation [265]. Additionally, daily intake of mustard seeds as a condiment increases the blood circulation to the bowels, increasing the rate of transit of food through the gastrointestinal tract and decreasing the absorption of liquid from the food residue [392]. B. juncea seeds have been reported to alter hepatic functions increasing the secretion of digestive enzymes into the gastrointestinal tract and increasing digestion. Moreover, mustard seeds have an abundance of mucilage (2–5% of dry seed weight) [13,459], composed of an extremely hydrophobic pectin-rich polymer, which serves to increase viscosity and volume of the stool and acts as a laxative against constipation [266]. Sinapis alba seeds contain hydrogen sulfide which irritates the skin and mucous membranes [460]. The seeds also have a minor amount of trypsin inhibitor proteins [292], which prevents the gastric enzyme trypsin from digesting proteins in the small intestine [458]. When seeds are eaten raw, trypsin inhibitor proteins present can irritate the human digestive system which can also cause laxation [292,458].

3.14. Development of Body Muscle and Aphrodisiac Action

Traditionally, mustards were used to develop body mass and as an aphrodisiac [268]. Brassinosteroids and isocyanates stimulate local capillaries and improve the blood flow at the site of application. For this reason, eating mustard seed and application of mustard oil are considered as an aphrodisiac and used to treat erectile dysfunction in some traditional practices [30,279,461]. Extract of B. rapa administered orally was found to increase sperm motility and volume in an animal reproductive system model [268]. Mustards also produce aphrodisiac action by altering serum testosterone levels, and smooth muscle relaxation in the male genitalia arbitrated by a spinal reflex. They can also induce androgenic effects such as the development of muscle, increase blood pressure, and raise water/salt retention in tissues and blood in animals [147]. Mustard brassinosteroids are structural analogs of cholesterol-derived animal steroids, which promote growth regulation activity in plants and can have an anabolic effect in humans by increasing protein synthesis and lowering the breakdown of muscle proteins without coupling to the androgen receptor [462].

3.15. Treatment of Baldness

The application of mustard oil onto the skin surface increases blood flow and causes vasodilation. Therefore, it has been used as a remedy to treat baldness by applying topically on the skull [445], and on skin to revitalize body hair growth [463]. Traditionally, it is recommended by herbal practitioners to rub the oil onto the scalp twice a day to increase hair growth and prevent further hair loss. The action of mustard in alopecia (hair loss) is quite similar to that of minoxidil, an over-the-counter approved drug by the Food and Drug Administration (FDA) to treat hair loss. Both act by stimulating cell proliferation in the hair follicles on the scalp by providing increased blood flow and the stimulation of prostaglandin synthesis [464]. Dandruff related to fungal infection on the scalp is another cause of hair loss and baldness. The anti-fungal activity of mustard oil helps to prevent fungal infections [465].

3.16. Effects on Blood Flow and Bodily Secretions

Mustard has a secretory effect on several organs and glands such as salivary, mucus, milk, sweat, and bile glands, as well as increasing blood flow to the site of application [256]. It has traditionally been used as a poultice of bread, milk, and mustard applied on the breasts to promote lactation when a lactating mother’s milk is low [256].
Mustard seeds have also been found to increase the secretion of saliva in the mouth and bile acids in the intestine and thus act as a digestive stimulant. Because of these properties and as mentioned above, it has traditionally been used as an appetizer [276,277,466]. The ingestion of garlic mustard leaves causes or increases sweating by opening the sweat ducts [122].
Among the secondary metabolites of mustard, only the allyl isothiocyanate has been reported to have a negative effect on secretion. This metabolite was found to directly inhibit the (H+ + K+)-ATPase and thus reduce the acid secretion in the membrane of the parietal cells in the stomach [467].
In Asia, it is a common practice to massage a newborn with mustard oil and the oil massage has been found to improve blood flow, blood vessel diameter, and ultimately induce sleep, and increase the growth of the newborn [388,468].

3.17. Reduction in Fat and Body Weight

Traditionally, mustard is used to burn body fat and reduce body weight [469]. Rapeseed proteins and their enzymatic hydrolysis products were found to inhibit fat accumulation in the murine mesenchymal stem cells line in vitro, similar to or slightly less than that of the widely used anti-obesity drug Orlistat which was used as a control [470]. In another study, an anti-hypertensive peptide derived from rapeseed napin protein Arg-Ile-Tyr, called Rapakinin, was found to have anorexigenic activity, suppressing the appetite and lowering the intake of food and gastric emptying time in a rodent model [399]. It was suggested that the Arg-Ile-Tyr protein acted by stimulating the secretion of the peptide hormone cholecystokinin [471]. To elucidate the underlying molecular mechanism of anti-obesity activity, Brassica juncea extracts were applied to in vivo high-fat diet-induced obese mice [472,473,474] as well as in vitro pre-adipocyte cells [472]. Results suggested that the oral administration of the extracts lowered the body weight, improved liver damage, and inhibited lipid accumulation in high-fat diet-fed obese mice [472,473] compared to the standard anti-obesity extract of Garcinia cambogia extracts with anti-obesity effects [475]. In particular, the extract reduced the mesenteric, epididymal, and total adipose tissue weights as well as the bio-markers of obesity in blood namely serum triglyceride level, total cholesterol profile, and high-risk-factor low-density lipoprotein (LDL) cholesterol and increased the healthy high-density lipoprotein (HDL) cholesterol [474]. The in vitro assay on preadipocyte cells indicated that the extract reduced the expression of the development and accumulation of storage fat tissues as well as lipid synthesis proteins. Similar studies on high-fat diet-fed obese mice models indicated that feeding rapeseed diacylglycerol oil improved the serum obesity-related indices and lipid metabolism in the fat storage organs including adipose tissue, liver, and intestine [476]. In addition, the extract escalated the expression of heat generation and fatty acid oxidation proteins [473,474].

3.18. Antidepressant Effects

Traditionally, the application of mustard seed oil to the skin surface is believed to have a soothing and relaxing effect. Constituents of rapeseed, including eicosapentaenoic acid, and other omega-3 fatty acids regulate the hypothalamus–pituitary–adrenal axis activity in the brain and lower cytokines involved in inflammation [477] reducing stress. An extract of B. rapa subspecies chinensis (L.) was tested for antidepressant activity and was found to have significant antidepressant activity compared to a control [434]. Several antidepressants have the ability to enhance glucocorticoid receptor function [478] which controls a number of physiological functions like intermediary metabolism, skeletal growth, the performance of the immune system and cardiovascular system, reproductive system, and cognitive functions [479]. The rapeseed peptide, rapakinin, was also reported to have vasorelaxing activity [402].

3.19. Use in Adrenoleukodystrophy and Adrenomyeloneuropathy

Two components of mustard oil, erucuic acid and oleic acid, are constituents of Lorenzo’s oil [344,480], which is used to treat associated inherited genetic disorders of the nervous system, namely adrenoleukodystrophy found in children; and adrenomyeloneuropathy, which arises in adults, both linked to the accumulation of saturated very-long-chain fatty acids in the brain white matter, adrenal glands, fibroblasts, and plasma [344,480]. The application of Lorenzo’s oil inhibits the synthesis of very-long-chain fatty acids as well as limits the accumulation of saturated long-chain fatty acids in the brain [480,481] and in the blood [482]. Docosahexaenoic acid (DHA) in rapeseed oil is a major component of the nervous system including in the brain and eye tissues and supplementation of DHA and antioxidants are thought to be two of the reasons that improve nervous system disorders [483].

4. Adverse Effects and Other Antinutritional Effects of Mustard

In addition to the beneficial effects of mustards for human health, there is also evidence that they can cause some adverse effects, ranging from minor allergenic reactions to life-threatening anaphylactic shock to cardiac arrest. However, these reactions vary greatly depending on the dose and from individual to individual.

4.1. Cardiac Effects

S. officinale seeds contain the steroid glucosides corchorosid A and helveticosid, which are utilized to treat cardiac dysfunction by increasing myocardial contractability [39]. However, the consumption of large amounts of leaves and seeds of S. officinale (greater than 5 g per day) can affect the cardiovascular system by hyperactivating the heart leading to palpitations and even causing death depending upon the dose and the medical history of the patient [43,460].

4.2. Allergic Effects

Mustard seeds are recognized by the human immune system, triggering an IgE-mediated allergic reaction [73,484,485]. In an allergic reaction, the immune system produces antibodies to fight seemingly harmless substances, this causes a range of responses from minor irritation, and gastrointestinal upset, to the more serious anaphylaxis [73]. Mustard/rapeseed intolerance or IgE-mediated allergy is the most common among the allergies associated with foods, accounting for about 7% of allergic patients globally [486,487]. Mustard seeds contain considerably high amounts of indigestible 2S albumin-type napin proteins which are not digested by pepsin in the human digestive tract and remain intact [488]. The undigested protein can induce an immediate immune response in the gastrointestinal tract [489] by increasing the levels of specific IgE antibodies and initiating the response of inflammatory mediators producing antigen–antibody reactions [487], and in severe cases can result in anaphylactic shock leading to death.
Among European countries, France is the largest producer and consumer of mustard products, and after eggs, peanuts, and cow’s milk, mustard is the fourth most significant allergen [90]. Conversely, mustard has been reported to reduce the allergenic response caused by contact dermatitis by lowering the quantity of infiltrating Langerhans cells in tissue and suppressing the expression of lymphocyte activating factor, tumor necrosis factor alpha, and interleukin (IL)-6 mRNA [14,352].

4.3. Goitrogenic Effects

Mustard seeds and rapeseeds contain glucosinolates bound to glucose (Section 2.2, Table 2) which break down into the goiter-causing agent goitrin by the enzymatic action of myrosinase (Figure 2). The consumption of Brassicaceae plant products may result in the lowering of thyroid function and enlargement of the thyroid gland due to the presence of these goitrogenic glucosinolates and their metabolites epigoitrin, progoitrin, napoleiferin, and thiocyanate [464].
In humans and animals, the dietary micronutrient iodine facilitates the production of thyroid hormone, the hormone necessary for normal metabolic function and growth. Some glucosinolate metabolites namely goitrin and gluconapoleiferin inhibit the thyroperoxidase enzyme which leads to the decreased production of the thyroid hormone, resulting in the enlargement of the thyroid tissue which is the disease goiter [490]. Another glucosinolate hydrolysis metabolite, thiocyanate, decreases iodine uptake by the thyroid. As a consequence, the synthesis of the thyroid hormone is reduced [491]. To minimize this, the thyroid gland has to increase its function and become enlarged [492]. Selective breeding of Brassicaceae mustards has lowered the amounts of glucosinolates, for example, conventional rapeseed meals can have 3–8% glucosinolate whereas Canola contains less than 0.2% [493] which is a level below that causing physiological effects associated with thyroid problems.

4.4. Hematological Effects

B. oleracea has been reported to have hematological effects—antiplatelet and hypocholesterolemic activities in experimental rabbits [494]. High ingestion of Brassica vegetables including rape, kale, and raphnobrassica may cause the accumulation of high concentrations of nitriles in cattle blood which might reduce the ability of carrying oxygen capacity and thus there is a shortage of sufficient healthy red blood cells or hemoglobin in blood to carry oxygen to the tissue. This condition is termed as ‘kale anemia’, ‘red water’, or specifically ‘hemolytic anemia’ in cattle [477]. Small to moderate ingestion can cause scours, salivation, abdominal pain, abortions, staggers, and convulsions while a large amount of ingestion can often result in sudden death in gazing cattle [495,496]. B. rapa var. campestris can accumulate toxic quantities of s-methyl-L-cysteine and s-methyl-L-cysteine sulfoxide (SMCO) in the aerial organs including flowers, leaves, and stems. After ingestion, rumen microorganisms transform this to toxic dimethyl disulfide which causes hemolytic anemia in livestock. Consumed in large amounts, SMCO (more than 1% of dry matter of animal feed) can be toxic to certain livestock [497,498]. However, there is a dearth of reports on the hematological effects of brassica vegetables on human health probably because they do not eat those in bulk amounts and eat mostly after cooked.

4.5. Neurological Effects

Thiamine (vitamin B1) is a coenzyme necessary for the metabolism of carbohydrates, fats, and proteins [499]. The intricate chemical composition of Brassica vegetables causes thiamine depletion in ruminants. In addition, Brassica vegetables are rich in sulfur. The alteration of thiamine level and concurrent exposure to sulfur cause the necrosis of gray matter of the cerebral cortex in the brain and swelling in the ruminants known as polioencephalomalacia [499]. In this neurological disease, cattle may experience sudden onset of blindness, muscle tremors and convulsions, head-pressing, star gazing), rapid eye movements, incoordination, recumbency, and later, death. If the clinical signs could addressed at the early stage, the toxicity could be successfully treated with vitamin B1 [496,499].

5. Possible Application in Pharmaceutical Manufacturing

Rapeseed oil and its metabolites have the potential to be used as active ingredients and excipients for pharmaceutical products. As an example, rapeseed oil was found to enhance in vitro platelet aggregation and thromboxane production [85]. Thromboxane is one of the main cyclooxygenase products of human platelets and a potent vasoconstrictor which enhances the activity of platelets [500]. Patients who have bleeding disorders or suffer from thrombosis are treated with substances that boost in vitro platelet aggregation and thromboxane production and for this, rapeseed oil could have possible medicinal applications. The absorption and binding pattern, sensitivity, and efficacy of the mustard oil could be tested on the skin surface and also with human serum [501] for the identification of sensitivity patterns and could be used topically to stop bleeding at the site of hemorrhaging [409,502].
In Asian traditional herbal medicine, rapeseed oil is blended with active painkilling ingredients to produce a balm to treat acute traumatic pain [503]. The mustard seed essential oil could be a safe and favorable vehicle also for the formulation of anti-microbial compounds in soft gelatine microcapsules because it has strong bactericidal properties and mustard oil is found to provide strong chemical stability under a range of relative humidity and temperature when encapsulated in complex coacervation microcapsules. The presence of mustard could also help to harden the microcapsules depending on the selection of the coacervate microsphere [157]. The use of protein and other components as active ingredients and excipients is still marginally developed [4]. Drugs which are required to stay longer in the stomach for maximum effect can be formulated with the addition of mustard seed fibers which would allow for prolonged gastric exposure (as mentioned in the previous section). Research found that the major rapeseed protein cruciferin is an ideal material as a carrier molecule for the delivery of poorly soluble, hydrophobic, and less bioavailable bioactive compounds like curcumin. Therefore, cruciferin could be used as a drug vehicle in nanoencapsulation because of its amino acid composition resistance to gastric degradation; biocompatibility and good emulsifying and gelling properties; formation of homogeneous, fairly dense spherical and stable structures in colloid systems; and non-toxic nature to other drug carriers and vehicles as well as enhancing the cellular transport of active ingredients [504,505,506,507,508]. It was effectively used in curcumin delivery systems as a polyelectrolyte complex nanocarrier in encapsulated curcumin preparations and it was found to increase the bioavailability of curcumin [507].

6. Summary and Outlook

The potential health benefits of mustards are enormous. Although the chemical characterization of metabolites present in mustards has been performed, more studies are needed on the individual components and their bioactivity. Where analyses have been carried out, experimental evidence is mostly based on in vivo rat and mice models; however, rodent models are limited in their ability to mimic the extremely complex processes of human physiology. For example, differences in the action of sulforaphane and neoglucobrassicin on the induction of the quinone reductase enzyme and the inhibition of nitrite production were detected when these metabolites were tested in human and rodent cell lines. Neoglucobrassicin was found to inhibit the effect of sulforaphane on the quinone reductase enzyme in human hepatoma cells but not in rodent hepatoma cell lines [509].
Another example showing the importance of using correct models is related to erucic acid toxicity. In the United States and many European countries, consumption and import of mustard oil are restricted due to the high erucic acid profile. While no adverse effects have been reported for human exposure to erucic acid, acceptance levels have been determined based solely on animal models [54], with no direct analysis of acceptance levels for human exposure. To date, there are no known human clinical trials conducted to evaluate the therapeutic activity of the individual chemical components of mustard.
A mixture of multiple plant secondary metabolites can have synergistic effects but also can even antagonize the activity of each other [321]. For instance, the effect of iberin on modifying phase I and phase II detoxification enzymes in experimental rats was shown to have an increased effect when combined with a mixture of glucosinolate derivatives than when given alone [152]. Complexation of some known drug molecules with the natural mustard secondary metabolite can also enhance or synergize the activity of the secondary metabolite or the activity of both of the molecules. For example, the complexation of allyl isothiocyanate with the known painkiller drug celecoxib, which alone has no evident anti-cancer activity, was found to exert greater inhibition of urinary bladder cancer growth and muscle invasion in a rat bladder cancer cell line than that of either allyl isothiocyanate or celecoxib alone [156]. To explore the effects of the chemical modification of individual natural mustard secondary metabolites, effects of concurrent administration or complexation with other molecules or chemical groups, more studies, including structure–activity relationship (SAR) and quantitative structure–activity relationship (qSAR) analysis and in silico approaches need to be carried out. Lots of work is still needed before the phytoconstituents of mustard seeds can make their way from traditional folklore uses into the modern mainstream medical domain.

7. Conclusions

The diverse components of mustards have been employed against a wide range of altered health conditions since their domestication in ancient times up until the contemporary days. However, the current scientific knowledge regarding the phytochemical composition and biological activities associated with Brassicaceae oilseeds and mustards, insights into their mechanism of action, and potential therapeutic applications is limited. The medicinal properties of these mustard species can be attributed to the diverse array of bioactive compounds they produce, including sulfur-containing glucosinolates, omega-3 fatty acids, terpenoids, phenylpropanoids, flavonoids, tannins, S-methyl cysteine sulfoxide, and trace elements. This study underlines and links traditional knowledge with contemporary scientific approaches to bridge the gap between ancient medicinal practices and modern healthcare solutions. The diversity in chemical nature and variety of bioactivities make them intriguing starting templates for the development of novel therapeutics. The information on the bioavailability and pharmacokinetics could be investigated using the latest technologies like UPLC-MS/MS, GC-MS/MS, and NMR-based metabolomics, and advanced animal and cell models could be used to determine the safe dose for human health benefits and ensure rational dosage regimen.

Author Contributions

Conceptualization and original draft preparation, M.R.; review and drafting revision, A.K.; review and editing, B.J.B., M.R. and A.K.; supervision, L.L. and B.J.B. All authors have read and agreed to the published version of the manuscript.

Funding

This study was undertaken as part of the first author’s PhD study who received an International Postgraduate Research Scholarship (IPRS), an Australian Postgraduate Award (APA) scholarship, and a Southern Cross Postgraduate Association grant to complete the study.

Acknowledgments

The authors acknowledge Sharon Wheeler and Jeff Smith from Southern Cross University Library for providing resources for this study.

Conflicts of Interest

Southern Cross Analytical Services is an Analytical Services within Southern Cross University. Mahmudur Rahman and Amina Khatun are currently working there. Dr. Rahman is also confirming that there is no conflicts of interest among Mahmudur Rahman, Amina Khatun, and Southern Cross Analytical Services regarding the manuscript/study.

References

  1. Rahman, M.; Khatun, A.; Liu, L.; Barkla, B.J. Brassicaceae mustards: Traditional and agronomic uses in Australia and New Zealand. Molecules 2018, 23, 231. [Google Scholar] [CrossRef]
  2. Nesi, N.; Delourme, R.; Brégeon, M.; Falentin, C.; Renard, M. Genetic and molecular approaches to improve nutritional value of Brassica napus L. seed. Comptes Rendus Biol. 2008, 331, 763–771. [Google Scholar] [CrossRef]
  3. Chew, S.C. Cold pressed rapeseed (Brassica napus) oil. In Cold Pressed Oils; Elsevier: Amsterdam, The Netherlands, 2020; pp. 65–80. [Google Scholar]
  4. González-Pérez, S.; Arellano, J. Vegetable protein isolates. In Handbook of Hydrocolloids, 2nd ed.; Phillips, G.O., Williams, P.A., Eds.; Woodhead Publishing Limited: Sawston, UK, 2009; pp. 1–27. [Google Scholar]
  5. Callaway, R.M.; Ridenour, W.M. Novel weapons: Invasive success and the evolution of increased competitive ability. Front. Ecol. Environ. 2004, 2, 436–443. [Google Scholar] [CrossRef]
  6. Kumarasamy, Y.; Byres, M.; Cox, P.; Delazar, A.; Jaspars, M.; Nahar, L.; Shoeb, M.; Sarker, S. Isolation, structure elucidation, and biological activity of flavone 6-C-glycosides from Alliaria petiolata. Chem. Nat. Compd. 2004, 40, 122–128. [Google Scholar] [CrossRef]
  7. Wiersema, J.H.; Leon, B. World Economic Plants: A Standard Reference; CRC Press: Melbourne, VIC, Australia, 2016. [Google Scholar]
  8. Agnihotri, A.; Prem, D.; Gupta, K. Biotechnology in quality improvement of oilseed Brassicas. In Plant Biotechnology and Molecular Markers; Springer: Berlin/Heidelberg, Germany, 2004; pp. 144–155. [Google Scholar]
  9. Bai, S.; Malik, A.; Seasotiya, L.; Bharti, P.; Dalal, S. In vitro antioxidant activity, total phenolic content and therapeutic potential of Brassica campestris L. (Brassicaceae) seed in inhibiting human pathogens. Int. J. Recent Adv. Pharm. Res. 2014, 4, 15–24. [Google Scholar]
  10. Kabir, S.M.R.; Rahman, M.; Khatun, A.; Saha, S.; Roy, A.; Rashid, A.H.M.A.; Hossain, S.J.; Mahmud, A. Total flavonoids content and reducing power assay of twelve common Bangladeshi leafy vegetables. PharmacologyOnline 2016, 2016, 6–14. [Google Scholar]
  11. Labana, K.S.; Banga, S.S.; Banga, S.K. Breeding Oilseed Brassicas; Springer: Berlin/Heidelberg, Germany, 2013. [Google Scholar]
  12. Lozano-Baena, M.-D.; Tasset, I.; Obregón-Cano, S.; de Haro-Bailon, A.; Muñoz-Serrano, A.; Alonso-Moraga, Á. Antigenotoxicity and tumor growing inhibition by leafy Brassica carinata and sinigrin. Molecules 2015, 20, 15748. [Google Scholar] [CrossRef] [PubMed]
  13. Cui, W.; Eskin, N.; Biliaderis, C. Chemical and physical properties of yellow mustard (Sinapis alba L.) mucilage. Food Chem. 1993, 46, 169–176. [Google Scholar] [CrossRef]
  14. Yang, R.; Zhou, Q.; Wen, C.; Hu, J.; Li, H.; Zhao, M.; Zhao, H. Mustard seed (Sinapis alba Linn) attenuates imiquimod-induced psoriasiform inflammation of BALB/c mice. J. Dermatol. 2013, 40, 543–552. [Google Scholar] [CrossRef]
  15. Hedrick, U. Sturtevant’s Edible Plants of the World; Dover: New York, NY, USA, 1972; 686p. [Google Scholar]
  16. Hill, F. How to Grow Microgreens: Nature’s Own Superfood; David Bateman: Auckland, New Zealand, 2011. [Google Scholar]
  17. Houbein, L. One Magic Square: Grow Your Own Food on One Square Metre; Wakefield Press: Adelaide, SA, Australia, 2008. [Google Scholar]
  18. Jham, G.N.; Moser, B.R.; Shah, S.N.; Holser, R.A.; Dhingra, O.D.; Vaughn, S.F.; Berhow, M.A.; Winkler-Moser, J.K.; Isbell, T.A.; Holloway, R.K. Wild Brazilian mustard (Brassica juncea L.) seed oil methyl esters as biodiesel fuel. J. Am. Oil Chem. Soc. 2009, 86, 917–926. [Google Scholar] [CrossRef]
  19. Salama, H.M.; Al Watban, A.A.; Al-Fughom, A.T. Effect of ultraviolet radiation on chlorophyll, carotenoid, protein and proline contents of some annual desert plants. Saudi J. Biol. Sci. 2011, 18, 79–86. [Google Scholar] [CrossRef]
  20. Li, L.F.; Olsen, K.M. Chapter Three—To Have and to Hold: Selection for Seed and Fruit Retention During Crop Domestication. In Current Topics in Developmental Biology; Orgogozo, V., Ed.; Academic Press: Cambridge, MA, USA, 2016; Volume 119, pp. 63–109. [Google Scholar]
  21. Saeidnia, S.; Gohari, A.R. Importance of Brassica napus as a medicinal food plant. J. Med. Plants Res. 2012, 6, 2700–2703. [Google Scholar] [CrossRef]
  22. Sinha, S.; Jha, J.K.; Maiti, M.K.; Basu, A.; Mukhopadhyay, U.K.; Sen, S.K. Metabolic engineering of fatty acid biosynthesis in Indian mustard (Brassica juncea) improves nutritional quality of seed oil. Plant Biotechnol. Rep. 2007, 1, 185–197. [Google Scholar] [CrossRef]
  23. Thompson, L.U.; Liu, R.F.K.; Jones, J.D. Functional Properties and Food Applications of Rapeseed Protein Concentrate. J. Food Sci. 1982, 47, 1175–1180. [Google Scholar] [CrossRef]
  24. Greve, M.; Leyel, C.F. A Modern Herbal; Merchant Books: Dublin, Ireland, 1973. [Google Scholar]
  25. Kim, J.W.; Minamikawa, T. Hydroxyl radical-scavenging effects of spices and scavengers from brown mustard (Brassica nigra). Biosci. Biotechnol. Biochem. 1997, 61, 118–123. [Google Scholar]
  26. Oduor, A.M.; Lankau, R.A.; Strauss, S.Y.; Gómez, J.M. Introduced Brassica nigra populations exhibit greater growth and herbivore resistance but less tolerance than native populations in the native range. New Phytol. 2011, 191, 536–544. [Google Scholar] [CrossRef]
  27. Lim, T.K. Edible Medicinal and Non-Medicinal Plants; Springer: Dordrecht, The Netherlands, 2013; Volume 5, Fruits. [Google Scholar]
  28. Mailer, R.J.; McFadden, A.; Ayton, J.; Redden, B. Anti-nutritional components, fibre, sinapine and glucosinolate content, in Australian canola (Brassica napus L.) meal. J. Am. Oil Chem. Soc. 2008, 85, 937–944. [Google Scholar] [CrossRef]
  29. Rękas, A.; Wroniak, M.; Krygier, K. Effects of different roasting conditions on the nutritional value and oxidative stability of high-oleic and yellow-seeded Brassica napus oils. Grasas Aceites 2015, 66, e092. [Google Scholar] [CrossRef]
  30. Zareba, G.; Serradelf, N. Chemoprotective effects of broccoli and other Brassica vegetables. Drugs Future 2004, 29, 1097–1104. [Google Scholar] [CrossRef]
  31. Zekic, M.; Radonic, A.; Marijanovic, Z. Glucosinolate profiling of Calepina irregularis. Nat. Prod. Commun. 2016, 11, 1329–1332. [Google Scholar]
  32. Cojocariu, R.O.; Balmus, I.-M.; Lefter, R.; Hritcu, L.; Ababei, D.C.; Ciobica, A.; Copaci, S.; Mot, S.E.; Copolovici, L.; Copolovici, D.M. Camelina sativa Methanolic and Ethanolic Extract Potential in Alleviating Oxidative Stress, Memory Deficits, and Affective Impairments in Stress Exposure-Based Irritable Bowel Syndrome Mouse Models. Oxid. Med. Cell. Longev. 2020, 2020, 9510305. [Google Scholar] [CrossRef] [PubMed]
  33. Ghidoli, M.; Geuna, F.; De Benedetti, S.; Frazzini, S.; Landoni, M.; Cassani, E.; Scarafoni, A.; Rossi, L.; Pilu, S.R. Genetic study of Camelina sativa oilseed crop and selection of a new variety by the bulk method. Front. Plant Sci. 2024, 15, 1385332. [Google Scholar] [CrossRef]
  34. Huang, X.; Renwick, J.; Sachdev-Gupta, K. A chemical basis for differential acceptance of Erysimum cheiranthoides by two Pieris species. J. Chem. Ecol. 1993, 19, 195–210. [Google Scholar] [CrossRef] [PubMed]
  35. Azimova, S.S.; Glushenkova, A.I.; Vinogradova, V.I. Lipids, Lipophilic Components and Essential Oils from Plant Sources; Springer: London, UK, 2011. [Google Scholar]
  36. Walsh, N.G.; Entwisle, T.J. Flora of Victoria: Dicotyledons: Winteraceae to Myrtaceae; Inkata Press: Melbourne, VIC, Australia, 1996; Volume 3. [Google Scholar]
  37. Angelo, R.; Boufford, D.E. Atlas of the flora of New England: Salicaceae to Brassicaceae. Phytoneuron 2011, 12, 1–16. [Google Scholar]
  38. Blažević, I.; Radonić, A.; Mastelić, J.; Zekić, M.; Skočibušić, M.; Maravić, A. Hedge mustard (Sisymbrium officinale): Chemical diversity of volatiles and their antimicrobial activity. Chem. Biodivers. 2010, 7, 2023–2034. [Google Scholar] [CrossRef] [PubMed]
  39. Di Sotto, A.; Vitalone, A.; Nicoletti, M.; Piccin, A.; Mazzanti, G. Pharmacological and phytochemical study on a Sisymbrium officinale Scop. extract. J. Ethnopharmacol. 2010, 127, 731–736. [Google Scholar] [CrossRef]
  40. Grieve, M. A Modern Herbal; Penguin Books: Melbourne, Australia, 1984. [Google Scholar]
  41. Lust, J. The Herb Book; Penguin Books: Melbourne, Austraslia, 1983. [Google Scholar]
  42. Buckley, R. Alien plants in central Australia. Bot. J. Linn. Soc. 1981, 82, 369–379. [Google Scholar] [CrossRef]
  43. Gruenwald, J.; Brendler, T.; Jaenicke, C. PDR for Herbal Medicines; Medical Economics Company, Inc.: Montvale, NJ, USA, 2000. [Google Scholar]
  44. Awaad, A.S.; Al-Jaber, N.A. Antioxidant natural plant. RPMP Ethnomed. Source Mech. 2010, 27, 1–35. [Google Scholar]
  45. Azimova, S.S.; Glushenkova, A.I. Sisymbrium erysimoides (Desf.). In Lipids, Lipophilic Components and Essential Oils from Plant Sources; Azimova, S.S., Glushenkova, A.I., Eds.; Springer: London, UK, 2012; p. 274. [Google Scholar]
  46. Iranshahi, M. A review of volatile sulfur-containing compounds from terrestrial plants: Biosynthesis, distribution and analytical methods. J. Essent. Oil Res. 2012, 24, 393–434. [Google Scholar] [CrossRef]
  47. Warwick, S.I. Brassicaceae in agriculture. In Genetics and Genomics of the Brassicaceae; Springer: Berlin/Heidelberg, Germany, 2011; pp. 33–65. [Google Scholar]
  48. Hemphill, J.; Hemphill, R. Book of Herbs and Spices; Omega: London, UK, 1984. [Google Scholar]
  49. Murdoch, R. Maori Healing and Herbal: New Zealand Ethnobotanical Sourcebook; Viking Sevenseas: Paraparaumu, New Zealand, 1994. [Google Scholar]
  50. Stewart, A. A review of Brassica species, cross-pollination and implications for pure seed production in New Zealand. Agron. N. Z. 2002, 32, 63–82. [Google Scholar]
  51. Webb, C.J.; Sykes, W.R.; Garnock-Jones, P.J. Flora of New Zealand. Vol. IV. Naturalised Pteridophytes, Gymnosperms, Dicotyledons; Botany Division DSIR: Christchurch, New Zealand, 1988.
  52. Wilson, H. ‘Alpine Plants—Highest of All’, Te Ara—The Encyclopedia of New Zealand. Available online: http://www.TeAra.govt.nz/en/alpine-plants/page-4 (accessed on 19 November 2019).
  53. Williams, P.M. Te Rongoa Maori: Maori Medicine; Reed Books: Birkenhead, UK, 1996; 79p, ISBN 790005107. [Google Scholar]
  54. Food Standards Australia New Zealand. Commonwealth of Australia, 2009. ISSN 1446-9685. Available online: https://www.foodstandards.gov.au/sites/default/files/food-standards-code/changes/gazette/Documents/Gazette%20Notice%20Amendment%20No%20112%20WEB%20VERSION.pdf (accessed on 2 August 2017).
  55. Rahman, S.; Parvez, A.K.; Islam, R.; Khan, M.H. Antibacterial activity of natural spices on multiple drug resistant Escherichia coli isolated from drinking water, Bangladesh. Ann. Clin. Microbiol. Antimicrob. 2011, 10, 10. [Google Scholar] [CrossRef] [PubMed]
  56. Raymer, P.L. Canola: An emerging oilseed crop. Trends New Crops New Uses 2002, 1, 122–126. [Google Scholar]
  57. Rahman, M. Identification, Molecular and Proteomic Characterisation of Brassica rapa Seed Storage Proteins with Allergenic and Antimicrobial Potential. Ph.D. Thesis, Southern Cross University, Lismore, NSW, Australia, 2020. [Google Scholar]
  58. Khattab, R.; Rempel, C.; Suh, M.; Thiyam, U. Quality of Canola oil obtained by conventional and supercritical fluid extraction. Am. J. Anal. Chem. 2012, 3, 966–976. [Google Scholar] [CrossRef]
  59. Shahidi, F. Canola and Rapeseed: Production, Chemistry, Nutrition, and Processing Technology; Springer Science & Business Media: New York, NY, USA, 1990. [Google Scholar]
  60. Fiocchi, A.; Dahdah, L.; Riccardi, C.; Mazzina, O.; Fierro, V. Preacutionary labelling of cross-reactive foods: The case of rapeseed. Asthma Res. Pract. 2016, 2, 13. [Google Scholar] [CrossRef] [PubMed]
  61. Shahidi, F.; Gabon, J.E. Individual glucosinolates in six Canola varieties. J. Food Qual. 1989, 11, 421–431. [Google Scholar] [CrossRef]
  62. Wanasundara, J.P.D. Proteins of Brassicaceae oilseeds and their potential as a plant protein source. Crit. Rev. Food Sci. Nutr. 2011, 51, 635–677. [Google Scholar] [CrossRef]
  63. Velisek, J. The Chemistry of Food; John Wiley & Sons: Hoboken, NJ, USA, 2013. [Google Scholar]
  64. He, Z.; Ji, R.; Havlickova, L.; Wang, L.; Li, Y.; Lee, H.T.; Song, J.; Koh, C.; Yang, J.; Zhang, M. Genome structural evolution in Brassica crops. Nat. Plants 2021, 7, 757–765. [Google Scholar] [CrossRef] [PubMed]
  65. Kang, L.; Qian, L.; Zheng, M.; Chen, L.; Chen, H.; Yang, L.; You, L.; Yang, B.; Yan, M.; Gu, Y. Genomic insights into the origin, domestication and diversification of Brassica juncea. Nat. Genet. 2021, 53, 1392–1402. [Google Scholar] [CrossRef] [PubMed]
  66. Li, J.; Qiu, M.; Ritonga, F.N.; Wang, F.; Zhou, D.; Li, C.; Li, H.; Zhang, Y.; Gao, J. Metabolite Profiling and Comparative Metabolomics Analysis of Jiaozhou Chinese Cabbage (Brassica rapa L. ssp. pekinensis) Planted in Different Areas. Front. Biosci. Landmark 2023, 28, 345. [Google Scholar]
  67. Liu, Y.; Rossi, M.; Liang, X.; Zhang, H.; Zou, L.; Ong, C.N. An integrated metabolomics study of glucosinolate metabolism in different Brassicaceae genera. Metabolites 2020, 10, 313. [Google Scholar] [CrossRef]
  68. Shu, J.; Ma, X.; Ma, H.; Huang, Q.; Zhang, Y.; Guan, M.; Guan, C. Transcriptomic, proteomic, metabolomic, and functional genomic approaches of Brassica napus L. during salt stress. PLoS ONE 2022, 17, e0262587. [Google Scholar] [CrossRef] [PubMed]
  69. Zhang, L.; Ma, C.; Chao, H.; Long, Y.; Wu, J.; Li, Z.; Ge, X.; Xia, H.; Yin, Y.; Batley, J. Integration of metabolome and transcriptome reveals flavonoid accumulation in the intergeneric hybrid between Brassica rapa and Raphanus sativus. Sci. Rep. 2019, 9, 18368. [Google Scholar] [CrossRef]
  70. Yang, J.; Liu, D.; Wang, X.; Ji, C.; Cheng, F.; Liu, B.; Hu, Z.; Chen, S.; Pental, D.; Ju, Y.; et al. The genome sequence of allopolyploid Brassica juncea and analysis of differential homoeolog gene expression influencing selection. Nat. Genet. 2016, 48, 1225. [Google Scholar] [CrossRef]
  71. Rahman, M.; Guo, Q.; Khartun, A.; Baten, A.; Mauleon, R.; Liu, L.; Barkla, B.J. Shotgun proteomics of Brassica rapa seed proteins identifies vicilin as a major seed storage protein in the mature seed. PLoS ONE 2021, 16, e0253384. [Google Scholar] [CrossRef] [PubMed]
  72. King, G.; Baten, A.; Mauleon, R.; Borapatragohain, P.; Rahman, M.; Barkla, B. Brassica Rapa Subsp. Trilocularis R-o-18 (NCBI:txid1813537) Genome Sequencing and Assembly; National Center for Biotechnology Information (NCBI): Bethesda, MD, USA, 2021.
  73. Rahman, M.; Baten, A.; Mauleon, R.; King, G.J.; Liu, L.; Barkla, B.J. Identification, characterization and epitope mapping of proteins encoded by putative allergenic napin genes from Brassica rapa. Clin. Exp. Allergy 2020, 50, 848–868. [Google Scholar] [CrossRef]
  74. Von Der Haar, D.; Müller, K.; Bader-Mittermaier, S.; Eisner, P. Rapeseed proteins–Production methods and possible application ranges. OCL 2014, 21, D104. [Google Scholar] [CrossRef]
  75. Wink, M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry 2003, 64, 3–19. [Google Scholar] [CrossRef] [PubMed]
  76. Hartmann, T. From waste products to ecochemicals: Fifty years research of plant secondary metabolism. Phytochemistry 2007, 68, 2831–2846. [Google Scholar] [CrossRef]
  77. Idrees, N.; Tabassum, B.; Sarah, R.; Hussain, M.K. Natural compound from genus brassica and their therapeutic activities. In Natural Bio-Active Compounds Volume 1: Production and Applications; Akhtar, M., Swamy, M., Sinniah, U., Eds.; Springer: Singapore, 2019; pp. 477–491. [Google Scholar]
  78. Jahangir, M.; Kim, H.K.; Choi, Y.H.; Verpoorte, R. Health-affecting compounds in Brassicaceae. Compr. Rev. Food Sci. Food Saf. 2009, 8, 31–43. [Google Scholar] [CrossRef]
  79. Mann, S.K.; Khanna, N. Health promoting effects of phytochemicals from Brassicaceae: A review. Indian J. Pharm 2013, 1, 3. [Google Scholar] [CrossRef]
  80. Shankar, S.; Segaran, G.; Sundar, R.D.V.; Settu, S.; Sathiavelu, M. Brassicaceae—A classical review on its pharmacological activities. Int. J. Pharm. Sci. Rev. Res. 2019, 55, 107–113. [Google Scholar]
  81. Ramirez, D.; Abellán-Victorio, A.; Beretta, V.; Camargo, A.; Moreno, D.A. Functional ingredients from Brassicaceae species: Overview and perspectives. Int. J. Mol. Sci. 2020, 21, 1998. [Google Scholar] [CrossRef]
  82. Bhat, M.; Gupta, M.; Banga, S.; Raheja, R.; Banga, S.; Rakow, G. Erucic acid heredity in Brassica juncea-some additional information. Plant Breed. 2002, 121, 456–458. [Google Scholar] [CrossRef]
  83. Burns, M.; Barnes, S.; Bowman, J.; Clarke, M.; Werner, C.; Kearsey, M. QTL analysis of an intervarietal set of substitution lines in Brassica napus: (i) Seed oil content and fatty acid composition. Heredity 2003, 90, 39–48. [Google Scholar] [CrossRef]
  84. George, L.; Abraham, V.; Suryavanshi, D.; Sipahimalani, A.; Srinivasan, V. Yield, oil content and fatty acid composition evaluated in androgenetic plants in Brassica juncea. Plant Breed. 1987, 98, 72–74. [Google Scholar] [CrossRef]
  85. Mutanen, M.; Freese, R.; Valsta, L.; Ahola, I.; Ahlström, A. Rapeseed oil and sunflower oil diets enhance platelet in vitro aggregation and thromboxane production in healthy men when compared with milk fat or habitual diets. Thromb. Haemost. 1992, 67, 352–356. [Google Scholar] [CrossRef] [PubMed]
  86. Sharafi, Y.; Majidi, M.M.; Goli, S.A.H.; Rashidi, F. Oil content and fatty acids composition in Brassica species. Int. J. Food Prop. 2015, 18, 2145–2154. [Google Scholar] [CrossRef]
  87. Valsta, L.M.; Jauhiainen, M.; Aro, A.; Katan, M.B.; Mutanen, M. Effects of a monounsaturated rapeseed oil and a polyunsaturated sunflower oil diet on lipoprotein levels in humans. Arterioscler. Thromb. Vasc. Biol. 1992, 12, 50–57. [Google Scholar] [CrossRef]
  88. Walsh, T.A.; Bevan, S.A.; Gachotte, D.J.; Larsen, C.M.; Moskal, W.A.; Merlo, P.A.O.; Sidorenko, L.V.; Hampton, R.E.; Stoltz, V.; Pareddy, D.; et al. Canola engineered with a microalgal polyketide synthase-like system produces oil enriched in docosahexaenoic acid. Nat. Biotechnol. 2016, 34, 881–887. [Google Scholar] [CrossRef]
  89. Lin, L.; Allemekinders, H.; Dansby, A.; Campbell, L.; Durance-Tod, S.; Berger, A.; Jones, P.J. Evidence of health benefits of canola oil. Nutr. Rev. 2013, 71, 370–385. [Google Scholar] [CrossRef]
  90. Preedy, V.R.; Watson, R.R.; Patel, V.B. Nuts and Seeds in Health and Disease Prevention; Academic Press: Cambridge, MA, USA, 2011. [Google Scholar]
  91. Linnemann, A.R.; Dijkstra, D.S. Toward sustainable production of protein-rich foods: Appraisal of eight crops for Western Europe. Part I. Analysis of the primary links of the production chain. Crit. Rev. Food Sci. Nutr. 2002, 42, 377–401. [Google Scholar] [CrossRef]
  92. Maršalkienė, N.; Sliesaravičius, A.; Karpavičienė, B.; Dastikaitė, A. Oil content and fatty acid composition of seeds of some Lithuanian wild crucifer species. Agron. Res. 2009, 7, 654–661. [Google Scholar]
  93. Singh, B.K.; Bala, M.; Rai, P.K. Fatty acid composition and seed meal characteristics of Brassica and allied genera. Natl. Acad. Sci. Lett. 2014, 37, 219–226. [Google Scholar] [CrossRef]
  94. Bretagnolle, F.; Matejicek, A.; Grégoire, S.; Reboud, X.; Gaba, S. Determination of fatty acids content, global antioxidant activity and energy value of weed seeds from agricultural fields in France. Weed Res. 2016, 56, 78–95. [Google Scholar] [CrossRef]
  95. Chen, B.; Heneen, W. Fatty acid composition of resynthesized Brassica napus L., B. campestris L. and B. alboglabra Bailey with special reference to the inheritance of erucic acid content. Heredity 1989, 63, 309–314. [Google Scholar] [CrossRef]
  96. Ostrikov, A.; Kleimenova, N.; Kopylov, M.; Bolgova, I. The study of the fatty acid composition of camelina oil obtained by cold pressing. IOP Conf. Ser. Earth Environ. Sci. 2021, 640, 042009. [Google Scholar] [CrossRef]
  97. Moser, B.R. Camelina (Camelina sativa L.) oil as a biofuels feedstock: Golden opportunity or false hope? Lipid Technol. 2010, 22, 270–273. [Google Scholar] [CrossRef]
  98. Riaz, R.; Ahmed, I.; Sizmaz, O.; Ahsan, U. Use of Camelina sativa and by-products in diets for dairy cows: A review. Animals 2022, 12, 1082. [Google Scholar] [CrossRef] [PubMed]
  99. Goffman, F.D.; Thies, W.; Velasco, L. Chemotaxonomic value of tocopherols in Brassicaceae. Phytochemistry 1999, 50, 793–798. [Google Scholar] [CrossRef]
  100. Abbadi, A.; Leckband, G. Rapeseed breeding for oil content, quality, and sustainability. Eur. J. Lipid Sci. Technol. 2011, 113, 1198–1206. [Google Scholar] [CrossRef]
  101. Food Standard Australia New Zealand. Technical Report 21—Erucic Acid in Food: A Toxicological Review and Risk Assessment; Food Standard Australia New Zealand: Canberra, ACT, Australia, 2003.
  102. Ghazani, S.; Marangoni, A. Nutrition and Food Grains in Encyclopedia of Food Grains; Academic Press: Cambridge, MA, USA, 2016. [Google Scholar]
  103. Nosenko, T.; Kot, T.; Kichshenko, V. Rape Seeds as a Source of Feed and Food Proteins. Pol. J. Food Nutr. Sci. 2014, 64, 109. [Google Scholar] [CrossRef]
  104. Murphy, D.J. The biotechnological utilisation of oilseeds. Acta Bot. Gall. 1993, 140, 767–777. [Google Scholar] [CrossRef]
  105. Wallace, H.; Knutsen, H.K.; Alexander, J.; Barregård, L.; Bignami, M.; Brüschweiler, B.; Ceccatelli, S.; Dinovi, M.; Edler, L.; Grasl-Kraupp, B. Erucic acid in feed and food. EFSA J. 2016, 14, e04593. [Google Scholar]
  106. Kramer, J.K.; Sauer, F.D.; Wolynetz, M.S.; Farnworth, E.R.; Johnston, K.M. Effects of dietary saturated fat on erucic acid induced myocardial lipidosis in rats. Lipids 1992, 27, 619–623. [Google Scholar] [CrossRef] [PubMed]
  107. Charlton, K.; Corner, A.; Davey, K.; Kramer, J.; Mahadevan, S.; Sauer, F. Cardiac lesions in rats fed rapeseed oils. Can. J. Comp. Med. 1975, 39, 261. [Google Scholar]
  108. Przybylski, R.; Mag, T.; Eskin, N.; McDonald, B. Canola oil. In Bailey’s Industrial Oil and Fat Products, 6th ed.; Shahidi, F., Ed.; John Wiley & Sons, Inc.: Milton, QLD, Australia, 2005; Volume 2, pp. 1–95. [Google Scholar]
  109. Slominski, B.A.; Kienzle, H.D.; Jiang, P.; Campbell, L.D.; Pickard, M.; Rakow, G. Chemical composition and nutritive value of canola-quality Sinapis alba mustared. In Proceedings of the 10th International Rapeseed Congress, Canberra, ACT, Australia, 26–29 September 1999; pp. 416–421. [Google Scholar]
  110. Goering, K.; Eslick, R.; Brelsford, D. A search for high erucic acid containing oils in the Cruciferae. Econ. Bot. 1965, 19, 251–256. [Google Scholar] [CrossRef]
  111. Bazinet, R.P.; Laye, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014, 15, 771–785. [Google Scholar] [CrossRef]
  112. Böttcher, C.; Pollmann, S. Plant oxylipins: Plant responses to 12-oxo-phytodienoic acid are governed by its specific structural and functional properties. FEBS J. 2009, 276, 4693–4704. [Google Scholar] [CrossRef] [PubMed]
  113. Pedras, M.S.C.; To, Q.H. Defense and signalling metabolites of the crucifer Erucastrum canariense: Synchronized abiotic induction of phytoalexins and galacto-oxylipins. Phytochemistry 2017, 139, 18–24. [Google Scholar] [CrossRef]
  114. Ryan, E.; Galvin, K.; O’Connor, T.P.; Maguire, A.R.; O’Brien, N.M. Phytosterol, squalene, tocopherol content and fatty acid profile of selected seeds, grains, and legumes. Plant Foods Hum. Nutr. 2007, 62, 85–91. [Google Scholar] [CrossRef] [PubMed]
  115. Meskin, M.S.; Bidlack, W.R.; Davies, A.J.; Omaye, S.T. Phytochemicals in Nutrition and Health; CRC Press: Boca Raton, FL, USA, 2002. [Google Scholar]
  116. Nollet, L.M.L.; Toldra, F. Handbook of Food Analysis, 3rd ed.; CRC Press: Boca Raton, FL, USA, 2015. [Google Scholar]
  117. Chahoud, G.; Aude, Y.W.; Mehta, J.L. Dietary recommendations in the prevention and treatment of coronary heart disease: Do we have the ideal diet yet? Am. J. Cardiol. 2004, 94, 1260–1267. [Google Scholar] [CrossRef] [PubMed]
  118. Batra, N. 1000 Indian Recipes; Houghton Mifflin Harcourt: Boston, MA, USA, 2011. [Google Scholar]
  119. Marwede, V.; Schierholt, A.; Möllers, C.; Becker, H.C. Genotype× environment interactions and heritability of tocopherol contents in canola. Crop Sci. 2004, 44, 728–731. [Google Scholar] [CrossRef]
  120. Carey, F.A.; Giuliano, R.M. Organic Chemistry; The McGraw-Hill Companies, Inc.: New York, NY, USA, 2011. [Google Scholar]
  121. Steinbrecher, A.; Linseisen, J. Dietary intake of individual glucosinolates in participants of the EPIC-Heidelberg cohort study. Ann. Nutr. Metab. 2009, 54, 87–96. [Google Scholar] [CrossRef] [PubMed]
  122. CABI Invasive Species Compendium. Available online: www.cabi.org/isc (accessed on 7 November 2019).
  123. Duke, J.A. Handbook of Energy Crops; Center for New Crops & Plants Products: Sydney, NSW, Australia, 1983. [Google Scholar]
  124. Guil-Guerrero, J.L.; GIimenea-Martinez, J.J.; Torija-Isasa, M.E. Nutritional composition of wild edible crucifer species. J. Food Biochem. 1999, 23, 283–294. [Google Scholar] [CrossRef]
  125. Duma, M.; Alsina, I.; Zeipina, S.; Lepse, L.; Dubova, L. Leaf vegetables as source of phytochemicals. In Proceedings of the 9th Baltic Conference on Food Science and Technology “Food for Consumer Well-Being”, Latvia University of Life Sciences and Technologies, Jelgava, Latvia, 8–9 May 2014; FOODBALT 2014 Conference Proceedings: Jelgava, Latvia, 2014; pp. 262–265. [Google Scholar]
  126. Mansour, E.H.; Dworschák, E.; Lugasi, A.; Gaál, Ö.; Barna, É.; Gergely, A. Effect of processing on the antinutritive factors and nutritive value of rapeseed products. Food Chem. 1993, 47, 247–252. [Google Scholar] [CrossRef]
  127. Chopra, R.; Nayar, S.; Chopra, I. Glossary of Indian Medicinal Plants; Council of Scientific and Industrial Research: New Delhi, India, 1986; pp. 2–79. [Google Scholar]
  128. Teh, S.-S.; Birch, J. Physicochemical and quality characteristics of cold-pressed hemp, flax and canola seed oils. J. Food Compos. Anal. 2013, 30, 26–31. [Google Scholar] [CrossRef]
  129. Gibney, M.J.; Lanham-New, S.A.; Cassidy, A.; Vorster, H.H. Introduction to Human Nutrition; Wiley-Blackwell: Chichester, UK, 2002. [Google Scholar]
  130. Claussen, F.A.; Taylor, M.L.; Breeze, M.L.; Liu, K. Measurement of vitamin k1 in commercial canola cultivars from growing locations in north and south America using high-performance liquid chromatography–tandem mass spectrometry. J. Agric. Food Chem. 2015, 63, 1076–1081. [Google Scholar] [CrossRef]
  131. Bukhari, S.A.B.H. Mustard as Medicinal Plant: Sources, Botanical Features, Genetics and Applications. Sch. Bull. 2021, 7, 123–129. [Google Scholar]
  132. Bhandari, S.; Jo, J.; Lee, J. Comparison of glucosinolate profiles in different tissues of nine Brassica crops. Molecules 2015, 20, 15827. [Google Scholar] [CrossRef]
  133. Nyerges, C. Foraging Wild Edible Plants of North America: More than 150 Delicious Recipes Using Nature’s Edibles; FalconGuides: Helena, MT, USA, 2016. [Google Scholar]
  134. Pengelly, A. The Constituents of Medicinal Plants: An Introduction to the Chemistry and Therapeutics of Herbal Medicine; University of Newcastle: Newcastle, NSW, Australia, 2004; Volume 108, pp. 28–159. [Google Scholar]
  135. Ishida, M.; Hara, M.; Fukino, N.; Kakizaki, T.; Morimitsu, Y. Glucosinolate metabolism, functionality and breeding for the improvement of Brassicaceae vegetables. Breed. Sci. 2014, 64, 48–59. [Google Scholar] [CrossRef]
  136. Wittstock, U.; Halkier, B.A. Glucosinolate research in the Arabidopsis era. Trends Plant Sci. 2002, 7, 263–270. [Google Scholar] [CrossRef]
  137. Mazumder, A.; Dwivedi, A.; du Plessis, J. Sinigrin and its therapeutic benefits. Molecules 2016, 21, 416. [Google Scholar] [CrossRef]
  138. Rangkadilok, N.; Nicolas, M.E.; Bennett, R.N.; Premier, R.R.; Eagling, D.R.; Taylor, P.W.J. Determination of sinigrin and glucoraphanin in Brassica species using a simple extraction method combined with ion-pair HPLC analysis. Sci. Hortic. 2002, 96, 27–41. [Google Scholar] [CrossRef]
  139. Neugart, S.; Baldermann, S.; Hanschen, F.S.; Klopsch, R.; Wiesner-Reinhold, M.; Schreiner, M. The intrinsic quality of brassicaceous vegetables: How secondary plant metabolites are affected by genetic, environmental, and agronomic factors. Sci. Hortic. 2018, 233, 460–478. [Google Scholar] [CrossRef]
  140. Sun, B.; Liu, N.; Zhao, Y.; Yan, H.; Wang, Q. Variation of glucosinolates in three edible parts of Chinese kale (Brassica alboglabra Bailey) varieties. Food Chem. 2011, 124, 941–947. [Google Scholar] [CrossRef]
  141. Robin, A.H.K.; Hossain, M.R.; Park, J.-I.; Kim, H.R.; Nou, I.-S. Glucosinolate profiles in cabbage genotypes influence the preferential feeding of diamondback moth (Plutella xylostella). Front. Plant Sci. 2017, 8, 1244. [Google Scholar] [CrossRef]
  142. Sugiyama, R.; Hirai, M.Y. Atypical Myrosinase as a Mediator of Glucosinolate Functions in Plants. Front. Plant Sci. 2019, 10, 1008. [Google Scholar] [CrossRef] [PubMed]
  143. Badenes-Pérez, F.R.; Reichelt, M.; Gershenzon, J.; Heckel, D.G. Phylloplane location of glucosinolates in Barbarea spp. (Brassicaceae) and misleading assessment of host suitability by a specialist herbivore. New Phytol. 2011, 189, 549–556. [Google Scholar] [CrossRef] [PubMed]
  144. Mithen, R. Glucosinolates–biochemistry, genetics and biological activity. Plant Growth Regul. 2001, 34, 91–103. [Google Scholar] [CrossRef]
  145. Benkeblia, N. Omics Technologies and Crop Improvement; CRC Press: Boca Raton, FL, USA, 2014. [Google Scholar]
  146. Fahey, J.W.; Zalcmann, A.T.; Talalay, P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001, 56, 5–51. [Google Scholar] [CrossRef] [PubMed]
  147. Liener, I. Toxic Constituents of Plant Foodstuffs; Elsevier: Amsterdam, The Netherlands, 2012. [Google Scholar]
  148. Son, H.-R.; Oh, S.-K.; Tsukamoto, C.; Choi, M.-R. ACE and α-glucosidase inhibitory activity of the glucosinolates in olsan Leaf mustard pickle during storage. KSBB J. 2016, 31, 165–170. [Google Scholar] [CrossRef]
  149. Tu, A. Handbook of Natural Toxins: Food Poisoning; Taylor & Francis: Abingdon, UK, 1992. [Google Scholar]
  150. Hayes, J.D.; Kelleher, M.O.; Eggleston, I.M. The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur. J. Nutr. 2008, 47, 73–88. [Google Scholar] [CrossRef]
  151. Park, M.-H.; Arasu, M.V.; Park, N.-Y.; Choi, Y.-J.; Lee, S.-W.; Al-Dhabi, N.A.; Kim, J.B.; Kim, S.-J. Variation of glucoraphanin and glucobrassicin: Anticancer components in Brassica during processing. Food Sci. Technol. 2013, 33, 624–631. [Google Scholar] [CrossRef]
  152. Peterson, C.J.; Tsao, R.; Coats, J.R. Glucosinolate aglucones and analogues: Insecticidal properties and a QSAR. Pestic. Sci. 1998, 54, 35–42. [Google Scholar] [CrossRef]
  153. Dinkova-Kostova, A.T.; Kostov, R.V. Glucosinolates and isothiocyanates in health and disease. Trends Mol. Med. 2012, 18, 337–347. [Google Scholar] [CrossRef]
  154. Rask, L.; Andréasson, E.; Ekbom, B.; Eriksson, S.; Pontoppidan, B.; Meijer, J. Myrosinase: Gene family evolution and herbivore defense in Brassicaceae. In Plant Molecular Evolution; Springer: Berlin/Heidelberg, Germany, 2000; pp. 93–113. [Google Scholar]
  155. Nastruzzi, C.; Cortesi, R.; Esposito, E.; Menegatti, E.; Leoni, O.; Iori, R.; Palmieri, S. In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis. J. Agric. Food Chem. 1996, 44, 1014–1021. [Google Scholar] [CrossRef]
  156. Bhattacharya, A.; Li, Y.; Shi, Y.; Zhang, Y. Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination. Carcinogenesis 2013, 34, 2593–2599. [Google Scholar] [CrossRef]
  157. Peng, C.; Zhao, S.-Q.; Zhang, J.; Huang, G.-Y.; Chen, L.-Y.; Zhao, F.-Y. Chemical composition, antimicrobial property and microencapsulation of Mustard (Sinapis alba) seed essential oil by complex coacervation. Food Chem. 2014, 165, 560–568. [Google Scholar] [CrossRef]
  158. Gupta, M. Pharmacological properties and traditional therapeutic uses of important Indian spices: A review. Int. J. Food Prop. 2010, 13, 1092–1116. [Google Scholar] [CrossRef]
  159. Gupta, M.; Shaw, B. Uses of medicinal plants in Panchakarma Ayurvedic therapy. Indian J. Tradit. Knowl. 2009, 8, 372–378. [Google Scholar]
  160. Dubey, N.K. Natural Products in Plant Pest Management; Centre for Agriculture and Bioscience International: Wallingford, UK, 2010. [Google Scholar]
  161. El-Beltagi, H.E.-D.S.; Mohamed, A.A. Variations in fatty acid composition, glucosinolate profile and some phytochemical contents in selected oil seed rape (Brassica napus L.) cultivars. Grasas Aceites 2010, 61, 143–150. [Google Scholar]
  162. Evans, W.C. Trease and Evans’ Pharmacognosy, 14th ed.; WB Saunders Company Ltd.: London, UK, 1997. [Google Scholar]
  163. Velasco, P.; Soengas, P.; Vilar, M.; Cartea, M.E.; del Rio, M. Comparison of glucosinolate profiles in leaf and seed tissues of different Brassica napus crops. J. Am. Soc. Hortic. Sci. 2008, 133, 551–558. [Google Scholar] [CrossRef]
  164. Xiao, D.; Srivastava, S.K.; Lew, K.L.; Zeng, Y.; Hershberger, P.; Johnson, C.S.; Trump, D.L.; Singh, S.V. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 2003, 24, 891–897. [Google Scholar] [CrossRef] [PubMed]
  165. Fauduet, H.; Coic, J.; Lessire, M.; Quinsac, A.; Ribaillier, D.; Rollin, P. Rapeseed meal upgrading—Pilot scale preparation of rapeseed meal materials with high or low glucosinolate contents. Anim. Feed Sci. Technol. 1995, 56, 99–109. [Google Scholar] [CrossRef]
  166. Oh, S.; Tsukamoto, C.; Kim, K.; Choi, M. Investigation of glucosinolates, and the antioxidant activity of Dolsan leaf mustard kimchi extract using HPLC and LC-PDA-MS/MS. J. Food Biochem. 2017, 41, e12366. [Google Scholar] [CrossRef]
  167. Horbowicz, M. The occurrence, role and contents of glucosinolates in Brassica vegetables. Vegetetable Crops Res. Bull. 2003, 58, 23–40. [Google Scholar]
  168. Stoner, G.D.; Morse, M.A. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett. 1997, 114, 113–119. [Google Scholar] [CrossRef]
  169. Lim, J.-H.; Kim, H.-W.; Jeon, J.-H.; Lee, H.-S. Acaricidal constituents isolated from Sinapis alba L. seeds and structure—Activity relationships. J. Agric. Food Chem. 2008, 56, 9962–9966. [Google Scholar] [CrossRef] [PubMed]
  170. Ernst, I.M.; Palani, K.; Esatbeyoglu, T.; Schwarz, K.; Rimbach, G. Synthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolin. Pharmacol. Res. 2013, 70, 155–162. [Google Scholar] [CrossRef] [PubMed]
  171. Watson, R.R.; Preedy, V.R. Bioactive Foods and Extracts: Cancer Treatment and Prevention; Taylor & Francis: Melbourne, VIC, Australia, 2010. [Google Scholar]
  172. Shapiro, T.A.; Fahey, J.W.; Dinkova-Kostova, A.T.; Holtzclaw, W.D.; Stephenson, K.K.; Wade, K.L.; Ye, L.; Talalay, P. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: A clinical phase I study. Nutr. Cancer 2006, 55, 53–62. [Google Scholar] [CrossRef] [PubMed]
  173. Singh, K.; Connors, S.L.; Macklin, E.A.; Smith, K.D.; Fahey, J.W.; Talalay, P.; Zimmerman, A.W. Sulforaphane treatment of autism spectrum disorder (ASD). Proc. Natl. Acad. Sci. USA 2014, 111, 15550–15555. [Google Scholar] [CrossRef]
  174. Raymond, S.M. Brassica Extracts or Sulforaphane in Combination with Resveratrol as Antitumor Agents. GB2363571A, 2 January 2000. [Google Scholar]
  175. Jadhav, U.; Ezhilarasan, R.; Vaughn, S.F.; Berhow, M.A.; Mohanam, S. Dietary isothiocyanate iberin inhibits growth and induces apoptosis in human glioblastoma cells. J. Pharmacol. Sci. 2007, 103, 247–251. [Google Scholar] [CrossRef]
  176. Al-Gendy, A.; El-Gindi, O.; Hafez, A.S.; Ateya, A. Glucosinolates, volatile constituents and biological activities of Erysimum corinthium Boiss. (Brassicaceae). Food Chem. 2010, 118, 519–524. [Google Scholar] [CrossRef]
  177. Avato, P.; D’Addabbo, T.; Leonetti, P.; Argentieri, M. Nematicidal potential of Brassicaceae. Phytochem. Rev. 2013, 12, 791–802. [Google Scholar] [CrossRef]
  178. Sayed, G.; Louveaux, A.; Mavratzotis, M.; Rollin, P.; Quinsac, A. Effects of glucobrassicin, epiprogoitrin and related breakdown products on locusts feeding: Schouwia purpurea and desert locust relationships. Entomol. Exp. Appl. 1996, 78, 231–236. [Google Scholar] [CrossRef]
  179. Guo, W.; Yuan, L.; Chen, P.; Guo, J. Determination of glucosinolates in rapeseeds by liquid chromatography–electrospray mass spectrometry. Anal. Lett. 2005, 38, 343–351. [Google Scholar] [CrossRef]
  180. Bunting, E.S. Production and Utilization of Protein in Oilseed Crops. In Proceedings of the Seminar in the EEC Programme of Coordination of Research on the Improvement of the Production of Plant Proteins, Institut für Pflanzenbau und Pflanzenzüchting, Braunschweig, Germany, 8–10 July 1980; Springer: Dordrecht, The Netherlands, 2012. [Google Scholar]
  181. Nilsson, T.; Rosenfeld, H.J. Symposium on Quality of Vegetables: Ås, Norway, 18–22 June 1984; International Society for Horticultural Science: Leuven, Belgium, 1984. [Google Scholar]
  182. Vageeshbabu, H.; Chopra, V. Genetic and biotechnological approaches for reducing glucosinolates from rapeseed-mustard meal. J. Plant Biochem. Biotechnol. 1997, 6, 53–62. [Google Scholar] [CrossRef]
  183. Lai, R.-H.; Miller, M.J.; Jeffery, E. Glucoraphanin hydrolysis by microbiota in the rat cecum results in sulforaphane absorption. Food Funct. 2010, 1, 161–166. [Google Scholar] [CrossRef] [PubMed]
  184. Tarozzi, A.; Angeloni, C.; Malaguti, M.; Morroni, F.; Hrelia, S.; Hrelia, P. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid. Med. Cell. Longev. 2013, 2013, 415078. [Google Scholar] [CrossRef]
  185. Prashar, A.; Siddiqui, F.; Singh, A.K. Synthetic and green vegetable isothiocyanates target red blood leukemia cancers. Fitoterapia 2012, 83, 255–265. [Google Scholar] [CrossRef]
  186. Mesimeri, I.-D.; Revelou, P.-K.; Constantinou-Kokotou, V.; Kokotou, M.G. Determination of phenethyl isothiocyanate, erucin, iberverin, and erucin nitrile concentrations in healthy and Pieris rapae-infected broccoli tissues using gas chromatography-mass spectrometry. Chemosensors 2024, 12, 16. [Google Scholar] [CrossRef]
  187. Matusheski, N.V.; Wallig, M.A.; Juvik, J.A.; Klein, B.P.; Kushad, M.M.; Jeffery, E.H. Preparative HPLC method for the purification of sulforaphane and sulforaphane nitrile from Brassica oleracea. J. Agric. Food Chem. 2001, 49, 1867–1872. [Google Scholar] [CrossRef] [PubMed]
  188. Matusheski, N.V.; Jeffery, E.H. Comparison of the bioactivity of two glucoraphanin hydrolysis products found in broccoli, sulforaphane and sulforaphane nitrile. J. Agric. Food Chem. 2001, 49, 5743–5749. [Google Scholar] [CrossRef] [PubMed]
  189. Aires, A.; Mota, V.; Saavedra, M.; Rosa, E.; Bennett, R. The antimicrobial effects of glucosinolates and their respective enzymatic hydrolysis products on bacteria isolated from the human intestinal tract. J. Appl. Microbiol. 2009, 106, 2086–2095. [Google Scholar] [CrossRef] [PubMed]
  190. Hanschen, F.S.; Herz, C.; Schlotz, N.; Kupke, F.; Bartolomé Rodríguez, M.M.; Schreiner, M.; Rohn, S.; Lamy, E. The Brassica epithionitrile 1-cyano-2, 3-epithiopropane triggers cell death in human liver cancer cells in vitro. Mol. Nutr. Food Res. 2015, 59, 2178–2189. [Google Scholar] [CrossRef] [PubMed]
  191. Hanschen, F.S.; Kaufmann, M.; Kupke, F.; Hackl, T.; Kroh, L.W.; Rohn, S.; Schreiner, M. Brassica vegetables as sources of epithionitriles: Novel secondary products formed during cooking. Food Chem. 2018, 245, 564–569. [Google Scholar] [CrossRef] [PubMed]
  192. Hanschen, F.S.; Schreiner, M. Isothiocyanates, Nitriles, and Epithionitriles from Glucosinolates Are Affected by Genotype and Developmental Stage in Brassica oleracea Varieties. Front. Plant Sci. 2017, 8, 1095. [Google Scholar] [CrossRef]
  193. Kumar, S.; Andy, A. Health promoting bioactive phytochemicals from Brassica. Int Food Res. J. 2012, 19, 141–152. [Google Scholar]
  194. Gland, A. Content and Pattern of Glucosinolates in Resynthesised Rapeseed. In Production and Utilization of Protein in Oilseed Crops, Proceedings of a Seminar in the EEC Programme of Coordination of Research on the Improvement of the Production of Plant Proteins, Institut für Pflanzenbau und Pflanzenzüchting, Braunschweig, Germany, 8–10 July 1980; Bunting, E.S., Ed.; Springer: Dordrecht, The Netherlands, 1981; pp. 127–135. [Google Scholar]
  195. Font, R.; del Río-Celestino, M.; Cartea, E.; de Haro-Bailón, A. Quantification of glucosinolates in leaves of leaf rape (Brassica napus ssp. pabularia) by near-infrared spectroscopy. Phytochemistry 2005, 66, 175–185. [Google Scholar]
  196. Hrncirik, K.; Valusek, J.; Velisek, J. Investigation of ascorbigen as a breakdown product of glucobrassicin autolysis in Brassica vegetables. Eur. Food Res. Technol. 2001, 212, 576–581. [Google Scholar] [CrossRef]
  197. Singh, N.P.; Singh, U.P.; Rouse, M.; Zhang, J.; Chatterjee, S.; Nagarkatti, P.S.; Nagarkatti, M. Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA. J. Immunol. 2016, 196, 1108–1122. [Google Scholar] [CrossRef]
  198. Patterson, C. Mustard: Protein, Mucilage and Bioactives; The Pathfinders: Sydney, NSW, Australia, 2016. [Google Scholar]
  199. Natella, F.; Maldini, M.; Leoni, G.; Scaccini, C. Glucosinolates redox activities: Can they act as antioxidants? Food Chem. 2014, 149, 226–232. [Google Scholar] [CrossRef] [PubMed]
  200. Pedras, M.S.C.; Zaharia, I.L. Sinalbins A and B, phytoalexins from Sinapis alba: Elicitation, isolation, and synthesis. Phytochemistry 2000, 55, 213–216. [Google Scholar] [CrossRef] [PubMed]
  201. Akagi, K.; Sano, M.; Ogawa, K.; Hirose, M.; Goshima, H.; Shirai, T. Involvement of toxicity as an early event in urinary bladder carcinogenesis induced by phenethyl isothiocyanate, benzyl isothiocyanate, and analogues in F344 rats. Toxicol. Pathol. 2003, 31, 388–396. [Google Scholar] [CrossRef] [PubMed]
  202. Thies, W. Isolation of sinigrin and glucotropaeolin from Cruciferous seeds. Lipid Fett 1988, 90, 311–314. [Google Scholar] [CrossRef]
  203. Vaughn, S.F.; Berhow, M.A. Allelochemicals isolated from tissues of the invasive weed garlic mustard (Alliaria petiolata). J. Chem. Ecol. 1999, 25, 2495–2504. [Google Scholar] [CrossRef]
  204. Stan, S.D.; Singh, S.V.; Whitcomb, D.C.; Brand, R.E. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model. Nutr. Cancer 2014, 66, 747–755. [Google Scholar] [CrossRef]
  205. Ordonez, A.A.; Bullen, C.K.; Villabona-Rueda, A.F.; Thompson, E.A.; Turner, M.L.; Merino, V.F.; Yan, Y.; Kim, J.; Davis, S.L.; Komm, O. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun. Biol. 2022, 5, 242. [Google Scholar] [CrossRef]
  206. Treasure, K.; Harris, J.; Williamson, G. Exploring the anti-inflammatory activity of sulforaphane. Immunol. Cell Biol. 2023, 101, 805–828. [Google Scholar] [CrossRef]
  207. Clarke, J.D.; Dashwood, R.H.; Ho, E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008, 269, 291–304. [Google Scholar] [CrossRef] [PubMed]
  208. Fang, J.; Reichelt, M.; Hidalgo, W.; Agnolet, S.; Schneider, B. Tissue-specific distribution of secondary metabolites in rapeseed (Brassica napus L.). PLoS ONE 2012, 7, e48006. [Google Scholar] [CrossRef] [PubMed]
  209. Cartea, M.E.; Francisco, M.; Soengas, P.; Velasco, P. Phenolic compounds in Brassica vegetables. Molecules 2010, 16, 251–280. [Google Scholar] [CrossRef]
  210. Kozlowska, H.; Rotkiewicz, D.A.; Zadernowski, R.; Sosulski, F.W. Phenolic acids in rapeseed and mustard. J. Am. Oil Chem. Soc. 1983, 60, 1119–1123. [Google Scholar] [CrossRef]
  211. Koubaa, M.; Mhemdi, H.; Sanlaville, Q.; Vorobiev, E. Recovery of Oil, Erucic Acid, and Phenolic Compounds from Rapeseed and Rocket Seeds. Chem. Eng. Technol. 2016, 39, 1431–1437. [Google Scholar] [CrossRef]
  212. Lim, T.K. Edible Medicinal and Non-Medicinal Plants. Volume 9: Modified Stems, Roots, Bulbs; Springer: Dordrecht, The Netherlands, 2015; Volume 9. [Google Scholar]
  213. Dubie, J.; Stancik, A.; Morra, M.; Nindo, C. Antioxidant extraction from mustard (Brassica juncea) seed meal using high-intensity ultrasound. J. Food Sci. 2013, 78, E542–E548. [Google Scholar] [CrossRef] [PubMed]
  214. Shahidi, F. Natural Antioxidants: Chemistry, Health Effects, and Applications; The American Oil Chemists Society: Urbana, IL, USA, 1997. [Google Scholar]
  215. Taghvaei, M.; Jafari, S.M. Application and stability of natural antioxidants in edible oils in order to substitute synthetic additives. J. Food Sci. Technol. 2015, 52, 1272–1282. [Google Scholar] [CrossRef]
  216. Tajkarimi, M.M.; Ibrahim, S.A.; Cliver, D.O. Antimicrobial herb and spice compounds in food. Food Control 2010, 21, 1199–1218. [Google Scholar] [CrossRef]
  217. Wijesundera, C.; Ceccato, C.; Fagan, P.; Shen, Z. Seed roasting improves the oxidative stability of canola (B. napus) and mustard (B. juncea) seed oils. Eur. J. Lipid Sci. Technol. 2008, 110, 360–367. [Google Scholar] [CrossRef]
  218. Siger, A.; Grygier, A.; Bąkowska, E.; Szczechowiak-Pigłas, J.; Bartkowiak-Broda, I. Phytochemical content of roasted seeds of three white mustard (Sinapis alba L.) varieties differing in their glucosinolate and erucic acid content. Ind. Crops Prod. 2024, 220, 119207. [Google Scholar] [CrossRef]
  219. Mizani, M.; Yousefi, M.; Rasouli, S.; Sharifan, A.; Bamani, M.M. The effect of different deheating processes on residual myrosinase activity, antimicrobial properties and total phenolic contents of yellow mustard (Sinapis alba). J. Food Biosci. Technol. 2016, 6, 1–12. [Google Scholar]
  220. Shahidi, F.; Varatharajan, V.; Oh, W.Y.; Peng, H. Phenolic compounds in agri-food by-products, their bioavailability and health effects. Food Bioact. 2019, 5, 57–119. [Google Scholar] [CrossRef]
  221. Hald, C.; Dawid, C.; Tressel, R.; Hofmann, T. Kaempferol 3-O-(2‴-O-sinapoyl-β-sophoroside) causes the undesired bitter taste of canola/rapeseed protein isolates. J. Agric. Food Chem. 2018, 67, 372–378. [Google Scholar] [CrossRef]
  222. Marnoch, R.; Diosady, L.L. Production of mustard protein isolates from oriental mustard seed (Brassica juncea L.). J. Am. Oil Chem. Soc. 2006, 83, 65–69. [Google Scholar] [CrossRef]
  223. Anjum, N.A.; Ahmad, I.; Pereira, M.E.; Duarte, A.C.; Umar, S.; Khan, N.A. The Plant Family Brassicaceae: Contribution Towards Phytoremediation; Springer: Dordrecht, The Netherlands, 2012. [Google Scholar]
  224. Heleno, S.A.; Martins, A.; Queiroz, M.J.R.; Ferreira, I.C. Bioactivity of phenolic acids: Metabolites versus parent compounds: A review. Food Chem. 2015, 173, 501–513. [Google Scholar] [CrossRef]
  225. Dileep, K.; Remya, C.; Cerezo, J.; Fassihi, A.; Pérez-Sánchez, H.; Sadasivan, C. Comparative studies on the inhibitory activities of selected benzoic acid derivatives against secretory phospholipase A 2, a key enzyme involved in the inflammatory pathway. Mol. BioSystems 2015, 11, 1973–1979. [Google Scholar] [CrossRef]
  226. Aider, M.; Barbana, C. Canola proteins: Composition, extraction, functional properties, bioactivity, applications as a food ingredient and allergenicity—A practical and critical review. Trends Food Sci. Technol. 2011, 22, 21–39. [Google Scholar] [CrossRef]
  227. Gruis, D.F.; Selinger, D.A.; Curran, J.M.; Jung, R. Redundant proteolytic mechanisms process seed storage proteins in the absence of seed-type members of the vacuolar processing enzyme family of cysteine proteases. Plant Cell 2002, 14, 2863–2882. [Google Scholar] [CrossRef] [PubMed]
  228. Wan, L.; Ross, A.R.; Yang, J.; Hegedus, D.D.; Kermode, A.R. Phosphorylation of the 12 S globulin cruciferin in wild-type and abi1-1 mutant Arabidopsis thaliana (thale cress) seeds. Biochem. J. 2007, 404, 247–256. [Google Scholar] [CrossRef] [PubMed]
  229. Wanasundara, J.P.; McIntosh, T.C.; Perera, S.P.; Withana-Gamage, T.S.; Mitra, P. Canola/rapeseed protein-functionality and nutrition. OCL 2016, 23, D407. [Google Scholar] [CrossRef]
  230. Schwenke, K. Rapeseed proteins. In New and Developing Sources of Food Proteins; Hudson, J.F., Ed.; Chapman and Hall: London, UK, 1994; pp. 281–306. [Google Scholar]
  231. Depree, J.; Howard, T.; Savage, G. Flavour and pharmaceutical properties of the volatile sulphur compounds of wasabi (Wasabia japonica). Food Res. Int. 1998, 31, 329–337. [Google Scholar] [CrossRef]
  232. Gulbransen, G.; Esernio-Jenssen, D. Aspiration of black mustard. J. Toxicol. Clin. Toxicol. 1998, 36, 591–593. [Google Scholar] [CrossRef]
  233. Jyothi, T.; Sinha, S.; Singh, S.A.; Surolia, A.; Rao, A.A. Napin from Brassica juncea: Thermodynamic and structural analysis of stability. Biochim. Biophys. Acta BBA Proteins Proteom. 2007, 1774, 907–919. [Google Scholar] [CrossRef] [PubMed]
  234. Hussain, S. Bioactive Compounds in Canola Meal. Ph.D. Thesis, Charles Sturt University, Bathurst, NSW, Australia, 2015. [Google Scholar]
  235. Kasprzak, M.; Houdijk, J.; Liddell, S.; Davis, K.; Olukosi, O.; Kightley, S.; White, G.; Wiseman, J. Raspeseed napin and cruciferin are readily digested by poultry. J. Anim. Physiol. Anim. Nutr. 2016, 101, 558–666. [Google Scholar]
  236. Bérot, S.; Compoint, J.; Larré, C.; Malabat, C.; Guéguen, J. Large scale purification of rapeseed proteins (Brassica napus L.). J. Chromatogr. B 2005, 818, 35–42. [Google Scholar] [CrossRef]
  237. Bos, C.; Airinei, G.; Mariotti, F.; Benamouzig, R.; Bérot, S.; Evrard, J.; Fénart, E.; Tomé, D.; Gaudichon, C. The poor digestibility of rapeseed protein is balanced by its very high metabolic utilization in humans. J. Nutr. 2007, 137, 594–600. [Google Scholar] [CrossRef]
  238. Li, J.; Gao, G.; Xu, K.; Chen, B.; Yan, G.; Li, F.; Qiao, J.; Zhang, T.; Wu, X. Genome-Wide Survey and Expression Analysis of the Putative Non-Specific Lipid Transfer Proteins in Brassica rapa L. PLoS ONE 2014, 9, e84556. [Google Scholar] [CrossRef] [PubMed]
  239. Naczk, M.; Shahidi, F. Carbohydrates of canola and rapeseed. In Canola and Rapeseed: Production, Chemistry, Nutrition and Processing Technology; Springer: New York, NY, USA, 1990; pp. 211–220. [Google Scholar]
  240. Biesek, J.; Kuźniacka, J.; Banaszak, M.; Kaczmarek, S.; Adamski, M.; Rutkowski, A.; Zmudzińska, A.; Perz, K.; Hejdysz, M. Growth Performance and Carcass Quality in Broiler Chickens Fed on Legume Seeds and Rapeseed Meal. Animals 2020, 10, 846. [Google Scholar] [CrossRef] [PubMed]
  241. Çakmakli, Ü.; Ünal, M.K. Composition and mineral distribution of rapeseed varieties tested for adaptation in Turkey. Lipid Fett 1988, 90, 386–389. [Google Scholar] [CrossRef]
  242. Khan, A.; Sankhyan, P.; Kumar, S. Biochemical characterization of Mustard Oil (Brassica campestris L.) with special reference to its fatty acid composition. Asian J. Adv. Basic Sci. 2013, 1, 1–9. [Google Scholar]
  243. Misra, A.; Kumar, S.; Verma, A.K.; Chanana, N.P.; Das, M.; Dhawan, V.; Dwivedi, P.D. Safety evaluation of genetically modified mustard (V4) seeds in terms of allergenicity. GM Crops Food 2012, 3, 273–282. [Google Scholar] [CrossRef]
  244. Sharif, R.; Paul, R.; Bhattacharjya, D.; Ahmed, K. Physicochemical characters of oilseeds from selected mustard genotypes. J. Bangladesh Agril. Univ. 2017, 15, 27–40. [Google Scholar] [CrossRef]
  245. Singh, P. Physico-chemical investigations of Mustard seed (Brassica juncea L). Int. J. Sci. Res. Multidiscip. Stud. 2018, 4, 24–27. [Google Scholar]
  246. Stojanović, Z.S.; Uletilović, D.D.; Kravić, S.Ž.; Kevrešan, Ž.S.; Grahovac, N.L.; Lončarević, I.S.; Đurović, A.D.; Marjanović Jeromela, A.M. Comparative Study of the Nutritional and Chemical Composition of New Oil Rape, Safflower and Mustard Seed Varieties Developed and Grown in Serbia. Plants 2023, 12, 2160. [Google Scholar] [CrossRef] [PubMed]
  247. Youssef, M.K.E.; El-Newihi, A.M.; Omar, S.M.; Ahmed, Z.S. Assessment of proximate chemical composition, nutritional status, fatty acid composition and antioxidants of curcumin (Zingiberaceae) and mustard seeds powders (Brassicaceae). Food Public Health 2014, 4, 286–292. [Google Scholar]
  248. British-Pharmacopoeia. British Bharmacopoeia; Spottiswoode and Co.: London, UK, 1867. [Google Scholar]
  249. Swami, S.S.T. The Ayurveda Encyclopedia: Natural Secrets to Healing, Prevention and Longevity; Sri Satguru Publication: New Delhi, India, 1998. [Google Scholar]
  250. Hashem, M.; Alamri, S.A.; Alrumman, S.A.; Moustafa, M.F. Suppression of phytopathogenic fungi by plant extract of some weeds and the possible mode of action. Br. Microbiol. Res. J. 2016, 15, 1–13. [Google Scholar] [CrossRef]
  251. Garland, S. The Complete Book of Herbs & Spices: An Illustrated Guide to Growing and Using Culinary, Aromatic, Cosmetic and Medicinal Plants; Hodder & Stoughton (Aust) Pty Ltd., Sydney & Aukland: Rydalmere, NSW, Australia, 1993. [Google Scholar]
  252. Turgis, M.; Han, J.; Caillet, S.; Lacroix, M. Antimicrobial activity of mustard essential oil against Escherichia coli O157: H7 and Salmonella typhi. Food Control 2009, 20, 1073–1079. [Google Scholar] [CrossRef]
  253. Khan, B.; Abraham, A.; Leelamma, S. Hypoglycemic action of Murraya koenigii (curry leaf) and Brassica juncea (mustard): Mechanism of action. Indian J. Biochem. Biophys. 1995, 32, 106. [Google Scholar]
  254. Srinivasan, K. Plant foods in the management of diabetes mellitus: Spices as beneficial antidiabetic food adjuncts. Int. J. Food Sci. Nutr. 2005, 56, 399–414. [Google Scholar] [CrossRef]
  255. Zargari, A. Medicinal Plants, 5th ed.; Tehran University Publications: Tehran, Iran, 2001; Volume 1. [Google Scholar]
  256. Thirumalai, T.; Therasa, S.V.; Elumalai, E.K.; David, E. Hypoglycemic effect of Brassica juncea (seeds) on streptozotocin induced diabetic male albino rat. Asian Pac. J. Trop. Biomed. 2011, 1, 323–325. [Google Scholar] [CrossRef] [PubMed]
  257. Roia, F.C. The use of plants in hair and scalp preparations. Econ. Bot. 1966, 20, 17–30. [Google Scholar] [CrossRef]
  258. Chiej, R. Encyclopaedia of Medicinal Plants; Macdonald & Co. (Publishers) Ltd.: London, UK, 1984. [Google Scholar]
  259. Quattrocchi, U. CRC World Dictionary of Medicinal and Poisonous Plants: Common Names, Scientific Names, Eponyms, Synonyms, and Etymology; CRC Press: Melbourne, VIC, Australia, 2016. [Google Scholar]
  260. Kayani, S.; Ahmad, M.; Zafar, M.; Sultana, S.; Khan, M.P.Z.; Ashraf, M.A.; Hussain, J.; Yaseen, G. Ethnobotanical uses of medicinal plants for respiratory disorders among the inhabitants of Gallies–Abbottabad, Northern Pakistan. J. Ethnopharmacol. 2014, 156, 47–60. [Google Scholar] [CrossRef]
  261. Shah, A.; Marwat, S.K.; Gohar, F.; Khan, A.; Bhatti, K.H.; Amin, M.; Din, N.U.; Ahmad, M.; Zafar, M. Ethnobotanical study of medicinal plants of semi-tribal area of Makerwal & Gulla Khel (lying between Khyber Pakhtunkhwa and Punjab Provinces), Pakistan. Am. J. Plant Sci. 2013, 4, 98–116. [Google Scholar]
  262. Kloss, J. Back to Eden: The Classic Guide to Medicine, Natural Foods and Home Remedies, 4th ed.; Lifeline Books: Adelaide, SA, Australia, 1974. [Google Scholar]
  263. Haq, F.; Ahmad, H.; Ullah, R.; Iqbal, Z. Species diversity and ethno botanical classes of the flora of Allai valley district Battagram Pakistan. Int. J. Plant Res. 2012, 2, 111–123. [Google Scholar] [CrossRef]
  264. Kizilarslan, Ç.; Özhatay, N. Wild plants used as medicinal purpose in the south part of İzmit (northwest Turkey). Turk. J. Pharm. Sci. 2012, 9, 199–218. [Google Scholar]
  265. Khare, C.P. Indian Medicinal Plants: An Illustrated Dictionary; Springer Science & Business Media: Berlin/Heidelberg, Germany, 2008. [Google Scholar]
  266. Eastwood, M.; Passmore, R. Dietary fibre. Lancet 1983, 322, 202–206. [Google Scholar] [CrossRef] [PubMed]
  267. Karpozilos, A.; Pavlidis, N. The treatment of cancer in Greek antiquity. Eur. J. Cancer 2004, 40, 2033–2040. [Google Scholar] [CrossRef] [PubMed]
  268. Qureshi, S.; Shah, A.H.; Tariq, M.; Ageel, A.M. Studies on herbal aphrodisiacs used in Arab system of medicine. Am. J. Chin. Med. 1989, 17, 57–63. [Google Scholar] [CrossRef] [PubMed]
  269. Foster, S.; Duke, J.A. A Field Guide to Medicinal Plants: Eastern and Central North America; Houghton Mifflin Company: Boston, MA, USA, 1990; 366p, ISBN 395353092. [Google Scholar]
  270. Hussain, A.; Khan, M.N.; Iqbal, Z.; Sajid, M.S. An account of the botanical anthelmintics used in traditional veterinary practices in Sahiwal district of Punjab, Pakistan. J. Ethnopharmacol. 2008, 119, 185–190. [Google Scholar] [CrossRef] [PubMed]
  271. Carlini, E.A.; Rodrigues, E.; Mendes, F.R.; Tabach, R.; Gianfratti, B. Treatment of drug dependence with Brazilian herbal medicines. Rev. Bras. Farmacogn. 2006, 16, 690–695. [Google Scholar] [CrossRef]
  272. Eichel, V.; Schüller, A.; Biehler, K.; Al-Ahmad, A.; Frank, U. Antimicrobial effects of mustard oil-containing plants against oral pathogens: An in vitro study. BMC Complement. Med. Ther. 2020, 20, 156. [Google Scholar] [CrossRef] [PubMed]
  273. Jo, S.H.; Cho, C.Y.; Ha, K.S.; Lee, J.Y.; Choi, H.Y.; Kwon, Y.I.; Apostolidis, E. In vitro and in vivo anti-hyperglycemic effects of green and red mustard leaves (Brassica juncea var. integrifolia). J. Food Biochem. 2018, 42, e12583. [Google Scholar] [CrossRef]
  274. Lietzow, J. Biologically active compounds in mustard seeds: A toxicological perspective. Foods 2021, 10, 2089. [Google Scholar] [CrossRef] [PubMed]
  275. Jang, M.; Hong, E.; Kim, G.H. Evaluation of Antibacterial Activity of 3-Butenyl, 4-Pentenyl, 2-Phenylethyl, and Benzyl Isothiocyanate in Brassica Vegetables. J. Food Sci. 2010, 75, M412–M416. [Google Scholar] [CrossRef]
  276. Borek, V.; Morra, M.J.; Brown, P.D.; McCaffrey, J.P. Allelochemicals produced during sinigrin decomposition in soil. J. Agric. Food Chem. 1994, 42, 1030–1034. [Google Scholar] [CrossRef]
  277. Brown, P.D.; Morra, M.J.; McCaffrey, J.P.; Auld, D.L.; Williams, L. Allelochemicals produced during glucosinolate degradation in soil. J. Chem. Ecol. 1991, 17, 2021–2034. [Google Scholar] [CrossRef] [PubMed]
  278. Aziz, M.; Karboune, S. Natural antimicrobial/antioxidant agents in meat and poultry products as well as fruits and vegetables: A review. Crit. Rev. Food Sci. Nutr. 2018, 58, 486–511. [Google Scholar] [CrossRef]
  279. Storm, D.R.; Rosenthal, K.S.; Swanson, P.E. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 1977, 46, 723–763. [Google Scholar] [CrossRef]
  280. Vernon, L.P.; Evett, G.E.; Zeikus, R.D.; Gray, W.R. A toxic thionin from Pyrularia pubera: Purification, properties, and amino acid sequence. Arch. Biochem. Biophys. 1985, 238, 18–29. [Google Scholar] [CrossRef] [PubMed]
  281. Rahman, M.; Browne, J.; Crugten, J.V.; Hasan, M.F.; Liu, L.; Barkla, B.J. In Silico, Molecular Docking and In Vitro Antimicrobial Activity of the Major Rapeseed Seed Storage Proteins. Front. Pharmacol. 2020, 11, 1340. [Google Scholar] [CrossRef]
  282. Ledger, E.V.; Sabnis, A.; Edwards, A.M. Polymyxin and lipopeptide antibiotics: Membrane-targeting drugs of last resort. Microbiology 2022, 168, 001136. [Google Scholar] [CrossRef] [PubMed]
  283. Drobnica, Ľ.; Zemanova, M.; Nemec, P.; Antoš, K.; Kristian, P.; Štullerová, A.; Knoppova, V. Antifungal activity of isothiocyanates and related compounds I. Naturally occurring isothiocyanates and their analogues. Appl. Microbiol. 1967, 15, 701–709. [Google Scholar] [CrossRef]
  284. Mari, M.; Leoni, O.; Iori, R.; Cembali, T. Antifungal vapour-phase activity of allyl-isothiocyanate against Penicillium expansum on pears. Plant Pathol. 2002, 51, 231–236. [Google Scholar] [CrossRef]
  285. Welke, J.E.; Hoeltz, M.; Dottori, H.A.; Noll, I.B. Patulin accumulation in apples during storage by Penicillium expansum and Penicillium griseofulvum Strains. Braz. J. Microbiol. 2011, 42, 172–180. [Google Scholar] [CrossRef] [PubMed]
  286. Bainard, L.; Brown, P.; Upadhyaya, M. Inhibitory effect of tall hedge mustard (Sisymbrium loeselii) allelochemicals on rangeland plants and arbuscular mycorrhizal fungi. Weed Sci. 2009, 57, 386–393. [Google Scholar] [CrossRef]
  287. Tesaki, S.; Tanabe, S.; Ono, H.; Fukushi, E.; Kawabata, J.; Watanabe, M. 4-Hydroxy-3-nitrophenylacetic and Sinapic Acids as Antibacterial Compounds from Mustard Seeds. Biosci. Biotechnol. Biochem. 1998, 62, 998–1000. [Google Scholar] [CrossRef]
  288. Meneguetti, B.T.; Machado, L.d.S.; Oshiro, K.G.N.; Nogueira, M.L.; Carvalho, C.M.E.; Franco, O.L. Antimicrobial Peptides from Fruits and Their Potential Use as Biotechnological Tools—A Review and Outlook. Front. Microbiol. 2017, 7, 2136. [Google Scholar] [CrossRef]
  289. Munir, A.; Iqbal, S.; Khaliq, B.; Saeed, Q.; Hussain, S.; Shah, K.H.; Ahmad, F.; Mehmood, S.; Ali, Z.; Munawar, A. In Silico Studies and Functional Characterization of a Napin Protein from Seeds of Brassica juncea. Int. J. Agric. Biol. 2019, 22, 1655–1662. [Google Scholar]
  290. Ngai, P.; Ng, T. A napin-like polypeptide from dwarf Chinese white cabbage seeds with translation-inhibitory, trypsin-inhibitory, and antibacterial activities. Peptides 2004, 25, 171–176. [Google Scholar] [CrossRef] [PubMed]
  291. Ngai, P.; Ng, T. A napin-like polypeptide with translation-inhibitory, trypsin-inhibitory, antiproliferative and antibacterial activities from kale seeds. Chem. Biol. Drug Des. 2004, 64, 202–208. [Google Scholar] [CrossRef]
  292. Nioi, C.; Kapel, R.; Rondags, E.; Marc, I. Selective extraction, structural characterisation and antifungal activity assessment of napins from an industrial rapeseed meal. Food Chem. 2012, 134, 2149–2155. [Google Scholar] [CrossRef]
  293. Rahman, M.; Browne, J.; Crugten, J.V.; Hasan, M.F.; Liu, L.; Barkla, B.J. In silico, molecular docking and in vitro evidences for rapeseed major seed storage proteins as antimicrobial peptides. In Proceedings of the Australasian Grain Science Association 2020 Online Conference, Charles Sturt University, Wagga Wagga, NSW, Australia, 26 August 2020. [Google Scholar]
  294. Rahman, M.; Khatun, A.; Liu, L.; Barkla, B. Identification of Allergenic Epitopes in the Sequences of Rapeseed Seed Proteins. In Proceedings of the First Canadian Peptide and Protein Community Virtual Symposium Session Peptide and Protein Applications in Cosmetic, Agricultural and High-Tech Products, Online, 27–28 May 2021. [Google Scholar]
  295. Wolfe, B.E.; Rodgers, V.L.; Stinson, K.A.; Pringle, A. The invasive plant Alliaria petiolata (garlic mustard) inhibits ectomycorrhizal fungi in its introduced range. J. Ecol. 2008, 96, 777–783. [Google Scholar] [CrossRef]
  296. Handley, T.N.; Li, W.; Welch, N.G.; O’Brien-Simpson, N.M.; Hossain, M.A.; Wade, J.D. Evaluation of Potential DnaK Modulating Proline-Rich Antimicrobial Peptides Identified by Computational Screening. Front. Chem. 2022, 10, 875233. [Google Scholar] [CrossRef] [PubMed]
  297. Barciszewski, J.; Maciej, S.; Haertlé, T. Minireview: Analysis of rape seed napin structure and potential roles of the storage protein. J. Protein Chem. 2000, 19, 249–254. [Google Scholar] [CrossRef] [PubMed]
  298. Rico, M.; Bruix, M.; González, C.; Monsalve, R.I.; Rodríguez, R. 1H NMR assignment and global fold of napin BnIb, a representative 2S albumin seed protein. Biochemistry 1996, 35, 15672–15682. [Google Scholar] [CrossRef] [PubMed]
  299. Taveira, G.B.; Mello, É.O.; Carvalho, A.O.; Regente, M.; Pinedo, M.; de La Canal, L.; Rodrigues, R.; Gomes, V.M. Antimicrobial activity and mechanism of action of a thionin-like peptide from Capsicum annuum fruits and combinatorial treatment with fluconazole against Fusarium solani. Pept. Sci. 2017, 108, e23008. [Google Scholar] [CrossRef] [PubMed]
  300. Ateeq, M.; Adeel, M.M.; Kanwal, A.; Tahir ul Qamar, M.; Saeed, A.; Khaliq, B.; Saeed, Q.; Atiq, M.N.; Bilal, M.; Alharbi, M.; et al. In Silico Analysis and Functional Characterization of Antimicrobial and Insecticidal Vicilin from Moth Bean (Vigna aconitifolia (Jacq.) Marechal) Seeds. Molecules 2022, 27, 3251. [Google Scholar] [CrossRef] [PubMed]
  301. Barbosa Pelegrini, P.; del Sarto, R.P.; Silva, O.N.; Franco, O.L.; Grossi-de-Sa, M.F. Antibacterial peptides from plants: What they are and how they probably work. Biochem. Res. Int. 2011, 2011, 9. [Google Scholar] [CrossRef] [PubMed]
  302. Duan, X.; Zhang, M.; Chen, F. Prediction and analysis of antimicrobial peptides from rapeseed protein using in silico approach. J. Food Biochem. 2021, 45, e13598. [Google Scholar] [CrossRef]
  303. Garcia, T.B.; Soares, A.A.; Costa, J.H.; Costa, H.P.S.; Neto, J.X.S.; Rocha-Bezerra, L.C.B.; Silva, F.D.A.; Arantes, M.R.; Sousa, D.O.B.; Vasconcelos, I.M.; et al. Gene expression and spatiotemporal localization of antifungal chitin-binding proteins during Moringa oleifera seed development and germination. Planta 2019, 249, 1503–1519. [Google Scholar] [CrossRef]
  304. Rahman, M.; Khatun, A.; Guo, Q.; Baten, A.; Mauleon, R.; King, G.J.; Browne, J.; Crugten, J.V.; Hasan, M.F.; Liu, L.; et al. Indexing and characterisation of a new class of protein from rapeseed Brassica rapa meal. In Research in Science and Engineering (RISE) Conference, 2021; Southern Cross University: Lismore, NSW, Australia, 2021. [Google Scholar]
  305. Ribeiro, S.F.F.; Taveira, G.B.; Carvalho, A.O.; Dias, G.B.; Da Cunha, M.; Santa-Catarina, C.; Rodrigues, R.; Gomes, V.M. Antifungal and other biological activities of two 2S albumin-homologous proteins against pathogenic fungi. Protein J. 2012, 31, 59–67. [Google Scholar] [CrossRef]
  306. Broekaert, W.F.; Cammue, B.P.A.; De Bolle, M.F.C.; Thevissen, K.; De Samblanx, G.W.; Osborn, R.W.; Nielson, K. Antimicrobial peptides from plants. Crit. Rev. Plant Sci. 1997, 16, 297–323. [Google Scholar] [CrossRef]
  307. Román, J.; Lagos, A.; Mahn, A.; Quintero, J. The Effect of Broccoli Glucosinolates Hydrolysis Products on Botrytis cinerea: A Potential New Antifungal Agent. Int. J. Mol. Sci. 2024, 25, 7945. [Google Scholar] [CrossRef]
  308. Jain, S.; Agarwal, S.; Malaiya, S. Antimycotic effect of fixed oils treated with herbal seeds on the growth of fungi causing otomycosis. Anc. Sci. Life 1993, 13, 160–164. [Google Scholar]
  309. Fotos, P.G.; Hellstein, J.W. Candida and candidosis: Epidemiology, diagnosis, and therapeutic management. Dent. Clin. N. Am. 1992, 36, 857–878. [Google Scholar] [CrossRef] [PubMed]
  310. Last, W. Heal Yourself the Natural Way Overcome Disease & Create Superior Health; Huckleberry Enterprises: Sydney, NSW, Australia, 2010. [Google Scholar]
  311. Bajpai, D.; Malaiappan, S.; Rajeshkumar, S. Evaluation of Anti-inflammatory and Antimicrobial Properties of Mustard Seed Extract-Based Hydrogel: An In Vitro Study. Cureus 2023, 15, e45146. [Google Scholar] [CrossRef]
  312. Rahman, M.; Afroz, M.; Liu, L.; Barkla, B.J. Rapeseed proteins-a treasure trove of bioactive peptides. In Phytochemical Society of Europe-Natural Product Scientists 2020 Summit; Khulna University: Khulna, Bangladesh, 2020. [Google Scholar]
  313. del Mar Yust, M.; Pedroche, J.; Megías, C.; Girón-Calle, J.; Alaiz, M.; Millán, F.; Vioque, J. Rapeseed protein hydrolysates: A source of HIV protease peptide inhibitors. Food Chem. 2004, 87, 387–392. [Google Scholar] [CrossRef]
  314. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free Radic. Biol. Med. 1997, 22, 749–760. [Google Scholar] [CrossRef]
  315. Kumar, M.; Sharma, S.; Vasudeva, N. In Vivo Assessment of Antihyperglycemic and Antioxidant Activity from Oil of Seeds of Brassica nigra in Streptozotocin Induced Diabetic Rats. Adv. Pharm. Bull. 2013, 3, 359–365. [Google Scholar]
  316. Anand, P.; Murali, K.; Tandon, V.; Chandra, R.; Murthy, P. Preliminary studies on antihyperglycemic effect of aqueous extract of Brassica nigra (L.) Koch in streptozotocin induced diabetic rats. Indian J. Exp. Biol. 2007, 45, 696. [Google Scholar]
  317. Grover, J.; Yadav, S.; Vats, V. Effect of feeding Murraya koeingii and Brassica juncea diet kidney functions and glucose levels in streptozotocin diabetic mice. J. Ethnopharmacol. 2003, 85, 1–5. [Google Scholar] [CrossRef]
  318. Grover, J.; Yadav, S.; Vats, V. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol. 2002, 81, 81–100. [Google Scholar] [CrossRef]
  319. Kim, K.; Nam, K.; Kurihara, H.; Kim, S. Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica. Phytochemistry 2008, 69, 2820–2825. [Google Scholar] [CrossRef] [PubMed]
  320. Bassaganya-Riera, J.; Skoneczka, J.; Kingston, D.; Krishnan, A.; Misyak, S.; Guri, A.; Pereira, A.; Carter, A.; Minorsky, P.; Tumarkin, R. Mechanisms of action and medicinal applications of abscisic acid. Curr. Med. Chem. 2010, 17, 467–478. [Google Scholar] [CrossRef]
  321. Khatun, A.; Rahman, M.; Rahman, M.M.; Hossain, H.; Jahan, I.A.; Nesa, M.L. Antioxidant, antinociceptive and CNS activities of Viscum orientale and high sensitive quantification of bioactive polyphenols by UPLC. Front. Pharmacol. 2016, 7, 176. [Google Scholar] [CrossRef]
  322. Traber, M.G.; Stevens, J.F. Vitamins C and E: Beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 2011, 51, 1000–1013. [Google Scholar] [CrossRef] [PubMed]
  323. Kris-Etherton, P.M.; Pearson, T.A.; Wan, Y.; Hargrove, R.L.; Moriarty, K.; Fishell, V.; Etherton, T.D. High–monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am. J. Clin. Nutr. 1999, 70, 1009–1015. [Google Scholar] [CrossRef]
  324. Parillo, M.; Rivellese, A.; Ciardullo, A.; Capaldo, B.; Giacco, A.; Genovese, S.; Riccardi, G. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin-dependent diabetic patients. Metabolism 1992, 41, 1373–1378. [Google Scholar] [CrossRef]
  325. Guévin, N.; Jacques, H.; Nadeau, A.; Galibois, I. Postprandial glucose, insulin, and lipid responses to four meals containing unpurified dietary fiber in non-insulin-dependent diabetes mellitus (NIDDM), hypertriglyceridemic subjects. J. Am. Coll. Nutr. 1996, 15, 389–396. [Google Scholar] [CrossRef]
  326. Khan, B.; Abraham, A.; Leelamma, S. Anti-oxidant effects of curry leaf, Murraya koenigii and mustard seeds, Brassica juncea in rats fed with high fat diet. Indian J. Exp. Biol. 1997, 35, 148. [Google Scholar]
  327. Begin, F.; Vachon, C.; Jones, J.; Wood, P.; Savoie, L. Effect of dietary fibers on glycemia and insulinemia and on gastrointestinal function in rats. Can. J. Physiol. Pharmacol. 1989, 67, 1265–1271. [Google Scholar] [CrossRef]
  328. Grover, J.K.; Yadav, S.; Vats, V. Hypoglycemic and antihyperglycemic effect of Brassica juncea diet and their effect on hepatic glycogen content and the key enzymes of carbohydrate metabolism. Mol. Cell. Biochem. 2002, 241, 95–101. [Google Scholar] [CrossRef] [PubMed]
  329. Sukanya, V.; Pandiyan, V.; Vijayarani, K.; Padmanath, K. A study on insulin levels and the expression of glut 4 in streptozotocin (STZ) induced diabetic rats treated with mustard oil diet. Indian J. Clin. Biochem. 2020, 35, 488–496. [Google Scholar] [CrossRef] [PubMed]
  330. Mehmood, A.; Zeb, A.; Ateeq, M.K. In vivo antidiabetic effects of phenolic compounds of spinach, mustard, and cabbage leaves in mice. Heliyon 2023, 9, e16616. [Google Scholar] [CrossRef] [PubMed]
  331. Zhao, Q.; Xu, H.; Hong, S.; Song, N.; Xie, J.; Yan, Z.; Wang, R.; Yang, P.; Jiang, X. Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice. Mol. Pharm. 2019, 16, 371–381. [Google Scholar] [CrossRef] [PubMed]
  332. Ellegård, L.; Andersson, H.; Bosaeus, I. Rapeseed oil, olive oil, plant sterols, and cholesterol metabolism: An ileostomy study. Eur. J. Clin. Nutr. 2005, 59, 1374–1378. [Google Scholar] [CrossRef] [PubMed]
  333. Sengupta, A.; Ghosh, M. Hypolipidemic effect of mustard oil enriched with medium chain fatty acid and polyunsaturated fatty acid. Nutrition 2011, 27, 1183–1193. [Google Scholar] [CrossRef]
  334. Vahouny, G.V.; Tombes, R.; Cassidy, M.M.; Kritchevsky, D.; Gallo, L.L. Dietary fibers: V. Binding of bile salts, phospholipids and cholesterol from mixed micelles by bile acid sequestrants and dietary fibers. Lipids 1980, 15, 1012–1018. [Google Scholar] [CrossRef] [PubMed]
  335. Pedersen, A.; Baumstark, M.W.; Marckmann, P.; Gylling, H.; Sandström, B. An olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets. J. Lipid Res. 2000, 41, 1901–1911. [Google Scholar] [CrossRef]
  336. Khan, B.A.; Abraham, A.; Leelamma, S. Murraya koenigii and Brassica juncea—Alterations on lipid profile in 1–2 dimethyl hydrazine induced colon carcinogenesis. Investig. New Drugs 1996, 14, 365–369. [Google Scholar] [CrossRef] [PubMed]
  337. Khan, B.A.; Abraham, A.; Leelamma, S. Role of Murraya koenigii (curry leaf) and Brassica juncea (Mustard) in lipid peroxidation. Indian J. Physiol. Pharmacol. 1996, 40, 155–158. [Google Scholar]
  338. Chen, W.-J.L.; Anderson, J.W.; Jennings, D. Propionate may mediate the hypocholesterolemic effects of certain soluble plant fibers in cholesterol-fed rats. Exp. Biol. Med. 1984, 175, 215–218. [Google Scholar] [CrossRef]
  339. Hunninghake, D.B.; Miller, V.T.; LaRosa, J.C.; Kinosian, B.; Brown, V.; Howard, W.; DiSerio, F.; O’Connor, R. Hypocholesterolemic effects of a dietary fiber supplement. Am. J. Clin. Nutr. 1994, 59, 1050–1054. [Google Scholar] [CrossRef] [PubMed]
  340. Chung, K.W. Advances in understanding of the role of lipid metabolism in aging. Cells 2021, 10, 880. [Google Scholar] [CrossRef]
  341. Howard, B.V. Insulin resistance and lipid metabolism. Am. J. Cardiol. 1999, 84, 28–32. [Google Scholar] [CrossRef]
  342. Kensler, T.W.; Egner, P.A.; Agyeman, A.S.; Visvanathan, K.; Groopman, J.D.; Chen, J.-G.; Chen, T.-Y.; Fahey, J.W.; Talalay, P. Keap1-Nrf2 signaling: A target for cancer prevention by sulforaphane. Top. Curr. Chem. 2013, 329, 163–177. [Google Scholar] [PubMed]
  343. Rahman, M.S. Handbook of Food Preservation; Taylor & Francis: Abingdon, UK, 1999. [Google Scholar]
  344. Altinoz, M.A.; Bilir, A.; Elmaci, İ. Erucic acid, a component of Lorenzo’s oil and PPAR-δ ligand modifies C6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem.-Biol. Interact. 2018, 294, 107–117. [Google Scholar] [CrossRef]
  345. Ishtiaque, S.; Khan, N.; Siddiqui, M.A.; Siddiqi, R.; Naz, S. Antioxidant potential of the extracts, fractions and oils derived from oilseeds. Antioxidants 2013, 2, 246–256. [Google Scholar] [CrossRef] [PubMed]
  346. Mayengbam, S.; Aachary, A.; Thiyam-Holländer, U. Endogenous phenolics in hulls and cotyledons of mustard and canola: A comparative study on its Sinapates and antioxidant capacity. Antioxidants 2014, 3, 544–558. [Google Scholar] [CrossRef] [PubMed]
  347. He, R.; Alashi, A.; Malomo, S.A.; Girgih, A.T.; Chao, D.; Ju, X.; Aluko, R.E. Antihypertensive and free radical scavenging properties of enzymatic rapeseed protein hydrolysates. Food Chem. 2013, 141, 153–159. [Google Scholar] [CrossRef]
  348. Rahman, M.; Khatun, A.; Nesa, M.L.; Hossain, H.; Jahan, I.A. Bioactive polyphenols from the methanol extract of Cnicus arvensis (L.) Roth demonstrated antinociceptive and central nervous system depressant activities in mice. Evid.-Based Complement. Altern. Med. 2015, 2015, 794729. [Google Scholar] [CrossRef]
  349. Rahman, M.K.A.; Rahman, S.M.; Rashid, M.A. Antioxidant, antimicrobial and cytotoxic activities of Vitis trifolia Linn. J. Dhaka Int. Univ. 2009, 1, 181–184. [Google Scholar]
  350. Alfadda, A.A.; Sallam, R.M. Reactive oxygen species in health and disease. BioMed Res. Int. 2012, 2012, 936486. [Google Scholar] [CrossRef]
  351. Eskin, N.; Raju, J.; Bird, R. Novel mucilage fraction of Sinapis alba L. (mustard) reduces azoxymethane-induced colonic aberrant crypt foci formation in F344 and Zucker obese rats. Phytomedicine 2007, 14, 479–485. [Google Scholar] [CrossRef]
  352. Wen, C.; Yang, R.; Hu, J.; Jiao, Z.; Yang, Y.; Yang, J.; Li, H.; Zhao, H. Effects of mustard seed on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice. J. South. Med. Univ. 2012, 32, 569–572. [Google Scholar]
  353. Kesanakurti, D.; Sareddy, G.R.; Babu, P.P.; Kirti, P.B. Mustard NPR1, a mammalian IκB homologue inhibits NF-κB activation in human GBM cell lines. Biochem. Biophys. Res. Commun. 2009, 390, 427–433. [Google Scholar] [CrossRef]
  354. Yap, J.L.; Worlikar, S.; MacKerell, A.D., Jr.; Shapiro, P.; Fletcher, S. Small molecule inhibitors of the ERK signalling pathway: Towards novel anti-cancer therapeutics. ChemMedChem 2011, 6, 38. [Google Scholar] [CrossRef]
  355. Kim, J.S.; Han, S.; Kim, H.; Won, S.Y.; Park, H.W.; Choi, H.; Choi, M.; Lee, M.Y.; Ha, I.J.; Lee, S.-G. Anticancer Effects of High Glucosinolate Synthesis Lines of Brassica rapa on Colorectal Cancer Cells. Antioxidants 2022, 11, 2463. [Google Scholar] [CrossRef] [PubMed]
  356. Virk, P.; Awad, M.A.; Alanazi, M.M.; Hendi, A.A.; Elobeid, M.; Ortashi, K.M.; Alrowaily, A.W.; Bahlool, T.; Aouaini, F. Putative anti-proliferative effect of Indian mustard (Brassica juncea) seed and its nano-formulation. Green Process. Synth. 2023, 12, 20228119. [Google Scholar] [CrossRef]
  357. Savio, A.L.V.; da Silva, G.N.; de Camargo, E.A.; Salvadori, D.M.F. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil). Mutat. Res. Fundam. Mol. Mech. Mutagen. 2014, 762, 40–46. [Google Scholar] [CrossRef]
  358. Cui, H.; Bashar, M.A.; Rady, I.; El-Naggar, H.A.; Abd El-Maoula, L.M.; Mehany, A.B. Antiproliferative activity, proapoptotic effect, and cell cycle arrest in human cancer cells of some marine natural product extract. Oxid. Med. Cell. Longev. 2020, 2020, 7948705. [Google Scholar] [CrossRef] [PubMed]
  359. Ahmed, A.G.; Hussein, U.K.; Ahmed, A.E.; Kim, K.M.; Mahmoud, H.M.; Hammouda, O.; Jang, K.Y.; Bishayee, A. Mustard seed (Brassica nigra) extract exhibits antiproliferative effect against human lung cancer cells through differential regulation of apoptosis, cell cycle, migration, and invasion. Molecules 2020, 25, 2069. [Google Scholar] [CrossRef]
  360. Bafna, S.; Pink, J. Mustard Seeds: A Potential Treatment for Colorectal Cancer: 1978. Off. J. Am. Coll. Gastroenterol. ACG 2012, 107, S807. [Google Scholar] [CrossRef]
  361. Zhang, Y. The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. Carcinogenesis 2011, 33, 2–9. [Google Scholar] [CrossRef]
  362. Conaway, C.C.; Wang, C.-X.; Pittman, B.; Yang, Y.-M.; Schwartz, J.E.; Tian, D.; McIntee, E.J.; Hecht, S.S.; Chung, F.-L. Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. Cancer Res. 2005, 65, 8548–8557. [Google Scholar] [CrossRef] [PubMed]
  363. Xiao, D.; Vogel, V.; Singh, S.V. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol. Cancer Ther. 2006, 5, 2931–2945. [Google Scholar] [CrossRef] [PubMed]
  364. Zhu, M.; Li, W.; Dong, X.; Chen, Y.; Lu, Y.; Lin, B.; Guo, J.; Li, M. Benzyl-isothiocyanate Induces Apoptosis and Inhibits migration and invasion of hepatocellular carcinoma cells in vitro. J. Cancer 2017, 8, 240–248. [Google Scholar] [CrossRef]
  365. Kim, S.-H.; Singh, S.V. p53 Independent Apoptosis by Benzyl Isothiocyanate in Human Breast Cancer Cells Is Mediated by Suppression of XIAP Expression. Cancer Prev. Res. 2010, 3, 718–726. [Google Scholar] [CrossRef]
  366. Xiao, D.; Powolny, A.A.; Singh, S.V. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J. Biol. Chem. 2008, 283, 30151–30163. [Google Scholar] [CrossRef]
  367. Wu, C.L.; Huang, A.C.; Yang, J.S.; Liao, C.L.; Lu, H.F.; Chou, S.T.; Ma, C.Y.; Hsia, T.C.; Ko, Y.C.; Chung, J.G. Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J. Orthop. Res. 2011, 29, 1199–1209. [Google Scholar] [PubMed]
  368. Zhang, Y.; Tang, L.; Gonzalez, V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol. Cancer Ther. 2003, 2, 1045–1052. [Google Scholar] [PubMed]
  369. Malikova, J.; Swaczynova, J.; Kolar, Z.; Strnad, M. Anticancer and antiproliferative activity of natural brassinosteroids. Phytochemistry 2008, 69, 418–426. [Google Scholar] [CrossRef]
  370. Steigerova, J.; Oklestkova, J.; Levkova, M.; Rarova, L.; Kolar, Z.; Strnad, M. Brassinosteroids cause cell cycle arrest and apoptosis of human breast cancer cells. Chem. Biol. Interact. 2010, 188, 487–496. [Google Scholar] [CrossRef] [PubMed]
  371. Oklešt′ková, J.; Rárová, L.; Strnad, M. Brassinosteroids and their biological activities. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G., Mérillon, J.-M., Eds.; Springer: Berlin/Heidelberg, Germany, 2013; pp. 3851–3871. [Google Scholar]
  372. Jadhav, U.; Ezhilarasan, R.; Vaughn, S.F.; Berhow, M.A.; Mohanam, S. Iberin induces cell cycle arrest and apoptosis in human neuroblastoma cells. Int. J. Mol. Med. 2007, 19, 353–361. [Google Scholar] [CrossRef] [PubMed]
  373. Gerhäuser, C.; You, M.; Liu, J.; Moriarty, R.M.; Hawthorne, M.; Mehta, R.G.; Moon, R.C.; Pezzuto, J.M. Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes. Cancer Res. 1997, 57, 272–278. [Google Scholar] [PubMed]
  374. Kisbenedek, A.; Szabo, S.; Polyak, E.; Breitenbach, Z.; Bona, A.; Mark, L.; Figler, M. Analysis of trans-resveratrol in oilseeds by high-performance liquid chromatography. Acta Aliment. 2014, 43, 459–464. [Google Scholar] [CrossRef]
  375. Jin, J.; Sheraliev, G.; Xie, D.; Zhang, W.; Jin, Q.; Wang, X. Characteristics of specialty natural micronutrients in certain oilseeds and oils: Plastochromanol-8, resveratrol, 5-hydroxytryptamine phenylpropanoid amides, lanosterol, ergosterol and cyclolinopeptides. J. Am. Oil Chem. Soc. 2016, 93, 155–170. [Google Scholar] [CrossRef]
  376. Jiang, H.; Shang, X.; Wu, H.; Huang, G.; Wang, Y.; Al-Holou, S.; Gautam, S.C.; Chopp, M. Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochem. Res. 2010, 35, 152–161. [Google Scholar] [CrossRef]
  377. Tai, A.; Fukunaga, K.; Ohno, A.; Ito, H. Antioxidative properties of ascorbigen in using multiple antioxidant assays. Biosci. Biotechnol. Biochem. 2014, 78, 1723–1730. [Google Scholar] [CrossRef] [PubMed]
  378. Wagner, A.E.; Huebbe, P.; Konishi, T.; Rahman, M.M.; Nakahara, M.; Matsugo, S.; Rimbach, G. Free radical scavenging and antioxidant activity of ascorbigen versus ascorbic acid: Studies in vitro and in cultured human keratinocytes. J. Agric. Food Chem. 2008, 56, 11694–11699. [Google Scholar] [CrossRef]
  379. Stec, B. Plant thionins–the structural perspective. Cell. Mol. Life Sci. 2006, 63, 1370–1385. [Google Scholar] [CrossRef]
  380. Florack, D.; Stiekema, W. Thionins: Properties, possible biological roles and mechanisms of action. Plant Mol. Biol. 1994, 26, 25–37. [Google Scholar] [CrossRef] [PubMed]
  381. Wang, L.; Yang, J.; Wang, Y.; Zhang, J.; Gao, Y.; Yuan, J.; Su, A.; Ju, X. Study on antioxidant activity and amino acid analysis of rapeseed protein hydrolysates. Int. J. Food Prop. 2016, 19, 1899–1911. [Google Scholar] [CrossRef]
  382. Ferrero, R.L.; Soto-Maldonado, C.; Weinstein-Oppenheimer, C.; Cabrera-Muñoz, Z.; Zúñiga-Hansen, M.E. Antiproliferative Rapeseed Defatted Meal Protein and Their Hydrolysates on MCF-7 Breast Cancer Cells and Human Fibroblasts. Foods 2021, 10, 309. [Google Scholar] [CrossRef]
  383. Wang, L.; Zhang, J.; Yuan, Q.; Xie, H.; Shi, J.; Ju, X. Separation and purification of an anti-tumor peptide from rapeseed (Brassica campestris L.) and the effect on cell apoptosis. Food Funct. 2016, 7, 2239–2248. [Google Scholar] [CrossRef] [PubMed]
  384. Wang, Z.; Zhang, R.X.; Zhang, T.; He, C.; He, R.; Ju, X.; Wu, X.Y. In Situ Proapoptotic Peptide-Generating Rapeseed Protein-Based Nanocomplexes Synergize Chemotherapy for Cathepsin-B Overexpressing Breast Cancer. ACS Appl. Mater. Interfaces 2018, 10, 41056–41069. [Google Scholar] [CrossRef] [PubMed]
  385. Xu, F.; Zhang, J.; Wang, Z.; Yao, Y.; Atungulu, G.G.; Ju, X.; Wang, L. Absorption and Metabolism of Peptide WDHHAPQLR Derived from Rapeseed Protein and Inhibition of HUVEC Apoptosis under Oxidative Stress. J. Agric. Food Chem. 2018, 66, 5178–5189. [Google Scholar] [CrossRef]
  386. Zhang, M.; Yan, Z.; Bu, L.; An, C.; Wang, D.; Liu, X.; Zhang, J.; Yang, W.; Deng, B.; Xie, J. Rapeseed protein-derived antioxidant peptide RAP alleviates renal fibrosis through MAPK/NF-κB signaling pathways in diabetic nephropathy. Drug Des. Dev. Ther. 2018, 12, 1255. [Google Scholar] [CrossRef]
  387. International Agency for Research on Cancer. Cruciferous Vegetables, Isothiocyanates and Indoles; IARC: Lyon, France, 2004. [Google Scholar]
  388. Darmstadt, G.L.; Saha, S.K. Traditional practice of oil massage of neonates in Bangladesh. J. Health Popul. Nutr. 2002, 20, 184–188. [Google Scholar]
  389. Menon, S. 61 Home Remedies for Cold and Cough in Babies. Available online: http://www.bumpsnbaby.com/21-home-remedies-cold-cough-babies/ (accessed on 2 August 2017).
  390. Hiltz, S. Annas Herbal an Education in the Healing Power of Herbs. Available online: https://www.yumpu.com/en/document/read/12019238/annas-herbal-by-dr-sharon-hiltz-fairmont-state-university (accessed on 12 September 2019).
  391. Yardley, K. The Good Living Guide to Natural and Herbal Remedies: Simple Salves, Teas, Tinctures, and More; Good Books: New York, NY, USA, 2016. [Google Scholar]
  392. Mars, B.; Fiedler, C. The Country Almanac of Home Remedies: Time-Tested & Almost Forgotten Wisdom for Treating Hundreds of Common Ailments, Aches & Pains Quickly and Naturally; Fair Winds Press: Beverly, MA, USA, 2014. [Google Scholar]
  393. Olesen, J. The Headaches; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2006. [Google Scholar]
  394. WHO. Cardiovascular Diseases (CVDs) Fact Sheet. Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)/ (accessed on 11 April 2021).
  395. Mäkinen, S.; Streng, T.; Larsen, L.B.; Laine, A.; Pihlanto, A. Angiotensin I-converting enzyme inhibitory and antihypertensive properties of potato and rapeseed protein-derived peptides. J. Funct. Foods 2016, 25, 160–173. [Google Scholar] [CrossRef]
  396. Alashi, A.M.; Blanchard, C.L.; Mailer, R.J.; Agboola, S.O.; Mawson, A.J.; He, R.; Malomo, S.A.; Girgih, A.T.; Aluko, R.E. Blood pressure lowering effects of Australian canola protein hydrolysates in spontaneously hypertensive rats. Food Res. Int. 2014, 55, 281–287. [Google Scholar] [CrossRef]
  397. Girgih, A.T.; He, R.; Aluko, R.E. Kinetics and molecular docking studies of the inhibitions of angiotensin converting enzyme and renin activities by hemp seed (Cannabis sativa L.) peptides. J. Agric. Food Chem. 2014, 62, 4135–4144. [Google Scholar] [CrossRef] [PubMed]
  398. He, R.; Malomo, S.A.; Girgih, A.T.; Ju, X.; Aluko, R.E. Glycinyl-histidinyl-serine (GHS), a novel rapeseed protein-derived peptide has blood pressure-lowering effect in spontaneously hypertensive rats. J. Agric. Food Chem. 2013, 61, 8396–8402. [Google Scholar] [CrossRef]
  399. Marczak, E.D.; Ohinata, K.; Lipkowski, A.W.; Yoshikawa, M. Arg-Ile-Tyr (RIY) derived from rapeseed protein decreases food intake and gastric emptying after oral administration in mice. Peptides 2006, 27, 2065–2068. [Google Scholar] [CrossRef] [PubMed]
  400. Wu, J.; Muir, A. Comparative structural, emulsifying, and biological properties of 2 major canola proteins, cruciferin and napin. J. Food Sci. 2008, 73, C210–C260. [Google Scholar] [CrossRef] [PubMed]
  401. Yamada, Y.; Iwasaki, M.; Usui, H.; Ohinata, K.; Marczak, E.D.; Lipkowski, A.W.; Yoshikawa, M. Rapakinin, an anti-hypertensive peptide derived from rapeseed protein, dilates mesenteric artery of spontaneously hypertensive rats via the prostaglandin IP receptor followed by CCK1 receptor. Peptides 2010, 31, 909–914. [Google Scholar] [CrossRef]
  402. Yamada, Y.; Ohinata, K.; Lipkowski, A.W.; Yoshikawa, M. Rapakinin, Arg–Ile–Tyr, derived from rapeseed napin, shows anti-opioid activity via the prostaglandin IP receptor followed by the cholecystokinin CCK2 receptor in mice. Peptides 2011, 32, 281–285. [Google Scholar] [CrossRef]
  403. He, R.; Aluko, R.E.; Ju, X.-R. Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme. PLoS ONE 2014, 9, e91051. [Google Scholar] [CrossRef]
  404. He, R.; Girgih, A.T.; Rozoy, E.; Bazinet, L.; Ju, X.R.; Aluko, R.E. Selective separation and concentration of antihypertensive peptides from rapeseed protein hydrolysate by electrodialysis with ultrafiltration membranes. Food Chem. 2016, 197, 1008–1014. [Google Scholar] [CrossRef]
  405. He, R.; Malomo, S.A.; Alashi, A.; Girgih, A.T.; Ju, X.; Aluko, R.E. Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. J. Funct. Foods 2013, 5, 781–789. [Google Scholar] [CrossRef]
  406. He, R.; Wang, Y.; Yang, Y.; Wang, Z.; Ju, X.; Yuan, J. Rapeseed protein-derived ACE inhibitory peptides LY, RALP and GHS show antioxidant and anti-inflammatory effects on spontaneously hypertensive rats. J. Funct. Foods 2019, 55, 211–219. [Google Scholar] [CrossRef]
  407. He, R.; Yang, Y.-J.; Wang, Z.; Xing, C.-r.; Yuan, J.; Wang, L.-F.; Udenigwe, C.; Ju, X.-R. Rapeseed protein-derived peptides, LY, RALP, and GHS, modulates key enzymes and intermediate products of renin–angiotensin system pathway in spontaneously hypertensive rat. Npj Sci. Food 2019, 3, 1. [Google Scholar] [CrossRef] [PubMed]
  408. Li, Y.; Pan, D.; Zhang, W.; Xie, X.; Dang, Y.; Gao, X. Identification and molecular mechanism of novel ACE inhibitory peptides from broccoli protein. Food Biosci. 2024, 61, 104678. [Google Scholar] [CrossRef]
  409. Khatun, A.; Rahman, M.; Uddin, K.N.; Ahsan, K.; Shimu, S.N.; Kobra, K.; Shimu, S.A.; Haque, W.; Rahman, T.; Jessy, T.H. Preliminary study on thrombolytic property of thirty six different extracts of eight Bangladeshi medicinal plants with folkloric relevance. Orient. Pharm. Exp. Med. 2016, 16, 311–319. [Google Scholar] [CrossRef]
  410. Testai, L.; Martelli, A.; Cristofaro, M.; Breschi, M.C.; Calderone, V. Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts. J. Pharm. Pharmacol. 2013, 65, 750–756. [Google Scholar] [CrossRef] [PubMed]
  411. Geleijnse, J.M.; Hollman, P.C. Flavonoids and cardiovascular health: Which compounds, what mechanisms? Am. J. Clin. Nutr. 2008, 88, 12–13. [Google Scholar] [CrossRef] [PubMed]
  412. Nguemeni, C.; Delplanque, B.; Rovère, C.; Simon-Rousseau, N.; Gandin, C.; Agnani, G.; Nahon, J.L.; Heurteaux, C.; Blondeau, N. Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol. Res. 2010, 61, 226–233. [Google Scholar] [CrossRef] [PubMed]
  413. Bourourou, M.; Heurteaux, C.; Blondeau, N. Alpha-linolenic acid given as enteral or parenteral nutritional intervention against sensorimotor and cognitive deficits in a mouse model of ischemic stroke. Neuropharmacology 2016, 108, 60–72. [Google Scholar] [CrossRef]
  414. Zhang, W.; Wang, H.; Zhang, H.; Leak, R.K.; Shi, Y.; Hu, X.; Gao, Y.; Chen, J. Dietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke. Exp. Neurol. 2015, 272, 170–180. [Google Scholar] [CrossRef]
  415. Duke, J.A. Handbook of Medicinal Herbs, 2nd ed.; CRC Press: Melbourne, VIC, Australia, 2002. [Google Scholar]
  416. Ferreira, I.C.F.R.; Morales, P.; Barros, L. Wild Plants, Mushrooms and Nuts: Functional Food Properties and Applications; John Wiley & Sons Australia Ltd.: Milton, NSW, Australia, 2016. [Google Scholar]
  417. Harborne, J.B.; Baxter, H. Chemical Dictionary of Economic Plants; John Wiley & Sons: Hoboken, NJ, USA, 2001. [Google Scholar]
  418. Macarthur, J.G.; Alstead, S. Counter-irritants a method of assessing their effect. Lancet 1953, 262, 1060–1062. [Google Scholar] [CrossRef]
  419. Agarwal, Y. Reversing Back Pain: Doctors’ Guide to a Healthy Back; Orient Paperbacks: Delhi, India, 2008. [Google Scholar]
  420. Wynn, S.G.; Fougère, B. Veterinary Herbal Medicine; Mosby Elsevier: Amsterdam, The Netherlands, 2007. [Google Scholar]
  421. Morisset, M.; Moneret-Vautrin, D.A.; Maadi, F.; Fremont, S.; Guenard, L.; Croizier, A.; Kanny, G. Prospective study of mustard allergy: First study with double-blind placebo-controlled food challenge trials (24 cases). Allergy 2003, 58, 295–299. [Google Scholar] [CrossRef]
  422. Nicholson, W. The British Encyclopedia, or Dictionary of Arts and Sciences Comprising an Accurate and Popular View of the Present Improved State of Human Knowledge; Oxford University: Oxford, UK, 1809. [Google Scholar]
  423. Manchester, A.-F. Allergy information for: Mustard (Brassica nigra, Brassica juncea, Brassica hirta, Sinapis alba). Available online: http://research.bmh.manchester.ac.uk/informall/allergenic-food/?FoodId=56/ (accessed on 2 August 2017).
  424. Du Val, J. A Family Manual: In Which Are Found Directions for the Use of His Family Antispasmodic, in More Than Twenty Diseases, to Wit Asiatic Cholera; John W. Woods: Baltimore, MD, USA, 1851. [Google Scholar]
  425. Yabanoglu, H.; Akbulut, S.; Karakayali, F. Phytocontact dermatitis due to mustard seed mimicking burn injury: Report of a case. Case Rep. Med. 2012, 2012, 519215. [Google Scholar] [CrossRef] [PubMed]
  426. Dineeen, P.; Homan, W.P.; Grafe, W.R. Tuberculous peritonitis: 43 years’ expereince in diagnosis and treatment. Ann. Surg. 1976, 184, 717. [Google Scholar] [CrossRef]
  427. Brown, P.O. The Complete Herbalist; Editorial MAXTOR: Valladolid, Spain, 1872. [Google Scholar]
  428. Hoffmann, D. Healthy Bones and Joints: A Natural Approach to Treating Arthritis, Osteoporosis, Tendinitis, Myalgia & Bursitis; Storey Publishing, LLC.: North Adams, MA, USA, 2017. [Google Scholar]
  429. Erbay, M.Ş.; Anil, S.; Melikoglu, G. Plants used as painkiller in folk medicine in turkey-istomachache. Marmara Pharm. J. 2017, 21, 741–755. [Google Scholar] [CrossRef]
  430. Sharma, A.; Verma, A.K.; Gupta, R.K.; Neelabh; Dwivedi, P.D. A comprehensive review on mustard-induced allergy and implications for human health. Clin. Rev. Allergy Immunol. 2017, 57, 39–54. [Google Scholar] [CrossRef]
  431. Guimaraes, M.Z.; Jordt, S.-E. TRPA1: A sensory channel of many talents. In TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades; Liedtke, W., Ed.; Talyor and Francis: Abingdon, UK, 2006; pp. 151–161. [Google Scholar]
  432. Jordt, S.-E.; Bautista, D.M.; Chuang, H.-h.; McKemy, D.D.; Zygmunt, P.M.; Högestätt, E.D.; Meng, I.D.; Julius, D. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004, 427, 260–265. [Google Scholar] [CrossRef]
  433. Smith, C.H.; Barker, J.; Morris, R.W.; MacDonald, D.M.; Lee, T. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J. Immunol. 1993, 151, 3274–3282. [Google Scholar] [CrossRef]
  434. Rahman, M.S.; Jahan, N.; Rahman, S.M.A.; Rashid, M.A. Analgesic and antidepressant activities of Brassica rapa subspecies chinensis (L.) Hanelt on Swiss-albino mice model. Bangladesh Med. Res. Counc. Bull. 2016, 41, 7. [Google Scholar] [CrossRef] [PubMed]
  435. Swain, A.R.; Dutton, S.P.; Truswell, A.S. Salicylates in foods. J Am. Diet. Assoc. 1985, 85, 950–960. [Google Scholar] [CrossRef] [PubMed]
  436. Gibson, P.R.; Shepherd, S.J. Food choice as a key management strategy for functional gastrointestinal symptoms. Am. J. Gastroenterol. 2012, 107, 657–666. [Google Scholar] [CrossRef]
  437. Ateya, A.; Al-Gendy, A.; Kotob, S.; Hafez, A. Chemical constituents, antioxidant, antimicrobial and antiinflammatory activities of Erysimum corinthium boiss (Brassicaceae). Int. J. Pharmacogn. Phytochem. Res. 2016, 8, 1601–1609. [Google Scholar]
  438. da Silva, K.A.S.; Paszcuk, A.F.; Passos, G.F.; Silva, E.S.; Bento, A.F.; Meotti, F.C.; Calixto, J.B. Activation of cannabinoid receptors by the pentacyclic triterpene α, β-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain 2011, 152, 1872–1887. [Google Scholar] [CrossRef]
  439. Khan, N.; Afaq, F.; Mukhtar, H. Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid. Redox Signal. 2008, 10, 475–510. [Google Scholar] [PubMed]
  440. Davidson, R.; Jupp, O.; Bao, Y.; MacGregor, A.; Donell, S.; Cassidy, A.; Clark, I. Can sulforaphane prevent the onset or slow the progression of osteoarthritis? Nutr. Bull. 2016, 41, 175–179. [Google Scholar] [CrossRef]
  441. Sanossian, N.; Saver, J.L.; Navab, M.; Ovbiagele, B. High-density lipoprotein cholesterol. Stroke 2007, 38, 1104–1109. [Google Scholar] [CrossRef] [PubMed]
  442. Redondo, A.; Chamorro, P.A.F.; Riego, G.; Leánez, S.; Pol, O. Treatment with Sulforaphane Produces Antinociception and Improves Morphine Effects during Inflammatory Pain in Mice. J. Pharmacol. Exp. Ther. 2017, 363, 293–302. [Google Scholar] [CrossRef]
  443. Khaket, T.P.; Redhu, D.; Dhanda, S.; Singh, J. In Silico evaluation of potential DPP-III inhibitor precursors from dietary proteins. Int. J. Food Prop. 2015, 18, 499–507. [Google Scholar] [CrossRef]
  444. Altman, R.; Asch, E.; Bloch, D.; Bole, G.; Borenstein, D.; Brandt, K.; Christy, W.; Cooke, T.; Greenwald, R.; Hochberg, M. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum. 1986, 29, 1039–1049. [Google Scholar] [CrossRef] [PubMed]
  445. Shaw, J. Australian Medical Association Guide to Medicine and Drugs; Reader’s Digest (Australia) Pty Ltd.: Sydney, NSW, Australia, 1990. [Google Scholar]
  446. Wichtl, M. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis; Medpharm: Guildford, UK, 2004. [Google Scholar]
  447. Ali, F.B.; Heidari, F. Transformation of manitol 1-phosphate dehydrogenase (MTLD) gene into canola (Brassica napus L.) to improve salinity tolerance. Acta Medica Mediterr. 2017, 33, 935–943. [Google Scholar]
  448. Al-Snafi, A.E. Chemical constituents and pharmacological importance of Agropyron repens—A review. Res. J. Pharmacol. Toxicol. 2015, 1, 37–41. [Google Scholar]
  449. Tiyagi, S.A.; Alam, M.M. Efficacy of oil-seed cakes against plant-parasitic nematodes and soil-inhabiting fungi on mungbean and chickpea. Bioresour. Technol. 1995, 51, 233–239. [Google Scholar] [CrossRef]
  450. Larkin, R.P.; Griffin, T.S. Control of soilborne potato diseases using Brassica green manures. Crop Prot. 2007, 26, 1067–1077. [Google Scholar] [CrossRef]
  451. Rahman, M. Chemical and Biological Screening of Ecbolium linneanum (Family-Acanthaceae) Leaves and Stems Extracts. Ph.D. Thesis, Khulna University, Khulna, Bangladesh, 2014. [Google Scholar]
  452. Basha, S.N.; Rekha, R.; Saleh, S.; Yemane, S. Evaluation of in vitro anthelmintic activities of Brassica nigra, Ocimum basilicum and Rumex abyssinicus. Pharmacogn. J. 2011, 3, 88–92. [Google Scholar] [CrossRef]
  453. Sayre, R.; Patrick, Z.; Thorpe, H. Identification of a selective nematicidal component in extracts of plant residues decomposing in soil. Nematologica 1965, 11, 263–268. [Google Scholar]
  454. Singh, R.; Sitaramaiah, K. Control of plant parasitic nematodes with organic soil amendments. PANS Pest Artic. News Summ. 1970, 16, 287–297. [Google Scholar]
  455. Butool, F.; Haseeb, A.; Shukla, P. Management of root-knot nematode, Meloidogyne incognita, infesting Egyptian henbane, Hyoscyamus muticus L., by the use of nematicides and oilcakes. Int. J. Pest Manag. 1998, 44, 199–202. [Google Scholar] [CrossRef]
  456. Linford, M. The feeding of the root-knot nematode in root tissue and nutrient solution. Phytopathology 1937, 27, 824–835. [Google Scholar]
  457. Quiroz-Castañeda, R.E.; Dantán-González, E. Control of avian coccidiosis: Future and present natural alternatives. BioMed Res. Int. 2015, 2015, 430610. [Google Scholar] [CrossRef] [PubMed]
  458. VanderJagt, D.J.; Freiberger, C.; Vu, H.-T.N.; Mounkaila, G.; Glew, R.S.; Glew, R.H. The trypsin inhibitor content of 61 wild edible plant foods of Niger. Plant Foods Hum. Nutr. 2000, 55, 335–346. [Google Scholar] [CrossRef]
  459. Woods, D.; Downey, R. Mucilage from yellow mustard. Can. J. Plant Sci. 1980, 60, 1031–1033. [Google Scholar] [CrossRef]
  460. Bown, D. Encyclopaedia of Herbs and Their Uses; Dorling Kindersley: London, UK, 1995. [Google Scholar]
  461. Ghanbari, R.; Zarei, M.; Ebrahimpour, A.; Abdul-Hamid, A.; Ismail, A.; Saari, N. Angiotensin-I converting enzyme (ACE) inhibitory and anti-oxidant activities of sea cucumber (Actinopyga lecanora) hydrolysates. Int. J. Mol. Sci. 2015, 16, 28870–28885. [Google Scholar] [CrossRef]
  462. Esposito, D.; Komarnytsky, S.; Shapses, S.; Raskin, I. Anabolic effect of plant brassinosteroid. FASEB J. 2011, 25, 3708–3719. [Google Scholar] [CrossRef]
  463. Mitrović, P.M.; Stamenković, O.S.; Banković-Ilić, I.; Djalović, I.G.; Nježić, Z.B.; Farooq, M.; Siddique, K.H.M.; Veljković, V.B. White Mustard (Sinapis alba L.) Oil in Biodiesel Production: A Review. Front. Plant Sci. 2020, 11, 299. [Google Scholar] [CrossRef] [PubMed]
  464. Fenwick, G.; Heaney, R. Glucosinolates and their breakdown products in cruciferous crops, foods and feedingstuffs. Food Chem. 1983, 11, 249–271. [Google Scholar]
  465. Malik, A.H.; Khuroo, A.A.; Dar, G.; Khan, Z. Ethnomedicinal uses of some plants in the Kashmir Himalaya. Indian J. Tradit. Knowl. IJTK 2011, 10, 28. [Google Scholar]
  466. Nameth, I. Medicinal Plants and Drugs; Europian Union: Brussels, Belgium, 2012. [Google Scholar]
  467. Takeguchi, N.; Nishimura, Y.; Watanabe, T.; Mori, Y.; Morii, M. A pungent ingredient of mustard, allylisothiocyanate, inhibits (H+ + K+)-ATPase. Biochem Biophys. Res. Commun. 1983, 112, 464–468. [Google Scholar] [CrossRef]
  468. Agarwal, K.; Gupta, A.; Pushkarna, R.; Bhargava, S. Effects of massage & use of oil on growth, blood flow & sleep pattern in infants. Indian J. Med. Res. 2000, 112, 212. [Google Scholar]
  469. Paulún, F. 50 Ways to Boost Your Metabolism: How Mustard, Red Wine, and Days at the Beach Can Help You Lose Weight & Stay Healthy; Skyhorse Publishing: New York, NY, USA, 2013. [Google Scholar]
  470. Alashi, A.M.; Blanchard, C.L.; Mailer, R.J.; Agboola, S.O.; Mawson, A.J.; Aluko, R.E.; Strappe, P. Effects of canola proteins and hydrolysates on adipogenic differentiation of C3H10T/2 mesenchymal stem cells. Food Chem. 2015, 185, 226–232. [Google Scholar] [CrossRef] [PubMed]
  471. Aachary, A.A.; Thiyam, U. A pursuit of the functional nutritional and bioactive properties of canola proteins and peptides. Crit. Rev. Food Sci. Nutr. 2012, 52, 965–979. [Google Scholar]
  472. Lim, J.-S.; Im, J.-H.; Han, X.; Men, X.; Oh, G.; Fu, X.; Hwang, W.; Choi, S.-I.; Lee, O.-H. The Mechanism of the Anti-Obesity Effects of a Standardized Brassica juncea Extract in 3T3-L1 Preadipocytes and High-Fat Diet-Induced Obese C57BL/6J Mice. Nutrients 2024, 16, 846. [Google Scholar] [CrossRef] [PubMed]
  473. Park, S.-J.; Kim, H.-D.; Lee, Y.-H. Anti-obesity Effects of Treatment with Air-classified Brassica juncea L. Extract in High-Fat Diet-Induced Obese C57BL/6J Mice. J. Agric. Life Environ. Sci. 2021, 33, 379–390. [Google Scholar]
  474. Lee JaeJoon, L.J.; Kim HyunA, K.H.; Lee JooMin, L.J. The effects of Brassica juncea L. leaf extract on obesity and lipid profiles of rats fed a high-fat/high-cholesterol diet. Nutr. Res. Pract. 2018, 12, 298–306. [Google Scholar] [PubMed]
  475. Jamila, N.; Khan, N.; Hwang, I.M.; Choi, J.Y.; Nho, E.Y.; Khan, S.N.; Atlas, A.; Kim, K.S. Determination of macro, micro, trace essential, and toxic elements in Garcinia cambogia fruit and its anti-obesity commercial products. J. Sci. Food Agric. 2019, 99, 2455–2462. [Google Scholar] [CrossRef] [PubMed]
  476. Mao, Y.; Zheng, D.; He, L.; Chen, J. The Lipid-Metabolism-Associated Anti-Obesity Properties of Rapeseed Diacylglycerol Oil. Nutrients 2024, 16, 2003. [Google Scholar] [CrossRef] [PubMed]
  477. Jazayeri, S.; Keshavarz, S.A.; Tehrani-Doost, M.; Djalali, M.; Hosseini, M.; Amini, H.; Chamari, M.; Djazayery, A. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Psychiatry Res. 2010, 178, 112–115. [Google Scholar] [CrossRef]
  478. Pace, T.W.; Hu, F.; Miller, A.H. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007, 21, 9–19. [Google Scholar] [CrossRef] [PubMed]
  479. Oakley, R.H.; Cidlowski, J.A. The Biology of the Glucocorticoid Receptor: New Signaling Mechanisms in Health and Disease. J. Allergy Clin. Immunol. 2013, 132, 1033–1044. [Google Scholar]
  480. Aubourg, P.; Adamsbaum, C.; Lavallard-Rousseau, M.-C.; Rocchiccioli, F.; Cartier, N.; Jambaque, I.; Jakobezak, C.; Lemaitre, A.; Boureau, F.; Wolf, C. A two-year trial of oleic and erucic acids (“Lorenzo’s oil”) as treatment for adrenomyeloneuropathy. N. Engl. J. Med. 1993, 329, 745–752. [Google Scholar] [CrossRef] [PubMed]
  481. Poulos, A.; Gibson, R.; Sharp, P.; Beckman, K.; Rattan-Smith, P.G. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo’s oil. Ann. Neurol. 1994, 36, 741–746. [Google Scholar] [CrossRef]
  482. Aubourg, P. Efficacy of Lorenzo’s Oil in Adrenoleukodystrophy. CNS Drugs 1994, 1, 323–329. [Google Scholar] [CrossRef]
  483. Jackson, C.; Paliyath, G. Functional Foods and Ingredients. In Handbook of Food Products Manufacturing: Principles, Bakery, Beverages, Cereals, Cheese, Confectionary, Fats, Fruits, and Functional Foods; Hui, Y., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2007. [Google Scholar]
  484. Pałgan, K.; Żbikowska-Gotz, M.; Bartuzi, Z. Dangerous anaphylactic reaction to mustard. Arch Med. Sci. 2018, 14, 477–479. [Google Scholar] [CrossRef]
  485. Sirvent, S.; Akotenou, M.; Cuesta-Herranz, J.; Vereda, A.; Rodríguez, R.; Villalba, M.; Palomares, O. The 11S globulin Sin a 2 from yellow mustard seeds shows IgE cross-reactivity with homologous counterparts from tree nuts and peanut. Clin. Transl. Allergy 2012, 2, 23. [Google Scholar] [CrossRef] [PubMed]
  486. Shim, Y.-Y.; Wanasundara, J.P. Quantitative detection of allergenic protein Sin a 1 from yellow mustard (Sinapis alba L.) seeds using enzyme-linked immunosorbent assay. J. Agric. Food Chem. 2008, 56, 1184–1192. [Google Scholar] [CrossRef] [PubMed]
  487. Oñaderra, M.; Monsalve, R.I.; Mancheño, J.M.; Villalba, M.; Pozo, A.M.; Gavilanes, J.G.; Rodriguez, R. Food mustard allergen interaction with phospholipid vesicles. Eur. J. Biochem. 1994, 225, 609–615. [Google Scholar] [PubMed]
  488. Puumalainen, T.J.; Puustinen, A.; Poikonen, S.; Turjanmaa, K.; Palosuo, T.; Vaali, K. Proteomic identification of allergenic seed proteins, napin and cruciferin, from cold-pressed rapeseed oils. Food Chem. 2015, 175, 381–385. [Google Scholar] [CrossRef] [PubMed]
  489. Untersmayr, E.; Jensen-Jarolim, E. Mechanisms of type I food allergy. Pharmacol. Ther. 2006, 112, 787–798. [Google Scholar] [CrossRef] [PubMed]
  490. Larsen, D.; Singh, S.; Brito, M. Thyroid, diet, and alternative approaches. J. Clin. Endocrinol. Metab. 2022, 107, 2973–2981. [Google Scholar]
  491. Richards, I.S.; Bourgeois, M. Principles and Practice of Toxicology in Public Health; Jones & Bartlett Learning, LLC: Burlington, MA, USA, 2013. [Google Scholar]
  492. Felker, P.; Bunch, R.; Leung, A.M. Concentrations of thiocyanate and goitrin in human plasma, their precursor concentrations in Brassica vegetables, and associated potential risk for hypothyroidism. Nutr. Rev. 2016, 74, 248–258. [Google Scholar] [CrossRef] [PubMed]
  493. Van Kempen, G.; Jansman, A. Use of EC produced oil seeds in animal feeds. Recent Adv. Anim. Nutr. 1994, 128, 31–56. [Google Scholar]
  494. Khan, R.A.; Asad, T.; Feroz, Z.; Ahmed, M. In vivo examination of the anticoagulant effect of the Brassica oleracea methanol extract. Arch. Biol. Sci. 2015, 67, 631–638. [Google Scholar] [CrossRef]
  495. Smith, R.; Watt, W.; Lawson, W.; Rice-Evans, C. Red cell membrane changes in a Heinz body anaemia (kale anaemia). In Protides of the Biological Fluids; Elsevier: Amsterdam, The Netherlands, 1982; Volume 29, pp. 125–128. [Google Scholar]
  496. Braine, K. Grazing Brassicas and Livestock Health. Available online: https://www.lls.nsw.gov.au/regions/murray/articles,-plans-and-publications/production-advice-june-2021/grazing-brassicas-and-livestock-health (accessed on 8 August 2024).
  497. Benevenga, N.; Case, G.; Steele, R. Occurrence and metabolism of S-methyl-L-cysteine and S-methyl-L-cysteine sulfoxide in plants and their toxicity and metabolism in animals. Toxic. Plant Orig. 1989, 3, 203–228. [Google Scholar]
  498. Gustine, D.L. Determination of S-methyl cysteine sulfoxide in Brassica extracts by high-performance liquid chromatography. J. Chromatogr. A 1985, 319, 450–453. [Google Scholar] [CrossRef]
  499. Mrowicka, M.; Mrowicki, J.; Dragan, G.; Majsterek, I. The importance of thiamine (vitamin B1) in humans. Biosci. Rep. 2023, 43, BSR20230374. [Google Scholar]
  500. FitzGerald, G.A.; Healy, C.; Daugherty, J. Thromboxane A2 biosynthesis in human disease. Fed. Proc. 1987, 46, 154–158. [Google Scholar] [PubMed]
  501. Hossain, M.K.; Khatun, A.; Rahman, M.; Akter, M.N.; Chowdhury, S.A.; Alam, S.M.M. Characterization of the effect of drug-drug interaction on protein binding in concurrent administration of sulfamethoxazol and diclofenac sodium using bovine serum albumin. Adv. Pharm. Bull. 2016, 6, 589–595. [Google Scholar] [CrossRef]
  502. Ijiri, Y.; Ishii, H.; Yamamoto, J. Diet of fruits and vegetables with experimental antithrombotic effect may be beneficial to humans in the prevention of arterial thrombotic diseases. Int. J. Drug Dev. Res. 2016, 8, 12–16. [Google Scholar]
  503. Arjariya, A.; Chaurasia, K. Some medicinal plants among the tribes of Chhatarpur district (MP) India. Ecoprint. Int. J. Ecol. 2009, 16, 43–50. [Google Scholar] [CrossRef]
  504. Akbari, A.; Wu, J. Cruciferin nanoparticles: Preparation, characterization and their potential application in delivery of bioactive compounds. Food Hydrocoll. 2016, 54, 107–118. [Google Scholar] [CrossRef]
  505. Aluko, R.E.; McIntosh, T. Polypeptide profile and functional properties of defatted meals and protein isolates of canola seeds. J. Sci. Food Agric. 2001, 81, 391–396. [Google Scholar] [CrossRef]
  506. Alashi, A.M.; Blanchard, C.L.; Mailer, R.J.; Agboola, S.O. Technological and bioactive functionalities of canola meal proteins and hydrolysates. Food Rev. Int. 2013, 29, 231–260. [Google Scholar]
  507. Wang, F.; Yang, Y.; Ju, X.; Udenigwe, C.C.; He, R. Polyelectrolyte complex nanoparticles from chitosan and acylated rapeseed cruciferin protein for curcumin delivery. J. Agric. Food Chem. 2018, 66, 2685–2693. [Google Scholar] [CrossRef] [PubMed]
  508. Wang, Z.; Zhang, R.X.; Zhang, C.; Dai, C.; Ju, X.; He, R. Fabrication of stable and self-assembling rapeseed protein nanogel for hydrophobic curcumin delivery. J. Agric. Food Chem. 2019, 67, 887–894. [Google Scholar] [CrossRef] [PubMed]
  509. Das, N.; Berhow, M.; Jeffery, E. Comparison of bioactivity between sulforaphane and neoglucobrassicin hydrolysis product in murine and human cell lines (372.5). FASEB J. 2014, 28, 372–375. [Google Scholar] [CrossRef]
Figure 2. Enzymatic hydrolysis of progoitrin by the action of myrosinase yields the potent goitrogenic metabolite goitrin. The same reaction happens in the intestine by the action of bacterial thioglucosidases.
Figure 2. Enzymatic hydrolysis of progoitrin by the action of myrosinase yields the potent goitrogenic metabolite goitrin. The same reaction happens in the intestine by the action of bacterial thioglucosidases.
Ijms 25 09039 g002
Table 1. Different mustards in Brassicaceae species.
Table 1. Different mustards in Brassicaceae species.
Scientific NameCommon NameHabitatReferences
Alliaria petiolata (M. Bieb.) Cavara and Grande,
Syn: Alliaire officinalis
Garlic mustard, hedge garlic mustard, and jack-by-the-hedge mustard.A biennial herb, native to various regions of Africa, temperate and tropical Asia, and Europe, and naturalized to the United States and Canada.[5,6,7]
Brassica rapa var. campestris L.Field mustard, wild turnip mustard, bird rape, turnip rape, and winter mustard.A winter annual or biennial plant native to central Asia and Europe.[8,9,10,11]
Brassica carinata A. Braun.Ethiopian mustard and Abyssinian mustard.Traditional African vegetable cultivated in Ethiopian highlands.[7,12]
Sinapis alba Boiss. (Hook f. & Th.), Syn: B. hirta Moench, B. alba Linn. White mustard, yellow mustard, and rai mustard.Best known mustard in Europe, grown in the Mediterranean region, India, and China.[13,14]
Brassica juncea (L.) Czerniak. Coss., Syn: B. integrifoliaBrown mustard, Asian mustard, Oriental Mustard, Chinese mustard, Indian mustard, leaf mustard, giant red, sarepta mustard, Asiatic mustard, mustard green, and wild Brazilian mustard.An annual herb native to Eastern and Southern Asia. It is widely cultivated throughout India, central Africa, south Russia, and steppes of the northeast Caspian Sea. It is a natural hybrid of B. rapa and B. nigra. [15,16,17,18,19]
Brassica napus (var. napus or var. oleifera)Rapeseed, oilseed rape, colza, rutabaga, swede, Swedish turnip, leaf rape winter oilseed rape, and summer rape.Native to South-East Asia and Eurasia and is most commonly grown in northern temperate regions including northern Asia, Japan, Korea, Northern China, Scandinavia, and Russia. Dominant species in Europe. [8,20,21,22,23]
Brassica nigra (L.) W.D.J. Koch.
Syn.: Sinapis nigra, B. sinapioides
Black mustard, brown mustard, cadlock, Scurvy mustard, Senvil mustard, short-pod mustard, true mustard, and warlock.An annual herb native to most parts of Europe, the Mediterranean region, and other parts of north Africa, and has been naturalized in Great Britain and North America. [15,24,25,26,27]
Brassica rapa L.Oilseed rape, rape oilseed, kale rape, rapa, rappi, keblock, colza, bird rape, rape mustard, field mustard, or rapeseed.The most cultivated oilseed in many countries like Australia, Canada, and Poland.[28,29]
Calepina irregularis (Asso) Thellung.White ball mustard, smooth ball mustard.Native to the countries in central Asia, the Mediterranean basin and naturalized in central Europe, North America, and Australia.[30,31]
Camelina sativaCamelina, false flax, wild flax, gold-of-pleasure, linseed dodder, German sesame, and Siberian oilseed.Central Asia and northern Europe[32,33]
Erysimum corinthiumWormseed mustard and wallflower.Native to temperate Eurasia (Southeastern Europe), North Africa and Macaronesia, and North America south to Costa Rica.[34]
Erysimum repandum L.Spreading wallflower, bushy wallflower, and spreading treacle-mustard.NF
Neslia paniculata (L.) Desv.
Syn.: Myagrum paniculatum
Ball mustard, common ball mustard, yellow weed, neslia, neslie, or moutarde.Native Eurosiberian southern-temperate species commonly naturalized in South Australia, Canada, Europe, and Asia, South America.[35,36]
Sisymbrium officinale L. Scop., Syn.: Erysimum officinaleErysimum, English watercress, mustard, hedge mustard, St. Barbara’s Hedge Mustard, common hedge, singer’s plant, and thalictroc.An annual or biennial mustard found on roadsides and wastelands as a weed of arable land in Eurasia, the Mediterranean area, northern Africa, Scandinavia to north Africa, and Asia and naturalized in New Zealand.[37,38,39,40,41]
Sisymbrium orientale
Syn.: S. columnae Jacq.
Asian hedge mustard, Indian hedge mustard, eastern rocket, oriental wild rocket, and London rocket.Native to Europe, Asia, and north Africa, and further introduced in much of the rest of the world, including parts of North America and Australia.[37,42,43]
Sisymbrium erysimoides Desf.Smooth mustard, and Mediterranean rocket.A desert plant native to Middle Eastern Arab countries and naturalized in Australia, North America, and New Zealand.[44,45,46]
Syn.: Synonym; NF: Information not found.
Table 2. Total oil content, fatty acid composition, and total polyphenol content of different Brassicaceae mustards.
Table 2. Total oil content, fatty acid composition, and total polyphenol content of different Brassicaceae mustards.
Fatty Acid Alliaria petiolataSinapis albaB. carinataB. junceaB. napusB. nigraB. rapaCalepina irregularisCamelina sativaErysimum repandumNeslia paniculataSisymbrium erysimoidesS. officinaleS. orientaleCanola (low-erucic acid) B. napus
Total oil content (% od seed weight) 15–3025–3630–4725–4540–5021–4025–4516–3638–4320.1–4015–25307–1222–3033–50
Saturated fatty acids
Palmitic acid (C16:0) 3–42–72–122–4.52–72–42–4.50–154–87.03–1710–152–8.08–103.3–6
Stearic acid (C18:0)0.3–0.50.1–32–3.51–20.5–2.51–21.5–2.52–32.1–2.32.01–40.5–10.3–1.50.1–11.1–2.5
Behenic acid (C22:0)ND0.5–1ND0–10–1NDNDND0.30.7NDNDNDND~2.0
Lignoceric acid (C24:0)NDNDND0–10–1NDNDNDNDNDNDNDNDND~0.2
Arachidic acid (C20:0)0.4–10.5–1ND0.5–1.50.1–2.50.5–1.5NDND1–1.82.0NDNDNDND0.2–0.8
Unsaturated fatty acids
Monounsaturated fatty acids
Palmitoleic acid (C16:1)ND0.1–0.20.1–0.20.2–0.50.2–1.50.1–0.20.1–2.0ND0.07–0.1NDNDNDNDND0.1–0.6
Oleic acid (C18:1)6–915–397–198–338–639–2311–620.1–212.7–14.87.09–3610–151–7.53–752–66.9
Gadoleic/eicosenoic acid (20:1)4–56–125–95–121–135–81–11ND11.1–12.89.0ND3–4ND1–4ND
Erucic acid (C22:1)41–4923–5135–4522–5514–5527–469–513–72.3–3.517.00.1–115–208–1711–180.3–1.6
Nervonic acid (C24:1)6–81.2–3ND0–2.50–2NDND0.1–1ND1.00.1–0.3ND0.5–1.51–0.6ND
Polyunsaturated fatty acids
Linoleic acid (C18:2)18–227–3315–2212–2112–216–1710–13ND2.4–24.317.0ND15–20ND10–1416.1–28.8
Eicosadienoic acid (C20:2)0.5–1NDND0.3–10.53–4NDND11.1–12.82.0NDNDNDND~0.1
Linolenic acid (C18:3)4–78–2016–208–208–143–151–177–2633.7–36.933.04–1020–3118–3035–426.4–14.1
Roughanic acid (C16:3)NDNDNDND0.7–1NDNDNDNDNDNDNDNDNDND
Other fatty acids1.70.1–2.2ND6–8NDNDNDNDNDNDNDNDNDNDND
Total MUFA ND72.1962.4966.56ND60.8ND46.530–36NDND38.439.8NDND
Total PUFA ND2.0532.6529.59ND31.5ND39.650–60NDND38.947.2NDND
Total SFA ND4.484.573.82ND6.7ND13.513.3NDND21.413ND<7
TUFA/TSFA NDNDND10.4ND13.8ND6.5NDNDND3.66.7NDND
Total polyphenol content ND72.5623.521.0247.48NDNDNDNDNDNDNDNDNDND
References[92][93][93][93,94][95][94][86][31,94][96,97,98][35][94][35][38,39,94][99][63,100,101,102]
Values are % on dry weight, oil content is expressed of % dry weight, and total polyphenol content is expressed as mg/g gallic acid equivalent and varies with cultivars, genotype, tissues, and plant age [12,86,93,103]; ND = not detected.
Table 3. Vitamins that have been reported in Brassicaceae mustard leaves (per 100 g edible portion).
Table 3. Vitamins that have been reported in Brassicaceae mustard leaves (per 100 g edible portion).
VitaminMustard Species (Amount per 100 g)References
Vitamin A/carotenoidAlliaria petiolata (contains more vitamin A than spinach, 13.3 mg), Sianpis alba, B. juncea (27 mg), B. nigra, Sisymbrium erysimoides[16,19,35,44,122,123,124,125]
Vitamin B Complex [126]
ThiamineB. napus (0.8 mg)[126]
Riboflavin B. napus (0.3 mg)[126]
Niacin B. napus (8.1 mg)[126]
PyridoxineB. napus (1.9 mg)[126]
Vitamin C/Ascorbic acidAlliaria petiolata (contains more vitamin C than orange—261 mg), B. nigra, Erysimum repandum, S. officinale, B. juncea (72–89 mg)[6,122,123,124,125,127], USDA National Nutrient data base
Vitamin E/tocopherols (α-, β-, γ-, and δ-tocopherol, γ tocopherol is predominant)Sinapis alba, Canola (B. napus) seed oil: (α tocopherols 12 mg, γ tocopherols 21.3 mg)[35,128]
Vitamin KAll rapeseeds including B. juncea (0.3 mg). Canola seed (B. napus) oil (70–150 µg) [16,129], USDA National Nutrient data base, [130,131]
Table 6. Traditional/folkloric use of mustard extracts.
Table 6. Traditional/folkloric use of mustard extracts.
Traditional Use MustardsReferences
Anti-microbial activityAlliaria petiolata, Sisymbrium officinale, S. erysimoides, B. hirta, and B. nigra[6,39,123,158,216,250,251,252]
Antidiabetic activityB. juncea, and B. nigra[253,254]
Treatment for vitamin C deficiency A. petiolata, B. rapa, B. napus, and Erysimum repandum are antiscorbutic[6,21,123,255]
Diuretic activityA. petiolata, B. juncea, B. napus, B. nigra, B. rapa, S. officinale, and S. orientale[6,21,38,40,41,123,255,256,257,258,259]
Expectorant activityA. petiolata, S. orientale, S. officinale, and S. erysimoides[6,38,40,41,258,259,260,261]
Stimulant activityA. petiolata, S. alba, B. juncea, and B. nigra[6,256,257,262]
Analgesic activityB. rapa var. campestris, B. juncea, B. napus, S. erysimoides, S. officinale, B. carinata, Neslia paniculata, and Calepina irregularis[21,44,123,160,242,256,263,264]
Activity in cold and flu Sinapis alba, S. officinale, S. erysimoides, B. napus, and B. nigra[39,251,258,260,261]
Anti-catarrhal activitySinapis alba, S. officinale, S. erysimoides, B. napus, and B. nigra[39,251,258,260,261,265]
BronchitisS. officinale, S. orientale, and S. erysimoides[259,260,261]
Anti-asthmatic activityS. officinale[38,39,40,41,258]
Emetic activitySinapis alba, B. nigra, B. juncea, S. officinale, and B. nigra[123,256,266]
Anti-cancer activityB. juncea, B. napus, B. rapa, S. officinale, and B compestris[39,123,158,256,267]
Effect on bowlSinapis alba, B. nigra, B. juncea, and S. officinale are used as laxatives. B. nigra is used as a carminative[123,256,257,262,266]
Rubefacient B. rapa, B. juncea, and S. officinale[24,30,39,256,268]
GalactagogueB. juncea[256]
Anti-gout potentialB. napus, and B. rapa[21,123,255]
Use in gall stoneB. napus, and B. rapa[162,255,265]
Use against alopeciaB. nigra[257]
Anti-dandruff activityB. nigra[257]
Use in neuralgiaB. nigra[257]
Anti-spasmodic activityB. nigra, and S. officinale[257]
Aphrodisiac activityB. rapa, and B. nigra[24,268]
Use in hepatic and kidney colicB. rapa[162,255]
Anti-inflammatory activityB. rapa, S. erysimoides, and S. officinale[44,255,269]
Anthelmintic activityS. orientale, and B. rapa var. campestris[259,270]
Remedial use in feverS. orientale, and Erysimum repandum[127,259]
Use in dysenteryS. orientale[259]
Anti-addiction activityS. officinale[271]
Use in the disorders voice and throatS. officinale[40]
Appetising and digestive activitiesS. officinale, B. nigra, and B. juncea[40,41,256,257,258]
Snake bite antidoteB. rapa var. campestris, and S. officinale[40,41,258,270]
Skin disordersNeslia paniculata[35,263]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Rahman, M.; Khatun, A.; Liu, L.; Barkla, B.J. Brassicaceae Mustards: Phytochemical Constituents, Pharmacological Effects, and Mechanisms of Action against Human Disease. Int. J. Mol. Sci. 2024, 25, 9039. https://doi.org/10.3390/ijms25169039

AMA Style

Rahman M, Khatun A, Liu L, Barkla BJ. Brassicaceae Mustards: Phytochemical Constituents, Pharmacological Effects, and Mechanisms of Action against Human Disease. International Journal of Molecular Sciences. 2024; 25(16):9039. https://doi.org/10.3390/ijms25169039

Chicago/Turabian Style

Rahman, Mahmudur, Amina Khatun, Lei Liu, and Bronwyn J. Barkla. 2024. "Brassicaceae Mustards: Phytochemical Constituents, Pharmacological Effects, and Mechanisms of Action against Human Disease" International Journal of Molecular Sciences 25, no. 16: 9039. https://doi.org/10.3390/ijms25169039

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop